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Summary
The term early-onset periodontitis (EOP) represents a collection of diseases diagnosed 
in children, adolescents and young adults. These disorders are aetiologically and 
clinically heterogeneous. They have a low frequency in the general population but 
when they do occur can result in rapid destruction of periodontal support. Without 
treatment tooth loss often ensues.
The major aetiological agent of periodontitis is microbial plaque. However, other 
factors also predispose to disease. These include smoking, systemic diseases and 
stress. Most of the tissue destruction seen in periodontitis is thought to be the result of 
an inappropriate host response to the bacterial challenge. Certain aspects of the 
inflammatory and immune response, such as cytokine levels and antibody titres, have 
been shown to vary between individuals. Convincing evidence now exists for a 
genetic susceptibility to periodontal disease. This is particularly strong for EOP.
One method of investigating the genetic basis of a disease is through studies of large 
cohorts of unrelated individuals. The frequencies of polymorphisms of candidate 
genes whose protein products play a role in the disease process can be compared 
between cases and controls using recently developed molecular genetic techniques. A 
significant difference in the frequency of a specific polymorphism between a disease 
group and a control group is evidence that the candidate gene plays some role in 
determining susceptibility to disease. An association indicates that either the candidate 
gene directly affects disease susceptibility or is in linkage disequilibrium with the 
disease locus.
The research reported in this thesis has applied this method to the study of genetic 
polymorphisms in the HLA (Human Leucocyte Antigen) complex and the IL10 gene in 
generalised early-onset periodontitis (GEOP). The polymerase chain reaction (PCR) 
technique was employed in order to amplify an atypical restriction site in the 
HLADQB1 gene using sequence specific oligonucleotide primers. The resulting 
products were subjected to restriction fragment length polymorphism (RFLP) analysis. 
The fragments obtained were the undigested 1000 base pair (bp) product representative
XIX
of allele two and the digested 700 and 300 bp fragments representative of allele one. 
The fragments were separated using agarose gel electrophoresis. Subjects were either 
homozygous for allele two or heterozygous. No differences in frequency of the 
presence or absence of the atypical restriction site were found between patients or 
controls.
PCR was also used to investigate microsatellites in the tumour necrosis factor (TNF) 
gene and the IL10 promoter region. Variable number of tandem repeats were 
amplified and used to distinguish the different alleles. The resulting products were 
separated according to size using denaturing polyacrylamide gel electrophoresis. The 
results of these studies showed no significant associations between any of the 
candidate genes investigated and GEOP. However, trends were observed in the 
occurrence of alleles at the IL10G and TNFa microsatellites. A decrease in IL10G9 
and an increase in IL10G13 in patients compared with controls were noticed. When 
smoking was included as a co-variate for the patient group the trend seen at this locus 
was found to be due to the smokers. An increase in TNFa2 was also seen in GEOP, 
although there were no differences in frequency between smokers and non-smokers. 
In addition, a significant association was found between the TNFa2TNFd4 allelic 
combination and GEOP, which had previously been identified as a disease genotype in 
Crohn’s disease. These observations warrant further investigation. However, they 
also highlight the problems of investigating candidate genes in EOP. Since EOP is a 
genetically and environmentally heterogeneous group of diseases, finding convincing 
associations with specific polymorphisms in populations of unrelated individuals is 
extremely difficult, even if the case and control groups have been racially matched.
Segregation analyses of families with a high prevalence of EOP have proposed X- 
linked dominant, autosomal dominant and autosomal recessive modes of transmission. 
One of the major problems of genetic studies of EOP is the clinical classification of 
relatives. Since signs and symptoms of EOP may not be seen until adolescence or 
later, and because EOP can be confused with adult periodontitis (AP) after the age of 
35 years, definitive diagnosis is difficult. In addition, multiple tooth loss in patients 
within the age range may result from other reasons than periodontitis. Some
XX
individuals are irregular attenders and general dental practitioners often fail to keep 
accurate records.
Because of the difficulty of diagnosis of relatives of EOP probands outlined above, 
confusion exists between different research groups with regard to the clinical 
classification of EOP. This may affect the results of genetic model testing in families 
with an increased frequency of EOP. One of the studies presented in this thesis has 
attempted to define and validate an index which is suitable for the current and 
retrospective diagnosis of family members. The index was applied to a large family 
with fourteen affected individuals. Segregation analysis of this kindred supported the 
autosomal dominant theory of inheritance of GEOP. The ultimate aim of the clinical 
and genetic analysis of the large kindred presented here is to carry out a family linkage 
study. Therefore, in addition to the segregation analysis, an analysis of the power of 
the pedigree to detect linkage was performed. The phenocopy rate was also increased 
in order to take account of possible environmental aetiological factors. It was found 
that even with a phenocopy rate of 15% the pedigree would still be informative for 
linkage analysis.
The future identification of genetic markers of susceptibility to periodontal disease 
could have wide-ranging health and economic implications. Targeting preventive 
measures at individuals most likely to benefit from them, instead of employing a 
broad-based approach to the treatment of periodontitis would preserve valuable 
financial and healthcare resources. During the last five years a number of researchers 
have suggested that periodontal disease may predispose to atherosclerosis and 
coronary heart disease. If these initial findings are corroborated, the identification of 
risk markers for periodontal disease will become increasingly important in the 
prevention and treatment of cardiovascular disorders.
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Chapter 1 Introduction
1.1 General Introduction
Over the past thirty to forty years man’s understanding of the aetiology and 
pathogenesis of periodontal disease has advanced enormously. During the 1960s and 
1970s periodontitis was believed to be a purely infectious disease (Page and 
Schroeder, 1982). Both specific and non-specific microbial aetiologies were proposed 
(Loesche, 1979; Theilade, 1986). Chronic periodontitis was estimated to be 
universally prevalent and to affect almost all of the adult population by the age of 
thirty-five to forty years (Papapanou and Lindhe, 1997). More than 90% of the 
variation in disease severity was considered to be due to age and oral hygiene status.
Since the 1980s, it has become clear that the effectiveness of the host’s inflammatory 
and immune response to plaque bacteria also plays an important role in susceptibility 
to disease (Kinane and Lindhe, 1997). Some researchers believed that periodontal 
destruction was caused entirely by a defective immune system, since individuals with 
healthy periodontiums also harboured suspected periodontal pathogens. At the same 
time epidemiological surveys from around the world, contrary to earlier reports, began 
to show that a minority of the population (albeit a substantial one) were affected by 
severe disease (Hugoson and Jordan, 1982; Loe et al., 1986; Baelum, Fejerskov and 
Manji, 1988; Jenkins and Kinane, 1989; Burt, 1991; Brown and Loe, 1993). This level 
of disease could lead to tooth loss and compromise aesthetics, comfort and function. 
However even within susceptible individuals the extent of periodontal destruction was 
not uniform throughout the dentition and was also site-specific (Baelum, Fejerskov 
and Manji, 1988). The majority of individuals appeared not to be susceptible to severe 
disease. In addition some subjects were resistant to periodontal disease despite the 
presence of large plaque deposits over many years (Loe et al., 1986; Baelum, 
Fejerskov and Manji, 1988).
Included within the susceptible group were individuals with the early-onset forms of 
periodontitis, which are the subject of this thesis. Towards the end of the 1980s the
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idea of a possible underlying genetic predisposition for EOP re-emerged. Family 
histories of EOP had been recorded as early as the 1920s, but the concept of a 
hereditary component to the disease fell into disrepute during the 1950s (Hassell and 
Harris, 1995).
In the 1990s more evidence to support a genetic basis for periodontal disease has been 
reported in the literature (Michalowicz et al., 1991a; Michalowicz, 1994; Marazita et 
aL, 1994; Hart and Komman, 1997). However, the importance of other factors in the 
aetiology of the disease such as smoking and the presence of specific bacteria has also 
been highlighted (Grossi et al., 1994; Barbour et al., 1997). In addition the 
contribution of the subgingival microbiota to the aetiology of periodontitis has been 
investigated more fully (Socransky and Haffajee, 1997). Products produced by highly 
toxic strains of periodontal bacteria may cause tissue damage directly.
As we move towards the next millennium, the consensus is that the periodontal 
diseases are a complex heterogeneous group of related diseases with a multifactorial 
aetiology. Bacteria are essential to cause disease but may only do so in a susceptible 
host. In addition many other factors including lifestyle variables such as smoking, oral 
hygiene, diet and stress and also systemic disease and race may affect the clinical 
manifestation of periodontitis (Kinane and Davies, 1990; Genco, 1996; Offenbacher, 
1996; Moss et al., 1996; Barbour et al., 1997; Schenkein, 1998). It has been suggested 
that these disease modifiers can interact with different aspects of the host response and 
the microbial challenge. The nature of the immune response may vary between 
patients but manifest the same clinical symptoms. It is possible that the quality of an 
individual’s antibody response may influence the outcome of treatment (Mooney et al., 
1995). Various characteristics of the host response, which play a part in tissue 
homeostasis in the periodontium, are under genetic control.
This chapter reviews the current literature of relevance to the studies presented in this 
thesis. Although the subsequent chapters are concerned with genetic analysis of EOP, 
background knowledge of the aetiology and pathogenesis of periodontitis are included 
to place this work in context.
2
1.2 The Aetiology and Pathogenesis of Periodontitis
1.2.1 Introduction
The following review is not intended to be a comprehensive analysis of the literature. 
It is instead a general overview with an emphasis on particular areas relevant to the 
research reported in this thesis. Topics of special interest, discussed in separate 
sections, include the role of cytokines in the inflammatory and immune response and 
the major histocompatibility complex.
In order to understand the processes involved in the aetiology and pathogenesis of 
periodontitis, it is important to have some knowledge of the anatomy of the 
periodontium. The periodontium consists of the gingivae, the cementum, the 
periodontal ligament and the alveolar bone. The gingivae are made up of the 
keratinised oral epithelium, the oral sulcular epithelium and the thin junctional 
epithelium (JE) which is about fifteen cell layers thick. The gingivae have a core of 
connective tissue with a vascular network subjacent to the epithelium. The JE is 
highly permeable to the passage of cells and proteins of the immune system into the 
gingival crevice. The exudate produced in the gingival crevice, constitutes serum and 
plasma proteins that have passed from the gingival capillaries through the tissues and, 
is known as gingival crevicular fluid (GCF) (Egelberg, 1967; Cimasoni, 1983). 
Normal healthy gingiva should be pale pink in colour and have a firm texture. In some 
individuals it has a stippled appearance. The margin should have a scalloped outline 
and be well adapted to the tooth surface. The gingivae should not bleed on gentle 
probing into the gingival sulcus. The coronal margin should terminate in a knife-edge 
between the tooth and soft tissue.
Histologically normal clinically healthy gingiva shows evidence of a mild 
inflammatory infiltrate consisting of small numbers of leucocytes, predominantly 
polymorphonuclear leucocytes (PMN), migrating towards the gingival sulcus (Page 
and Schroeder, 1976). In addition monocytes, macrophages and lymphocytes, can be 
seen in the underlying connective tissue. This situation exists where the gingival 
margins have been kept relatively plaque free and is the realistic scenario. An 
alternative super healthy situation has been described where the gingival sulcus may be
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absent. The JE is attached to the tooth surface by hemidesmosomes and supported by 
dense collagen bundles in the underlying connective tissue. This can be accomplished 
by chemical plaque control or by professional supragingival hygiene therapy. Kinane 
and Lindhe (1997) defined this situation as ‘pristine gingiva’. Even in the pristine 
state, very small numbers of leucocytes (neutrophils and macrophages) can be seen in 
the JE. A few isolated lymphocytes and plasma cells may be associated with the sub- 
epithelial vascular network and in the deeper connective tissues (Attstrom, Graf-de- 
Beer and Schroeder, 1975; Payne et al., 1975). These cells do not constitute an 
infiltrate; microscopically and clinically no manifestations of tissue damage are 
evident (Page and Schroeder, 1976). In contrast normal healthy gingiva does show 
signs of up to 5% loss of connective tissue volume (Kinane and Lindhe, 1997).
1.2.2 Microbial Aetiology
Evidence for a microbial aetiology to gingivitis comes from reports of healthy gingival 
microflora and from naturally occurring and experimental gingivitis (Loe, Theilade 
and Jensen, 1965; Slots, 1977; Savitt and Socransky, 1984; van der Weijden et al., 
1994). Studies of experimental gingivitis demonstrated changes in the composition 
and structure of plaque preceding the developing gingival inflammation. A shift in the 
microflora from one dominated by Gram positive cocci and rods to one showing 
marked evidence of Gram negative anaerobic rods and spirochaetes was documented 
(Loe, Theilade and Jensen, 1965; Theilade et al., 1966). In the active phase of 
periodontitis the proportion of Gram negative rods increases to about two thirds of the 
subgingival plaque. Porphyromonas gingivalis (Pg), Bacteroides forsythus (Bf) and 
Actinobacillus actinomycetemcomitans (Aa) have been strongly associated with the 
various forms of destructive periodontitis (Socransky and Haffajee, 1997). Particular 
clonal types of these bacteria have the ability to initiate destruction of the connective 
tissue matrix. For example Pg produces potent enzymes such as collagenase. 
However most of the proteases present in periodontal lesions are of host origin. The 
bacterial toxins stimulate the host cells, which bring about the observed destruction 
(Page et al., 1997).
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It was assumed in the past that gingivitis progressed with time to periodontitis 
(Russell, 1956). Evidence from animal studies indicated that periodontitis was always 
preceded by gingivitis (Saxe et al., 1967; Lindhe, Hamp and Loe, 1973) and did not 
occur when microbial plaque was removed on a daily basis (Lindhe, Hamp and Loe, 
1975). However gingivitis may persist without ever progressing to periodontitis 
(Lindhe, Hamp and Loe, 1975; Page and Schroeder, 1982). Furthermore recent 
evidence indicates that individuals susceptible to periodontitis may have a very short 
or indistinguishable gingivitis stage, before progressing to periodontitis (Page et al., 
1997). It appears that gingivitis and periodontitis may in fact be different clinical 
presentations of the same pathological process.
1.2.3 Pathogenesis
1.2.3.1 Introduction
The clinical signs of gingivitis are usually manifested within ten to twenty days of 
plaque accumulation (Kinane and Lindhe, 1997). The gingival tissues become red and 
swollen. The gingival sulcus may have an increased tendency to bleed on gentle 
probing. The normal gingival contour changes and the surface of the gingivae may 
become smooth with the loss of stippling. As a result of the swelling, a gingival 
pocket forms where subgingival plaque may accumulate and aggravate the situation 
still further. Hormonal changes such as those that occur at puberty, during pregnancy 
and when taking the contraceptive pill, can exacerbate inflammation and swelling and 
cause marked gingival hyperplasia. Certain drugs (phenytoin, cyclosporin and the 
calcium channel blockers) may also produce similar effects (Seymour, Thomason and 
Ellis, 1996).
Page and Shroeder (1976) divided the histopathological stages of the development of 
gingivitis and periodontitis into the initial, early, established and advanced lesions. 
This designation will be used as a framework for the following discussion. It is 
important to be aware however, that based on recent evidence, the early lesion, with an 
infiltrate dominated by lymphocytes, does not exist in adults as a distinct entity. It
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does occur in children around erupting teeth and in chronic gingivitis in adolescents 
(Page et al., 1997).
1.2.3.2 The initial lesion
The initial lesion emerges within two to four days of plaque accumulation. 
Vasodilation and hyperpermeability of the gingival capillaries occurs, with a 
concomitant acute exudative inflammatory response. It has been shown that 
endothelial cells, resident connective tissue cells and JE cells, upregulate the 
expression of adhesion molecules under the influence of proinflammatory cytokines 
(Kinane et al., 1991; Moughal et al., 1992; Takahashi et al., 1994; Gemmell et al., 
1994; Gemmell, Sved and Seymour, 1995). Intercellular adhesion molecule-1 (ICAM- 
1) and endothelial leucocyte adhesion molecule-1 (ELAM-1) encourage the 
aggregation of leucocytes in the tissues and the passage of PMN through the tissues 
and into the gingival sulcus (Kinane et al., 1991; Moughal et al., 1992). Watanabe and 
co-workers (1991) demonstrated increased expression of ICAM-1 receptor on 
crevicular fluid PMN from healthy gingiva compared with peripheral blood PMN, 
giving further credence to the role of adhesion molecules in the inflammatory 
response.
The initial lesion is localised in the junctional epithelium and the most coronal region 
of the gingival connective tissue. It occupies no more than 5 to 10% of the connective 
tissue. It is possible that the initial lesion is indistinguishable from the normal 
situation or in fact from the early lesion. Clinically healthy gingivae may manifest a 
pre-established chronic lymphoid infiltrate, as seen in the early lesion, which on the 
initiation of gingival inflammation responds with an exacerbation of an acute exudate 
superimposed on the lymphoid infiltrate (Page and Schroeder, 1976).
1.2.3.3 The early lesion
The early lesion appears within four to seven days of plaque accumulation (Payne et 
al., 1975). The number of vessels in the sub-epithelial plexus increases due to the 
opening up of previously inactive capillary beds (Egelberg, 1967). The early lesion is 
characterised by a dense lymphoid infiltrate that makes up 75% percent of the total
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infiltrate population. There are numerous immunoblasts within the area and plasma 
cells if present are few in number and found at the periphery of the lesion (Listgarten 
and Ellegaard, 1973; Payne et al., 1975; Seymour et al., 1983; Seymour, Powell and 
Aitken, 1983; Brecx et al., 1987). The infiltrated area may occupy up to 15% of the 
connective tissue. Fibroblasts within the lesion degenerate, probably by apoptosis, and 
up to 60 to 70% collagen destruction occurs in order to make space for the infiltrating 
leucocytes (Page and Schroeder, 1976; Kinane and Lindhe, 1997). Inflammatory 
changes are detected clinically by this stage (Loe, Theilade and Jensen, 1965). The 
acute, exudative, inflammatory response persists in the early lesion, and reaches a 
peak, and levels off between six and twelve days after the onset of clinical gingivitis 
(Lindhe, Hamp and Loe, 1973). The junctional and sulcular epithelium proliferates 
and produces rete ridges, which project into the underlying connective tissue 
(Schroeder, Miinzel-Pedrazzoli and Page, 1973).
1.2.3.4 The established lesion
Page and Schroeder (1976) defined the established lesion as one dominated by plasma 
cells within the infiltrated connective tissue, without evidence of extensive alveolar 
bone loss (BL). Plasma cells are mainly situated in the coronal connective tissue but 
are also found clustered around blood vessels. A few cells are found in the deeper 
connective tissue. Other features of the established lesion include the persistence of 
the inflammatory exudate; the presence of immunoglobulins in the connective tissue 
and JE; the continued loss of collagen in the area of infiltration and fibrosis and 
scarring at sites removed from the region of destruction; and the progressive 
proliferation, apical migration and lateral extension of the JE, in an attempt to preserve 
epithelial integrity (Page and Schroeder, 1976). The coronal part of the JE may evolve 
into pocket epithelium and as a result become separated from the tooth surface, thus 
deepening the gingival crevice. If pocket epithelium is present vascular loops can be 
found, separated from the surface by only one or two epithelial cells, which may in 
some areas be ulcerated. The pocket epithelium allows easy access for microbial 
products to the underlying connective tissue and hastens the progression towards 
periodontitis.
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Early investigators believed that the established lesion with a predominant plasma cell 
infiltrate was evident within two to three weeks of plaque accumulation (Page and 
Schroeder, 1976). More recently Page and Shroeder (1982) suggested that in severe 
gingivitis lymphocytes still predominated over plasma cells and the T:B cell ratio was 
almost equal to one. Subsequently an experimental gingivitis study found that there 
was no increase in B cell numbers over the 21 days of the study (Seymour et al., 
1988). In another longitudinal study in adults, Brecx et al. (1988) demonstrated that 
even after six months of neglected oral hygiene the predominant cell types were 
granulocytes and lymphocytes. The number of plasma cells increased over the time 
period to 10% of total cell volume. This could reflect individual susceptibility since 
some adults seem to be resistant to established gingivitis (van der Weijden et al., 
1994).
1.2.3.5 The advanced lesion
Clinical signs of the advanced lesion include periodontal pocket formation, 
suppuration, fibrosis of the gingivae, attachment loss (AL), tooth mobility and 
migration, and eventual tooth exfoliation (Page and Schroeder, 1976).
The advanced lesion manifests all the features of the established lesion but also 
includes destruction of the connective tissue attachment to the tooth, apical migration 
of the JE, and BL (Schroeder and Lindhe, 1975; Page and Schroeder, 1976; Lindhe, 
Liljenberg and Listgarten, 1980; Okada, Kida and Yamagami, 1983; Zappa et al., 
1992). The lesion is no longer localised and may extend apically and laterally to form 
a wide band of infiltrated connective tissue, around the necks and roots of the teeth. 
Despite the destruction of the collagen fibre bundles of the marginal gingiva, the 
transseptal fibre bundles appear to be constantly regenerated as the lesion progresses 
apically. This has the effect of separating the progressing alveolar bone destruction 
from the lesion in the coronal gingiva. Whereas the infiltrated connective tissue is 
virtually free of collagen fibres, dense fibrotic tissue is present at more distant sites and 
in association with areas of bone resorption.
1.2.4 Susceptibility to Periodontitis
There are many similarities histopathologically between the established and advanced 
lesions. A number of investigators have therefore looked for subtle differences in cell 
number or type, which might indicate why progression to destructive periodontitis 
occurs. The general consensus is that a change from a T cell dominated to a B cell and 
plasma cell dominated lesion, precedes the development of destructive periodontitis 
(Mackler et al., 1977; Seymour, Powell and Davies, 1979; Seymour and Greenspan, 
1979; Page and Schroeder, 1982; Reinhardt et al., 1988a).
Zappa and co-workers found that there was a significantly increased number and 
percentage of overall inflammatory cells, macrophages, plasma cells, mast cells and 
lymphocytes, in periodontal sites which had recently undergone rapid destruction. 
Active sites were compared with matched non-progressing control sites. A significant 
decrease in the number and percentage of fibroblasts was also observed (Zappa et al., 
1990; 1991). More recently other groups have confirmed the above findings 
(Gemmell et al., 1994; Liljenberg et al., 1994; Yamazaki, Nakajima and Hara, 1995). 
Liljenberg et al. (1994) found the density of plasma cells was increased from 31% in 
inactive sites to 51.3% in active sites. In addition the proportion of macrophages 
increased from 0.3% to 2.1%. Gemmell et al. (1994) recorded a decrease in the mean 
(± standard error) of the T:B cell ratio in gingival biopsies taken from 
healthy/gingivitis and moderate/severe periodontitis patients with increasing size of 
infiltrate. The ratio decreased from 4.63 (± 1.25), in areas adjacent to the sulcular and 
junctional epithelium (small infiltrates), to 0.76 (± 0.16) in infiltrates extending 
throughout the whole of the gingiva. The latter situation was only found in patients 
with moderate or severe periodontitis. It seems possible that the established lesion 
with extensive plasma cell infiltration may in fact be early periodontitis (Kinane and 
Lindhe, 1997). Support for this theory, as previously mentioned, comes from the 
study of long-term gingivitis in man. In this report a lesion dominated by plasma cells 
did not occur even after six months of plaque accumulation (Brecx et al., 1988).
It has been suggested that in resistant patients neutrophils and antibodies are able to 
contain the destructive lesion (Page et al., 1997). Susceptibility to periodontitis may
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depend on the ability of Gram negative bacteria to circumvent neutrophil clearance. It 
has been shown that Pg lipopolysaccharide (LPS) does not activate the expression of 
adhesion molecules and chemoattractants by endothelial cells, fibroblasts and 
epithelial cells. It also blocks E-selectin expression by other bacteria and their LPS. 
This would allow the passage of LPS into the tissues, which would trigger the release 
of cytokines and proteases from resident tissue cells, macrophages and T cells. The T 
cell response controls the inflammatory response and humoral immunity. Antibodies 
enhance the effectiveness of neutrophils, which reduces the microbial challenge and 
the levels of LPS (Page et al., 1997). A dense plasma cell infiltrate could signify an 
inability to raise a successful immune response against periodontal pathogens (Kinane 
and Lindhe, 1997). The antibodies produced may be either ineffective at eliminating 
the bacteria or result in the formation of immune complexes which result in local 
tissue damage, including triggering fibroblast apoptosis. In a recent study, a higher 
proportion of T cells was demonstrated in EOP and gingivitis sections than in AP 
lesions, but the reverse was the case for B cells (Lappin et al., 1999). The authors 
suggested that EOP lesions might be at an earlier stage in the disease process; 
alternatively different immunopathological backgrounds may exist for AP and EOP.
It has been proposed that decreased numbers of fibroblasts may be the best way of 
differentiating between progressing and non-progressing sites (Zappa et al., 1992). 
Schor and co-workers (1996) have also recently shown that healthy gingival 
fibroblasts resemble foetal fibroblasts, with regard to cell migration and hyaluronic 
acid (HA) synthesis. These two effects are modulated by migration stimulation factor 
(MSF), which is produced by foetal fibroblasts but not by the adult phenotype. It 
appears that MSF stimulates HA synthesis, and the accumulation of HA in the 
collagen matrix results in activation of cell migration. It has been suggested that 
alteration in the phenotype of fibroblast subpopulations in the gingivae to an “adult­
like cell”, may have an influence on progression of periodontal disease (Schor et al., 
1996; Page et al., 1997). One possible mechanism might be through influencing apical 
downgrowth of JE (Mackenzie et al., 1991). It has also been demonstrated that under 
disease conditions fibroblasts switch from producing collagens and tissue inhibitors of 
matrix metalloproteinases (MMP) to synthesising and releasing MMP (Zappa et al.,
1992). They may also produce their own inflammatory mediators such as interleukin
10
(IL)-ip(Page et al., 1997). Takiguchi et al. (1997) have shown that increased 
production of IL-ip by “old” fibroblasts, compared with “young cells”, occurred in the 
presence of LPS from Campylobacter rectus (Cr). The higher levels of IL-lp also 
correlated with increased prostaglandin E2 (PGE2) release from “old” fibroblasts. 
Furthermore Wassenaar et al. (1997) have shown gingival fibroblasts able to influence 
infiltrating T cells in periodontal lesions of AP patients. Interferon gamma (IFNy)- 
treated fibroblasts act as antigen-presenting cells for superantigen mediated T cell 
proliferation. However fibroblasts were not able to present whole-cell antigens of 
periodontal pathogens and inhibited presentation of these antigens by professional 
APC. Addition of IL-2 overcame this inhibitory effect.
1.2.5 Host Responses
1.2.5.1 Defensive
Several periodontal pathogens have been associated with potent virulence factors, 
which may even cause death when injected parenterally into experimental animals 
(Neiders et al., 1989). In addition, it has been suggested that the selective gain of 
certain virulence factors may be increased or diminished by local interaction with other 
bacteria in the periodontal pocket (Socransky and Haffajee, 1992). As a result of these 
findings, the importance of the host response in localising the infection to the 
periodontal tissues has been highlighted (Genco, 1992). Although toxins and proteases 
produced by plaque bacteria can pass from the crevice into the gingival connective 
tissue, the following defence mechanisms serve to protect the intact gingival sulcus 
(Page, 1990):
1. The integrity of the epithelium and epithelial attachment, in which keratinocytes 
may play a major role (Nunes et al., 1994).
2. The flushing action of GCF and the antimicrobial effects of opsonins, antibodies, 
complement and other plasma components found within it.
3. Local antibody production.
4. The constant turnover of sulcular epithelial cells.
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5. The ever present low level inflammatory exudate containing PMN and other 
leucocytes.
The early events, which lead to an inflammatory and/or immune response, are not fully 
understood (Tonetti, 1993). Mounting an effective response depends upon 
transmission of inflammatory stimuli to the endothelial cells of the sub-epithelial 
gingival plexus. This is thought to occur by the passage of bacterial antigens into the 
intact epithelium. Alternatively stimulation of intraepithelial cells, such as 
keratinocytes, Langerhans or dendritic cells, and specific subsets of T cells, by direct 
contact with bacteria or their products is another possible hypothesis (Nunes et al.,
1994). Keratinocytes may respond to bacterial stimuli by producing cytokines, 
adhesion molecules and chemotactic factors. However HLA-DR+ keratinocytes have 
also been found to elicit a state of anergy and tolerance of T cells when exposed to 
bacterial antigens (Walsh, Seymour and Powell, 1986). The function of the other cell 
types is at present uncertain, but they increase at sites of inflammation and may be 
involved in limiting penetration of antigens and in antigen presentation (Page et al., 
1997).
Endothelial cells in turn, once activated, also upregulate the expression of adhesion 
molecules as has already been mentioned earlier (Kinane et al., 1991; Moughal et al., 
1992; Gemmell et al., 1994). PMN, monocytes and lymphocytes, constantly migrate 
from the capillaries towards the gingival sulcus. They are under the influence of 
chemoattractants of host origin, such as IL-8, monocyte chemoattractant protein 1 
(MCP-1), complement 5a and leukotriene B4, and microbial toxins (Bickel, 1993; 
Tonetti, 1993; Tonetti et al., 1994). Adhesion molecules found in the junctional 
epithelium also aid the passage of PMN towards the gingival crevice. Tonetti and co­
workers (1998) recently provided evidence of a transepithelial gradient of IL-8 and 
ICAM-1 guiding PMN towards the junctional epithelial surface and the area nearest to 
bacterial antigens. Initially passage of PMN occurs through the junctional epithelium 
and the pocket epithelium. As the size of the infiltrate increases the junctional, 
sulcular and oral epithelium may all express ICAM-1 (Gemmell et al., 1994). Pocket 
epithelium can also be activated to produce PGE2 and MMP, which aid the initiation
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and progression of the inflammatory response in the adjacent connective tissue (Page 
et al., 1997).
Lymphocytes are thought to be retained in the tissues by cell-cell and cell-matrix 
adhesion molecules (Hayashi et al., 1994; Takahashi et al., 1994; Gemmell et al., 
1994; Gemmell, Sved and Seymour, 1995). An increase in the percentage of ICAM-1, 
platelet endothelial cell adhesion molecule-1 (PECAM-1) and lectin adhesion 
molecule-1 (LECAM-1) positive infiltrating cells, with increasing size of 
inflammatory infiltrate, has been demonstrated (Gemmell et al., 1994). However with 
worsening inflammation expression of ICAM-1 by junctional epithelium keratinocytes 
adjacent to the infiltrate was not evident. Loss of the chemoattractant gradient may 
lead to retention of phagocytes within the tissues, where they are activated and release 
MMP. In addition, loss of the chemoattractant gradient leads to direct exposure of the 
tissues to LPS and other bacterial toxins (Page et al., 1997).
Another interesting finding in the study of Gemmell et al. (1994) was the low number 
of endothelial cells expressing ELAM-1, in contrast to results of studies of chronic 
dermatoses. It has been found that ELAM-1 mediates adhesion of a sub-population of 
memory T cells found in high numbers in chronic dermatoses and low numbers in 
extra-cutaneous areas of chronic inflammation (Picker et al., 1991). It is possible that 
ELAM-1 is upregulated in early gingival lesions to encourage the migration of PMN 
into the area. In periodontitis lesions dominated by lymphocytes, ELAM-1 expression 
disappears. This suggests that T cell clones vary between different sites of chronic 
inflammation. It has been found that heterogeneity and selective localisation of T cell 
clones exists, between human skin, gingival mucosa and peripheral blood, in healthy 
subjects (Kinane et al., 1993).
1.2.5.2 T cells
T cells are present at all stages of the development of the chronic periodontal lesion 
(Page and Schroeder, 1982; Okada, Kida and Yamagami, 1983; Reinhardt et al., 
1988b). T cell responses to oral pathogens may depend upon presentation of antigens 
by macrophages and Langerhans cells, in the context of HLA class II antigens (Nunes 
et al., 1994). It appears likely that antigen presenting cells (APC) transport antigens to
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the local lymph nodes, where presentation to naive T cells takes place, and 
proliferation of primed memory cells follows. The memory cells then circulate from 
the lymph nodes to the gingivae under the influence of bacterial chemoattractant 
products in the tissues and specific endothelial determinants (Wynne, Walsh and 
Seymour, 1988; Taubman et al., 1994). This process has been described as homing. 
Support for this theory comes from studies of T cell subsets expressing specific Vp 
receptors (Mathur et al., 1995; Yamazaki et al., 1996; 1998; Nakajima, Yamazaki and 
Hara, 1996; Gemmell et al., 1997; Berglundh et al., 1998). In addition a lack of 
proliferating cells in periodontitis lesions has been demonstrated (Takahashi, Lappin 
and Kinane, 1996; Koulouri et al., 1999).
Nearly all B cell responses are considered to be T cell dependent. A significant 
positive correlation between IL-4 producing cells and the B:T cell ratio in periodontitis 
sections has been demonstrated (Yamazaki, Nakajima and Hara, 1995). However, 
proliferation to B cell mitogens has not always correlated with absolute T cell counts 
or the relative proportions of specific subsets (Engel et al., 1984). It seems likely that 
regulation of B cell responses may be influenced more by the cytokine profile of T 
cells than by the numbers or proportions of T cell subsets (Mathur and Michalowicz, 
1997).
Different cell types may be differentiated histologically by cell-surface molecules, 
which are identified by a specific group of monoclonal antibodies. These molecules 
are known as cluster of differentiation antigens and designated CD. Changes in the 
relative number of T-helper (CD4):T-suppressor (CD8) cells are considered to be a 
sign of altered immune regulation. Studies of CD4:CD8 ratios in the peripheral blood 
and gingival tissues of EOP or AP patients have yielded conflicting results, probably 
due to wide individual variability (Takahashi et al., 1995; Mathur and Michalowicz, 
1997). In addition it has been found that human T cell lines reacting to different 
periodontal pathogens give rise to different proportions of CD4 and CD8 cells, 
depending on the bacteria used to establish the cell line (Ishii, Mahanonda and 
Seymour, 1992). Therefore, the equivocal findings in studies of the proportions of 
CD4 and CD8 cells in periodontal tissues may not only be due to different levels of 
disease activity and variation between subjects. Antigens that activate specific T cell
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subsets may be bacterial-species specific (Yamazaki et al., 1998). An 
immunosuppressive factor secreted by Aa has been identified which induces a specific 
population of activated dual-positive CD4+CD8+ cells (Shenker, Vitale and King,
1995). These cells do not express natural killer cell (NK) markers and may be 
responsible for inhibiting T- and B cell activation in vitro.
Although it appears that the number of CD4 and CD8 cells increases in periodontal 
lesions when compared with peripheral blood and healthy sites, the ratio of CD4:CD8 
cells seems to be depressed (Cole, Seymour and Powell, 1987; Stoufi et al., 1987; 
Seymour et al., 1997). This is partly due to a relative reduction in CD4 cells compared 
with CD8 cells, but also because of a small rise in the number of CD8 cells (Stoufi et 
al., 1987). CD8 cells have been found to down-regulate antibody production in an 
antigen specific manner (Taubman et al., 1991). However, more recently Wassenaar 
et al. (1996) suggested that CD8 cells might contribute to the local response by 
suppressing cell-mediated immunity and stimulating humoral immunity. It has been 
found that the CD4:CD8 ratio varies within the lesion and with the volume of the 
inflammatory infiltrate (Gemmell and Seymour, 1995). One study also found that 
reduced local CD4:CD8 ratios correlated well with deeper probing pocket depths in the 
same disease category (Stoufi et al., 1987). Taken together the results of the above 
studies indicate that any defect in immune response is restricted locally to the affected 
periodontal tissues and may not be revealed in the peripheral blood.
Naive and memory T cells may be recognised by the markers they express. CD45RA 
identifies naive (or resting memory) T cells and CD45RO activated memory T cells. 
Activated memory T cells respond to antigen by triggering intense CD8 cell 
proliferation, which suppresses antigen specific B cell responses. Naive T cells tend to 
respond by suppressing polyclonal antibody production (Taubman et al., 1991). The 
number of activated memory T-helper cells (CD4+ CD45RO+) in the peripheral blood 
of patients with AP are significantly elevated above the levels found in periodontally 
healthy individuals. In diseased tissues most of the CD4 cells are CD45RO+ 
(Gemmell, Feldner and Seymour, 1992; Yamazaki et al., 1993; Kinane et al., 1998; 
Lappin et al., 1999). However it has also been shown that a proportion of these cells 
are also CD45RA+, which suggests reactivation of the memory cell population by
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specific, but as yet unknown antigens, in the tissues (Gemmell and Seymour, 1994; 
Seymour et al., 1997). It appears therefore, that activated cells in these tissues are 
memory cells, which have been re-stimulated, rather than activated, naive cells 
(Taubman et al., 1994). Once cells are activated they acquire certain specific surface 
molecules, which act as ligands for adhesion molecules expressed by resident tissue 
cells. Memory cells respond to a particular antigen, and therefore retention of antigen- 
specific memory cells in the tissues ensures a rapid response to a secondary infection 
by the same antigen (Mathur and Michalowicz, 1997).
When memory T- and B cells are re-stimulated with antigen they express a number of 
surface markers. On T cells these include HLA-DR (a class II HLA molecule), CD25 
(IL-2 receptor), CD29 (possibly involved in cell-cell adhesion of antigen specific T- 
and B cells) and CD38 (nicotinamide adenine dinucleotide glycohydrolase -  augments 
B cell proliferation). Lipopolysaccharide and other antigens of periodontal pathogens 
induce IL-2 receptor expression on peripheral blood mononuclear cells (PBMC) in 
vitro. Monocytes regulate this expression, since IL-1 antibody and depletion of 
adherent monocytes inhibits IL-2 receptor expression (Lindemann, Kjeldsen and 
Cabret, 1995). It has been found that periodontitis patients have higher proportions of 
activated T cells locally, in diseased tissues, than in their peripheral blood (Okada, 
Kassai and Kida, 1984). The proportion of activated CD4 cells increases with disease 
severity and in sites showing recent AL. The number of T-helper cells increases only 
slightly, when the gingival lesion progresses from one showing mild inflammation to 
one exhibiting severe inflammation, but the number of activated cells quadruples 
(Reinhardt et al., 1988b; Malberg et al., 1992). The proportion of T-suppressor cells 
to activated T-suppressor cells has been demonstrated to remain relatively constant 
(Malberg et al., 1992). However Reinhardt et al. (1988b) found a three-fold increase 
in the percentage of activated T-suppressor cells between healthy and active sites. The 
expression of IL-2 and HLA-DR has been found to be highest on T-helper cells and B 
cells isolated from crevicular fluid, intermediate on gingival tissue cells and lowest on 
peripheral blood lymphocytes (Takeuchi, Yoshie and Hara, 1991). These studies 
indicate that cells are activated locally.
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1.2.5.3 T-helper cell subsets
Cytokines released by CD4 cells have been shown to determine the type of immune 
response, which occurs (Mosmann and Coffman, 1989). Activated CD4 cells in 
periodontal lesions have been shown to be capable of releasing various cytokines. The 
highest number of cytokine-producing cells has been found in the gingiva adjacent to 
the crevice where stimulation by antigens of plaque bacteria is most evident 
(Yamazaki, Nakajima and Hara, 1995). CD4 cells have been classified in the mouse 
according to their cytokine profiles into T-helper(Th)-l and Th-2 subsets (Mosmann et 
al., 1986; Romagnani, 1991). Th-1 and Th-2 cytokines may play an important role in 
determining the outcome of infection (Yamamura et al., 1992; Mosmann and Sad,
1996). Th-1 cells secrete IL-2, IFNy and tumour necrosis factor beta (TNFP); Th-2 
cells secrete IL-4, IL-5 IL-6, IL-10 and IL-13. Both subsets produce IL-3, tumour 
necrosis factor alpha (TNFa) and granulocyte-macrophage colony-stimulating factor 
(GM-CSF) (Mosmann and Coffman, 1989; Kelso, 1995). In humans, Th-1 and Th-2 
cells are not as clearly defined by their cytokine profiles and IL-2, IL-6, IL-10 and IL- 
13, are not restricted to a specific subset. Th-0 cells have also been identified which 
secrete IL-4 and IFNy; they may possibly represent a precursor T-helper cell type 
(Modlin and Nutman, 1993). In addition, cells producing large amounts of the anti­
inflammatory cytokine transforming growth factor-P have been named Th-3 
(Mosmann and Sad, 1996). However, Kelso (1995) disagrees with the theory of 
distinct Th subsets and suggests that cytokine-producing cells cannot be separated into 
distinct phenotypes.
Mixed cytokine patterns of human CD4 cells have been demonstrated in some studies 
(Kelso, 1995; Mosmann and Sad, 1996). It appears likely, that the appropriate Th-1 or 
Th-2 response is determined by a complex interaction between multiple factors. 
Specific pathogens and varying levels of antigen dose may illicit different responses 
(Mosmann and Sad, 1996). In addition, it has been shown that APC may determine 
the type of T cell subset which is induced (Gemmell, Marshall and Seymour, 1997). 
The CD4 cell subsets Th-1, Th-2 and Th-0 have all been identified in gingival and 
periodontal lesions. More than one subset has been identified simultaneously 
(Wassenaar et al., 1995; Gemmell and Seymour, 1998). Th-1 cytokines, IL-2 and
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IFNy enhance cell-mediated immunity while IL-4, produced by Th-2 cells, suppresses 
cell-mediated immunity and stimulates humoral immunity and B cell development 
(Mosmann and Coffman, 1989). Th-1 cells can provide some B cell help, but at higher 
T:B cell ratios this is suppressed (Romagnani, 1991).
The Th-1 cytokines IFNy and IL-2 have been shown to be produced spontaneously by 
gingival mononuclear cells (GMC) extracted from diseased tissues (Seymour et al.,
1985). Pg can further stimulate IL-2 release from GMC of patients with EOP 
(Manhart et al., 1994). Another study found cytokine production characteristic of a 
prominent Th-1 and a reduced Th-2 response in diseased GMC following culture and 
stimulation (Ebersole and Taubman, 1994). However, it has been demonstrated that 
peripheral blood mononuclear cell cultures stimulated with Pg or Fusobacterium 
nucleatum (Fn) show reduced IL-2 activity compared with unstimulated cell cultures 
(Gemmell and Seymour, 1994). In addition IFNy could not be detected in cultures 
containing both bacteria. In GMC cultures, IFNy was only detected at very low levels 
in 10 of 27 supernatants. Another study found no skewing of cytokines towards either 
a Th-1 or Th-2 profile in unstimulated GMC (Prabhu, Michalowicz and Mathur, 1996).
Cytokine production representative of Th-2 cells has been identified from memory T 
cells and GMC stimulated with periodontal bacteria from periodontal lesions (Manhart 
et al., 1994; Yamazaki, Nakajima and Hara, 1995). Reports of Pg T cell lines 
demonstrated cytokine profiles representative of Th-1, Th-2 and Th-0 in both 
gingivitis and periodontitis lesions (Gemmell, Marshall and Seymour, 1997). 
Considering the high numbers of B cells and plasma cells in the advanced periodontal 
lesion, it is possible that Th-2 cells play a major role in the pathogenesis of chronic 
periodontitis (Mathur and Michalowicz, 1997). This theory is supported by two recent 
studies showing a predominant Th-2 response in periodontitis lesions (Tokoro et al., 
1997; Iwasaki et al., 1998). In another report CD4 T cell clones active against type I 
collagen were isolated from a series of periodontitis tissue samples. Cytokines 
representative of Th-2 cells were expressed by eighty percent of these clones. In 
contrast T cell clones reactive to Pg, Aa and Prevotella intermedia (Pi) showed Th-0 
type cytokine profiles. They produced IFNy and IL-4. These results suggest that Th-2 
CD4 cells may contribute to the periodontitis lesion in an autoimmune manner, but are
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under the control of Th-0 clones which are stimulated by antigens of periodontal 
pathogens (Wassenaar et al., 1995).
Gemmell and Seymour (1998) used an intracellular technique to determine cytokine 
profiles and found no differences in the numbers of IL-4 and IFNy producing CD4 or 
CD8 cells, between gingivitis and periodontitis tissues. This study also demonstrated 
the presence of a higher percentage of CD30+ (a member of the TNF/nerve growth 
factor receptor family) cells, which were also CD4+ and CD8+, extracted from 
periodontitis lesions than from healthy/gingivitis lesions. CD30+ cells are found under 
normal conditions associated with B cell follicles of lymphoid tissue and germinal 
centres, rather than in the peripheral blood (Del Prete et al., 1995). CD30 molecules 
are also more often expressed on Th-2 and Th-0 cells. It is possible that these cells are 
important in the local activation of B cells, which occurs in the periodontitis lesion 
(Gemmell and Seymour, 1991). Another recent study by the same group showed a 
predominantly protective Th-1 response in the spleens of BALB/c mice after 
immunisation with Pg outer membrane proteins (Gemmell et al., 1998). In summary, 
studies of T-helper cells in periodontitis patients suggest that either no differentiation 
into distinct phenotypes exists, or that the range of subsets represents different stages 
of the disease.
1.2.5.4 B cells
As has already been stated above, B cell activation is considered to be an important 
feature of the chronic inflammatory periodontal lesion. B cells are under the control of 
helper T cells and therefore require close contact with them in order to be activated. 
The numbers of plasma cells have been found to correlate with CD4 cells. In addition, 
a tendency of plasma cells to form clusters near to T cells has also been noted (Tonetti,
1993).
It has recently been shown that T cell induced differentiation of B cells requires 
lymphocyte function-associated antigen-1 (LFA-1)/ICAM-1 and CD2/LFA-3 
interaction (Gemmell, Sved and Seymour, 1995) (Figure 1.2). A high percentage of 
gingival B cells from both healthy/gingivitis and AP tissues have been found to 
express the adhesion molecules ICAM-1 and LFA-3, compared with peripheral blood
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(50%:30%). In addition, gingival T cells from the same tissues have been found to 
express CD2 in a ratio of 50%:76% and LFA-1 in a ratio of 45%:45% with the 
peripheral blood. Stimulation of the gingival cells in vitro with Pg and Fn did not 
increase the percentage of CD2+ T cells and ICAM-1+ and LFA-3+ B cells, but did 
cause a rise in the number of T cells expressing LFA-1. The reverse situation occurred 
when peripheral blood cells were stimulated. These results indicate that gingival 
lymphocytes express adhesion molecules. They also suggest that these cells are 
already activated in vivo and that their phenotype is consistent with cell-cell contact 
occurring in the gingiva.
Intercellular adhesion used to be thought to precede antigen presentation. However, it 
has been reported that antigen binding induces the cell to express adhesion molecules, 
which augments the effect of other signals (Pardi, Inverardi and Bender, 1992). The 
increase in the percent of LFA-3 and ICAM-1 expressing B cells in both the 
healthy/gingivitis and AP tissues compared with peripheral blood, may indicate a rise 
in the numbers of antigen-specific cells which have already presented antigen to T 
cells. This supports previous studies that demonstrated local activation of B cells 
(Gemmell and Seymour, 1991). However two recent reports indicated the presence of 
pre-plasma cells in periodontitis sections, but no evidence of local proliferation of 
these cells. It was concluded that B-memory cells are recruited to periodontitis lesions 
from the lymph nodes where they differentiate into antibody-producing plasma cells 
(Takahashi, Lappin and Kinane, 1996; Kinane et al., 1998; Lappin et al., 1999).
The idea of polyclonal B cell activation has for a number of years been considered to 
be a possible mechanism for stimulation of the B cell response in periodontitis 
(Seymour, 1987; Tew, Engel and Mangan, 1989). This polyclonal B cell stimulation 
may be a feature of certain forms of periodontitis (Mallison et al., 1988). It may on 
the other hand occur as a result of gingival penetration of LPS, in the presence of IL-2 
(which can promote clonal expansion of B cells), thus augmenting specific B cell 
responses (Tew, Engel and Mangan, 1989). Alternatively, superantigenic stimulation 
of Vp T cell families may occur in the inflamed tissues (Zadeh and Kreutzer, 1996) 
(Figure 1.2). The large quantities of antibodies produced are non-protective and 
wasteful of the host’s antimicrobial responses.
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1.2.5.5 Natural killer cells
Natural killer cells are large granular lymphocytes. They are cytotoxic to virally 
infected cells and kill by inducing apoptosis (Mathur and Michalowicz, 1997). They 
may contribute to the pathogenesis of periodontitis by a similar activity against 
fibroblasts and other host cells (Seymour et al., 1984; Lindemann, 1988). The 
numbers of NK increase from health, where very few cells are present, to gingivitis, to 
periodontitis (Cobb et al., 1989). However the percentage of the total lymphocyte 
population occupied by NK decreases from 19% in health to 6.6% in gingivitis and 7% 
in periodontitis. It is possible NK may have a regulatory roll in periodontitis since 
clusters of B cells or plasma cells have been found to have NK associated with them, 
which may influence their activity and proliferation (Wynne, Walsh and Seymour,
1986). NK have a greater inhibitory effect than suppressor T cells and therefore an 
imbalance in the NK to non-NK ratio may up-regulate the humoral response. This 
may bring about the conversion of a stable T cell to a destructive B cell lesion. The 
major signal for up-regulation of NK cytotoxic activity seems to be LPS of Gram 
negative periodontal pathogens (Lindemann, 1988). In addition NK may be subject to 
regulation by activating and inhibitory signals (Cobb et al., 1989). NK activity is 
increased by IL-1 and may be down regulated by immune complexes and PGE2 which 
suppress IL-2 production and indirectly influence NK (Seymour, 1987).
1.2.6 Summary
Progression from gingivitis to periodontitis, or from a quiescent state to an inflamed 
active state in periodontitis is dependent on the balance between the host defence 
system and the microbial challenge, at any one point in time. Numerous as yet 
undiscovered features of bacterial pathogenicity might allow the plaque microbiota to 
overcome the inflammatory or immune defence mechanisms. In this situation the host 
might respond in such a way that the bacterial challenge is contained and the balance 
restored. Alternatively, the host may be unable to respond effectively and disease 
progression might occur. It has been suggested that loss of attachment moves the 
tissue away from the margin of the subgingival plaque. This may arrest the disease
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process until the plaque proliferates apically and again comes into close proximity to 
the lesion (Page et al., 1997).
It appears from recent research that the immune response present in chronic 
periodontitis is initiated and activated locally in the gingival tissues. Evidence for this 
theory comes from studies of the resident tissue cells, present in normal healthy 
periodontium. Fibroblasts, junctional epithelial cells and vascular endothelial cells 
play an important role in the activation of the inflammatory response. They also have 
the ability to produce inflammatory mediators and matrix metalloproteinases in 
response to LPS and other bacterial products, and thus contribute to tissue damage 
(Takata et al., 1988; Zappa et al., 1992).
Lymphocytes and antibodies have been found in peripheral blood, which respond to 
periodontal bacteria (Ebersole and Taubman, 1994). It is possible that these cells and 
antibodies have escaped from the lesion into the systemic circulation. Alternatively, 
cross-reactivity may occur between periodontal pathogens and the normal gut flora. In 
this case, interpretation of systemic antibody titre and avidity levels, in patients and 
controls, should be made with caution. Future research in this area should help to 
identify which are the immunodominant antigens involved in the aetiology of chronic 
periodontitis.
The presence of Th-0, Th-1, Th-2 and naive and resting and activated memory T cells 
in health, gingivitis and periodontitis may represent different stages in the disease 
process (Mathur and Michalowicz, 1997). Naive Th-0 cells may be representative of 
an early periodontal lesion reacting with periodontal pathogens. Th-2 cell clones could 
perpetuate the chronic nature of the disease (Wassenaar et al., 1995). However, 
separation into distinct T cell subsets may not exist. Therefore, investigating levels of 
specific cytokines in the gingival tissues, rather than concentrating on T cell clones, 
may be more relevant to furthering our understanding of the pathogenesis of 
periodontitis (Gemmell, Marshall and Seymour, 1997).
Immune susceptibility can influence the progression of periodontitis in two ways. 
Whether or not the lesion progresses rapidly resulting in marked destruction of 
connective tissue and bone may depend upon the quality of the humoral response. The
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production of specific antibodies that eradicate pathogenic micro-organisms could halt 
the disease process. In contrast, if the antibodies produced are either ineffective at 
eliminating the bacteria or directed against the host tissues the destruction may 
progress (Wassenaar et al., 1995; Mathur and Michalowicz, 1997). In addition, if B 
cells are activated polyclonally, an expansion of the B cell population would occur, 
secreting large amounts of IL-1 which would mediate tissue destruction via several 
pathways (Gemmell and Seymour, 1994; 1998).
1.3 The Role of Cytokines in the Inflammatory and Immune Response
1.3.1 Introduction
The etymon of “cytokine” derives from the Greek words kytos meaning vessel or 
hollow, and hence cell, and kinesis meaning movement. The term cytokine is 
therefore applied to molecules that move or transmit information between cells. 
Cytokines may be divided into two broad groups. These are the inflammatory or 
catabolic proteins and the reparatory or anabolic growth factors. The first group is 
further subdivided into:
1. The interleukins which carry information between leucocytes.
2. The chemokines (chemotactic cytokines) which are involved in cell recruitment.
3. The interferons which influence lymphoctye activity (Offenbacher, 1996).
1.3.2 General Characteristics of Cytokines
Cytokines are small proteins with molecular weights between 5 and 70 kDa (Bendtzen, 
1994). Many different cell types secrete cytokines in response to injury or infection. 
These proteins are secreted and are biologically active in very small amounts (in the 
range of picomolar to femtomolar). Most cytokines have been named according to a 
single biological property. However, the majority are multifunctional molecules with 
various biological actions and target cells. Generally their most important functions 
appear to be accomplished locally (Whicher and Evans, 1990). Cytokines exert their
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action by binding to specific receptors on the surface of effector cells. This stimulates 
intracellular activation of the cell, which modifies behaviour and leads to alterations in 
biological outcome. Signals transmitted between adjacent but different cell types are 
known as paracrine. Autocrine signals occur between similar cell types or on the same 
cell. In some situations where receptors become saturated, cytokines such as TNF, IL- 
1 and IL-6 may spill over into the systemic circulation and stimulate distant tissues and 
organs (Offenbacher, 1996).
1.3.2.1 Cytokine function
Many cytokines have overlapping functions and receptor binding specificities. They 
form a complex network which controls the immune response (Yamazaki et al., 1997). 
They may act synergistically or may inhibit the action of another cytokine (Kjeldsen, 
Holmstrup and Bendtzen, 1993). The concentration of a cytokine affects its functions 
(Page et al., 1997). A cytokine may have different forms of receptors on different cell 
types or on the same cell type, which may allow completely opposing biological 
outcomes. In addition, raised levels of the proinflammatory cytokines may be evident 
during periods of healing, as well as during bursts of destruction. It is important to 
bear these points in mind when interpreting results of in vitro experiments with single 
cytokines or simple combinations of cytokines. Results of experiments such as these 
may not mirror the true situation in the living organism (Whicher and Evans, 1990). 
Furthermore, association of a specific cytokine with a disease entity does not imply 
causation.
1.3.2.2 Regulation of cytokines
Cytokine regulation is achieved through several mechanisms. Control of cytokines 
takes place at the gene activation level, during secretion and circulation, and at the 
target T cell receptor (TCR) level (Bendtzen, 1994). Cytokine production is usually 
short-lived and self-limiting (Howells, 1995). In addition, many cytokine receptors 
exist in soluble forms, which may be cleaved from the target cells and bind and 
possibly neutralise cytokines in the extracellular environment (Bendtzen, 1994). The 
local environment may influence the level of expression of cell receptors. For
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example, platelet-derived growth factor (PDGF) usually triggers fibroblasts to increase 
the quantity of extracellular matrix they produce. In areas of inflammation however, 
IL-1 will stimulate fibroblasts to secrete PGE2 and PDGF receptors are down- 
regulated. Down-regulation of PDGF receptors causes the fibroblasts to be 
unresponsive to PDGF. In other words a catabolic response replaces an anabolic one 
(Offenbacher, 1996). Therefore the circumstances under which a particular cell is 
living at any one time influence the regulation of the cell by cytokines. 
Proinflammatory cytokines are also regulated by high affinity autoantibodies and anti­
inflammatory cytokines such as interleukin-1 receptor antagonist (IL-lra), IL-4 and IL- 
10 (Bendtzen, 1994).
1.3.3 Proinflammatory Cytokines
The most important catabolic cytokines are IL-1, IL-6 and TNF. Interleukin-1 and 
TNF will be discussed in more detail here, together with IL-lra and IL-10. Work 
reported in this thesis includes analysis of polymorphisms in the TNF and IL10 gene 
clusters. A discussion of IL-1 is included because of the similarity and overlap in 
biological function between this cytokine and TNF. IL-10 is included in the 
proinflammatory cytokines, despite serving to dampen many of the destructive aspects 
of the immune response. IL-lra another anti-inflammatory cytokine will be covered in 
the sections on IL-1.
1.3.3.1 Interleukin-1
IL-1 exists in two forms IL-1 a  and IL-1 p which share only 26% amino acid sequence 
homology despite binding to the same type of high affinity receptor (Whicher and 
Evans, 1990). Separate genes located on chromosome two code for each form. Both 
forms are produced as 31 kDa precursors, which undergo enzymatic cleavage to the 
active 17.5 kDa proteins (Tatakis, 1993). IL-1 is mainly secreted by monocytes or 
macrophages but can also be secreted by most nucleated cells (Jandinski et al., 1991; 
Matsuki, Yamamoto and Hara, 1991; 1992).
Bacterial lipopolysaccharide is a potent stimulator of IL-1 production (Offenbacher,
1996). IL-1 can modulate the biological activity of a wide range of cells and is
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autostimulatory in order to increase the production of IL-1. The most important 
function of IL-1 is to induce the expression of other cytokines. The first mode of 
action of IL-1 to be recognised was its ability to cause fever. It was known as 
endogenous pyrogen (Atkins, 1960). In addition, IL-1 has been found, together with 
TNF and IL-6, to induce hepatic acute phase protein synthesis (Whicher and Evans, 
1990), upregulate T and B lymphocyte responses (Offenbacher, 1996; Gemmell and 
Seymour, 1998), stimulate monocytes to release PGE2, instigate bone resorption by 
osteoclasts (Gowen, Nedwin and Mundy, 1986) and inhibit bone formation (Stashenko 
et al., 1987b).
The discovery of an antagonist of IL-1 activity had important implications for the role 
of IL-1 in disease (Bendtzen, 1994). IL-lra modulates the activity of IL-1. It is an 
inhibitor protein which can bind to the IL-1 receptor (IL-1R) without activating the 
cell. Monocytes and PMN produce IL-lra and keratinocytes produce an intracellular 
form of the antagonist (Gemmell, Marshall and Seymour, 1997). Steroids, IL-4 and 
IL-10 induce IL-lra synthesis (Tatakis, 1993). IL-1 receptors exist in four forms. 
These are the two membrane bound receptors IL-1RI and IL-1RII and the two soluble 
forms sIL-lRI and sIL-lRII. IL-1RI are found on T cells, fibroblasts, hepatocytes, 
endothelial and epithelial cells whereas IL-1RII are found on B cells, macrophages and 
neutrophils (Tatakis, 1993).
All three members of the IL-1 group (IL-1 a , ILl-p and IL-lra) bind to IL1-RI and 
IL1-RII. However, since IL1-RII has a very short cytoplasmic tail most of the 
signalling takes place through IL-1RI. In addition, sIL-lRI only binds IL-lra and sIL- 
1RII binds IL-1 p as effectively as the membrane-bound form and IL-lra 2000 times 
less so (Symons, Young and Duff, 1995). Soluble IL-1RII also binds the IL-1 p 
precursor (which cannot activate the type I membrane-bound IL-1R) thereby 
preventing it from being cleaved to the active 17 kDa form. Therefore sIL-lRII works 
together with IL-lra to control the bioactivity of IL-1 p. Corticosteroids induce IL- 
1RII mRNA synthesis and the release of sIL-lRII, mostly from neutrophils. This may 
partly explain their anti-inflammatory and immunosuppressive actions (Bendtzen,
1994).
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1.3.3.2 IL-1 in relation to periodontal disease
In the periodontium IL-lp is the predominant form over IL-loc and is present at higher 
levels in active diseased sites, compared with healthy or stable diseased sites (Honig et 
al., 1989; Jandinski et al., 1991; Stashenko et al., 1991b; Chen et al., 1997). The 
variation in IL-1 concentrations between sites in the same individual, and the lack of 
variation in serum IL-lp levels between AP patients and healthy controls, points 
towards localised rather than systemic production of IL-1 (Tatakis, 1993; Chen et al.,
1997). Activated keratinocytes and Langerhans cells, which are derived from 
monocytes and found within the gingival tissues, produce IL-1 a  and IL-lp (Hillmann, 
Hillmann and Geurtsen, 1995). Macrophages, PMN, B cells and fibroblasts secrete IL- 
ip  (Jandinski et al., 1991; Takahashi, Poole and Kinane, 1995; Hendley, Steed and 
Galbraith, 1995; Takiguchi et al., 1997; Gemmell and Seymour, 1998). IL-lra has 
been detected in GCF from patients with periodontitis (Howells, 1995; Kabashima et 
al., 1996). In addition, monocytes and macrophages in the tissues were found to stain 
positive for IL-lra.
It has been shown that a number of periodontopathic bacteria and their products can 
stimulate the production of IL-1 by host cells (Bom-van Noorloos et al., 1990; Takada 
et al., 1991; Gemmell and Seymour, 1993; 1998; Roberts, Richardson and Michalek,
1997). Levels of IL-1 p correlate with the numbers of infiltrating macrophages and 
other leucocytes (Tokoro, Yamamoto and Hara, 1996); the quantitiy of GCF IL-lp 
correlates with periodontal status (Preiss and Meyle, 1994; Hou, Liu and Rossomando, 
1995; Liu et al., 1996). IL-1 stimulates fibroblasts, endothelial cells, monocytes and 
granulocytes resident in the gingival connective tissue to express adhesion molecules 
(Takahashi et al., 1994; Ozaki et al., 1996). As discussed earlier, these adhesion 
molecules aid the passage of immune response cells from the capillaries into the 
inflamed tissues by chemotaxis. In addition, it has been suggested that lymphocytes 
and monocytes attach to fibroblasts and become resident in the inflamed connective 
tissue (Hayashi et al., 1994; Takahashi et al., 1994).
IL-1 is a key mediator in inflammation and tissue destruction in periodontal disease 
(Assuma et a l, 1998). Both IL-1 and TNFa strongly induce MMP expression in
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resident and immigrant cells, but IL-1 is far more potent than TNFa (Birkedal-Hansen, 
1993; van der Zee, Everts and Beertsen, 1997). MMP degrade the extracellular matrix. 
It has been demonstrated that IL-1 can induce the production of plasminogen activator, 
IL-6 and PGE2 as well as MMP in human gingival fibroblasts (Richards and 
Rutherford, 1988; Mochan, Armor and Sporer, 1988; Bartold and Haynes, 1991). IL-1 
has also been shown to increase the number of IL-1 RI on gingival fibroblasts. This 
was suggested to be a method of amplifying gingival inflammation (Kanda-Nakamura, 
Izumi and Sueda, 1996). IL-1 triggers procollagenase, stromelysin and prostaglandin 
synthesis in periodontal ligament cells (Richards and Rutherford, 1988; Tatakis, 1993; 
Nakaya et al., 1997). In addition, IL-1 stimulates osteoclasts to resorb bone (Horton et 
al., 1972; Dewhirst et al., 1985) and inhibits the formation of bone (Stashenko et al., 
1987b). More specifically, IL-1 mediated resorption of bone has been shown to be 
dependent on stimulation by periodontopathogens (Bom-van Noorloos et al., 1990; 
Ishihara et al., 1991).
Prostaglandin E2 causes increased vascular dilation and permeability. It also 
stimulates macrophages to secrete MMP and has been shown to trigger bone 
resorption in vitro (Birkedal-Hansen, 1993), thus acting synergistically with IL-1 and 
TNFa. IL-1 has been shown to stimulate gingival antigen-presenting cells to express 
HLA class II proteins in order to aid antigen recognition by T cells and B cells 
(Tatakis, 1993). It also upregulates receptors for complement and immunoglobulin on 
monocytes and neutrophils (Offenbacher, 1996).
A recent study used a quantitative method to measure cytokine mRNA levels in 
healthy and diseased gingival sections from the same AP patients. The samples were 
also assessed for macrophage and T cell markers using immunohistochemistry and for 
mRNA expression of cytokines, using in situ hybridisation (Roberts et al., 1997). The 
results showed that higher levels of both IL-lp and IL-lra were present in inflamed 
tissues than in healthy tissues. The levels of the two cytokines were also significantly 
correlated. In the diseased sections intense staining for IL-1 p and IL-lra was evident 
in the epithelium. In addition, there was some positive subepithelial staining of 
mononuclear cells for IL-lra mRNA. These results provide evidence of a protective 
response by macrophages and epithelial cells to antigens produced by plaque bacteria.
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1.3.3.3 Tumour necrosis factor
The TNF family consists of three members (Eigler et al., 1997); TNFa, formally 
known as cachectin, TNFp, also referred to as lymphotoxin alpha, and lymphotoxin 
beta. TNFa was originally described by its ability to cause in vitro and in vivo tumour 
necrosis (Carswell et al., 1975). Ten years later the role of cachectin in infections was 
investigated (Beutler et al., 1985). Amino acid sequencing and cDNA cloning showed 
the genes for these two factors to yield an identical 17 kDa protein (Whicher and 
Evans, 1990). TNFa in the same manner as IL-1 is secreted as a precursor protein, 
with a molecular weight of 26 kDa, which is cleaved to yield the active form. TNFa 
was also found to share 28% homology, some biological functions and a common 
receptor with lymphotoxin alpha. The genes encoding the TNF family lie within the 
class III HLA complex situated on the short arm of chromosome 6. TNFa is mainly 
secreted by macrophages, and TNFp by T cells. In areas of inflammation TNFa is 
more important but both forms have the same effects (Whicher and Evans, 1990). 
Nowadays TNFa is often referred to as TNF.
TNF and IL-1 are produced in response to the same stimuli and, other than B cell 
proliferation and T cell production of IL-2 (upregulated by IL-1), show similar 
biological effects (Whicher and Evans, 1990). Levels of TNF and IL-1 are often 
highly correlated. At low levels these cytokines stimulate the expression of class II 
HLA antigens, adhesion molecules and Fc gamma receptors (FcyR), thus assisting in 
microbial clearance (Offenbacher, 1996). At higher levels, as already discussed above, 
they cause connective tissue destruction and bone resorption. On its own TNF is a 
1000-fold less potent stimulator of bone resorption than IL-lp (Stashenko et al., 
1987a). However synergy between IL -la  or IL-1 p and TNF results in a two-fold 
increase in IL-1 activity and a 100-fold increase in TNF activity.
TNF receptors exist in membrane bound and soluble forms in the same manner as IL-1 
receptors (Bendtzen, 1994). TNF-RI and TNF-RII, the membrane bound receptors, 
bind TNFa and TNFp with equal affinity. However, the soluble forms (sTNF-RI and 
sTNF-RII) bind TNFa more effectively. They may serve to regulate the activity of 
TNFa, which is a more potent inflammatory cytokine than TNFp.
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1.3.3.4 TNF in relation to periodontal disease
TNFa, IL-1 a  and IL-1 p have been identified in periodontitis lesions from patients 
with AP (Stashenko et al., 1991a; Matsuki, Yamamoto and Hara, 1992). Levels of 
TNFa and IL-1 were significantly higher in diseased than healthy sites. However, 
cells containing IL-1 p were found in much greater numbers than those producing 
TNFa and IL-1 a  (Stashenko et al., 1991a). A recent study examined IL-1 p and TNFa 
production in oral PMN culture supernatants of 40 AP patients and 40 controls. 
Unstimulated oral PMN released significant amounts of both cytokines, but there were 
no differences between patients and controls. The authors noted that there was marked 
variability in TNFa production between individuals (Galbraith et al., 1997). Another 
group found negligible mRNA TNFa expression in the gingival tissues of 
periodontitis patients (Tokoro, Yamamoto and Hara, 1996).
Recently, Roberts et al. (1997) showed statistically significant differences in TNFa 
mRNA expression between diseased and healthy sections from the same AP patient. 
Macrophages and T lymphocytes were found to express TNFa mRNA using 
immunohistochemistry and in situ hybridization. This study provides convincing 
evidence of a role for TNFa in periodontal destruction. It employed in situ 
hybridisation, which has a higher threshold for detection of mRNA expression and 
only stains cells expressing increased amounts. In addition, by using patients as their 
own controls individual variability was excluded. The presence of low concentrations 
of TNFa in GCF has been demonstrated in both AP and EOP patients (Rossomando, 
Kennedy and Hadjmichael, 1990; Yavuzyilmaz et al., 1995). In both studies levels of 
the cytokine showed a weak negative correlation with mean pocket depths and gingival 
index scores. Howells (1995) also found that levels of TNFa in GCF were below 
detection when employing sensitive ELISA techniques. However levels of TNFa in 
the gingival tissues taken from the same sites were in the 200 pg pi* range.
The biological activities of IL-1 and TNF, which may be important in the 
pathogenesis of periodontal disease, have been discussed above. It has been 
demonstrated that IL-lp and TNFa can induce the expression of MCP-1 in human 
periodontal ligament fibroblasts. These cytokines also act synergistically to stimulate 
MCP-1 gene expression (Ozaki et al., 1996). Gingival fibroblasts produce collagenase
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and degrade type I collagen, resulting in connective tissue destruction, when 
stimulated by TNF (Meikle et al., 1989). In addition, periodontal ligament cells 
treated with TNFa show enhanced production of PGE2 and bone resorption in mouse 
calvaria (Saito et al., 1990).
When all the above findings are taken together, they appear to suggest that increased 
levels of TNFa in periodontal lesions are representative of an established 
inflammatory and immune response. Salvi and co-workers (1998) have examined 
GCF IL-lp, TNFa and PGE2 secretion patterns in type I diabetes mellitus patients with 
periodontal disease. They found that diabetics had significantly increased levels of 
GCF, PGE2 and IL-lp compared with non-diabetic controls with similar periodontal 
status. In addition diabetics with moderate to severe disease (group B) had almost 
two-fold higher levels of these mediators compared with diabetics with gingivitis or 
mild periodontitis (group A). However, TNFa GCF levels in diabetics were barely 
detectable and no differences were found between group A and group B. Low levels 
of TNFa in GCF from patients with periodontitis, and high levels in the tissues at 
disease active sites, may indicate loss of the chemotactic gradient with increasing 
inflammation. Monocytes and neutrophils retained in the tissues would then trigger 
destruction via a number of pathways. Alternatively, increased levels of the soluble 
forms of TNF receptor in the GCF of patients with periodontal disease might serve to 
mop up excess TNFa (Howells, 1995).
1.3.3.5 Interleukin-10
The gene encoding IL-10 is situated on chromosome one. It yields a protein with a 
molecular weight of 19 kDa. Macrophages, T cells (across all the various subsets), B 
cells, mast cells and keratinocytes can all produce IL-10 after activation (Bendtzen, 
1994; Gemmell, Marshall and Seymour, 1997).
A growing body of evidence implicates IL-10 as a key player in regulating the immune 
and inflammatory response. It has often been described as an anti-inflammatory 
cytokine (Isomaki et al., 1996). Its main function is to suppress monocyte/macrophage 
activity by counteracting the stimulatory effect of IFNy, IL-1 (3 and TNFa (De Waal 
Malefyt et al., 1991). TNFa secreted by macrophages stimulates the release of IL-10
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from the same cells, thereby suppressing TNF production in an autocrine manner 
(Platzer et al., 1995). IL-10 has also been found to reduce IL-l,IL-6 and IL-8 
synthesis by monocytes and neutrophils and to prolong the expression of IL-lra (De 
Waal Malefyt et al., 1991; Gemmell, Marshall and Seymour, 1997). IL-10 inhibits 
HLA class II and B7 expression by macrophages (Ding et al., 1993; Chadban et al.,
1998). B7 is an important co-stimulatory molecule for macrophage/T cell antigen 
presentation. IL-10 therefore abrogates antigen presentation by macrophages and 
indirectly inhibits T cell activation (Bendtzen, 1994). Another indirect effect of IL-10 
is through decreased production of IL-12 by macrophages, resulting in suppression of 
NK activity (Bendtzen, 1994). IL-10 production may also be down-regulated in a 
negative autoregulatory manner (Knolle et ah, 1998). It was suggested that this effect 
might allow the re-emergence of a state of functional responsiveness towards new 
proinflammatory stimuli.
IL-10 also acts directly on Th-1 and Th-2 cells to down-regulate the production of 
other cytokines. However, it appears that Th-1 responses are most affected (De Waal 
Malefyt, Yssel and de Vries, 1993; Bendtzen, 1994). Recently IL-10 has been shown 
to suppress T cell activation, matrix metalloproteinase production and extracellular 
matrix damage in human gut mucosa infections (Pender et al., 1998). It also appears 
to suppress the production of cyclooxygenase-2 (COX-2), the inducible form of 
prostaglandin H synthase by down-regulating transcription (Mertz et al., 1994). This 
in turn reduces PGE2 production, which inhibits MMP sythesis. Parks et al. (1998) 
have demonstrated that IL-10 can differentially affect chemokine production of 
monocytes and human umbilical vein endothelial cells. They suggested that IL-10 
might therefore influence the type of leucocytes that are recruited to the tissues at 
different stages of the inflammatory response. IL-10 itself has been shown to act as a 
chemotactic factor for CD8 cells; in addition, it may inhibit IL-8-induced movement of 
CD4 cells (Jinquan et al., 1993).
Another important function of IL-10 is the regulation of proliferation and 
differentiation of activated B cells (Rousset et al., 1992; Itoh and Hirohata, 1995). The 
effects of IL-10 are dependent on the state of activation of B cells after antigen 
binding. If IL-10 is present during initial activation it promotes apoptosis of B cells.
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However IL-10 may prolong viability and support differentiation of preactivated B 
cells (Bendtzen, 1994; Itoh and Hirohata, 1995). This cytokine may therefore serve to 
amplify the humoral immune response (Rousset et al., 1992). In a number of 
autoimmune inflammatory conditions, such as rheumatoid arthritis (RA) and systemic 
lupus erythematosus, raised IL-10 levels have been noted (Llorente et al., 1994). IL- 
10 has been found to trigger the production of rheumatoid factor (Perez, Orte and 
Brieva, 1995) and other autoantibodies (Llorente et al., 1995). IL-10 usually plays an 
anti-inflammatory role in response to infection and in a number of autoimmune 
diseases. However, this cytokine may on occasions enhance inflammation through the 
stimulation of B cell clones producing excessive amounts of autoantibodies.
1.3.3.6 IL-10 in relation to periodontal disease
It has been suggested that IL-10 may play an important role in the progression of 
periodontal disease. Gemmell et al. (1995) found that AP T cell lines from both 
peripheral blood and gingival tissue secreted IL-10 but clones derived from the 
peripheral blood of an individual with gingivitis did not. It has also been suggested by 
Stein and co-workers that IL-10 may contribute to auto-immune reactions against 
gingival tissues (Stein and Hendrix, 1996; Stein et al., 1997). They demonstrated that 
GMC from AP lesions produce more IL-10 than cells from healthy tissue (Stein and 
Hendrix, 1996). IL-10 is able to favour the development of a particular clone of B 
cells (CD5), which can secrete high levels of autoantibody and is found in increased 
numbers in inflamed gingival sections (Sugawara et al., 1992). Antibodies directed 
against IL-10 reduced the presence of cells secreting anti-collagen immunoglobulins 
by 80% (Stein and Hendrix, 1996). A further study of insulin-dependent (type I) 
diabetics investigated the response of PBMC to Pg LPS. In a subgroup of the study 
population, IL-10 production and the number of CD5 B cells was significantly 
increased compared to controls. A higher percentage of anti-collagen secreting cells 
was also observed. The authors suggested that a subset of type I diabetics may be 
more susceptible to developing periodontitis, through an autoimmune type of reaction 
directed against gingival connective tissue, if exposed to periodontal pathogens (Stein 
et al., 1997).
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Fujihashi et al. (1996) supported these findings in AP patients. They investigated 
cytokine profiles of CD4 cells extracted from inflamed periodontal lesions. Two 
distinct patterns emerged which were divided according to the presence or absence of 
mRNA for IL-10. When PBMC from the same patients were stimulated with 
concanavalin A, no distinct patterns were evident. These findings again support a 
localised defect in the immune response in periodontal disease.
More recently, another hypothesis for the role of IL-10 in periodontal disease has been 
proposed. Gemmell and Seymour (1998) demonstrated a significantly reduced number 
of IL-10+ CD8 cells from periodontitis lesions (AP) than from healthy/gingivitis 
(H/G) sections (p = 0.033). They suggested that in gingivitis IL-10 might suppress 
inflammation by decreasing macrophage activity, thereby preventing progression to 
periodontitis. No differences were found in the percentage of IL-10+ CD4 cells 
between the two disease categories. However, some individuals were found to have 
high numbers of IL10+ T cells, and others demonstrated low levels or none, regardless 
of disease category. It appears that the overall variation between the AP and H/G 
groups in IL-10+ CD8 cells may have been due to the distribution of individual IL-10 
secretion patterns, rather than due to differences in pathogenesis between the two 
disease categories. Further studies should help to elucidate the possible role of IL-10 
in periodontal disease.
1.3.4 Summary
The cytokine network plays a major role in immune homeostasis. Complex 
synergistic and inhibitory interactions exist between the various members. This allows 
for redundancy within the system without devastating effects to the host. IL-1 and 
TNF are proinflammatory cytokines. At low levels they activate the host defence 
mechanisms in a protective manner and at higher levels they cause collagen 
breakdown and bone destruction. The effects of these mediators are modulated by 
soluble cytokine receptors, steroids, autoantibodies to cytokines and by anti­
inflammatory cytokines such as IL-lra and IL-10 (Bendtzen, 1994).
There is sufficient evidence to implicate IL-1 and TNF in progressive periodontitis, but 
the role of IL-10 is at present less certain. Despite the anti-inflammatory nature of IL-
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There is sufficient evidence to implicate IL-1 and TNF in progressive periodontitis, but 
the role of IL-10 is at present less certain. Despite the anti-inflammatory nature of IL- 
10, it is possible that in some periodontitis patients IL-10 may contribute to the disease 
process by stimulating the production of autoantibodies against host tissues (Stein and 
Hendrix, 1996; Stein et al., 1997). These findings require corroboration.
1.4 The Major Histocompatibility Complex
1.4.1 Introduction
The human major histocompatibility complex (.MHC) is a large collection of multiple 
genes situated on the short arm of chromosome six (Figure 1.1). It covers an area of 
about 3800 kilobases of DNA (Schwartz, Felser and Mayr, 1995). The human MHC is 
also known as the human leucocyte antigen complex. The HLA complex is divided 
into three clusters of genes; classes I, II and III (Figure 1.1). Classes I and II loci code 
predominantly for cell surface antigens which are important for recognition of self and 
non-self peptides by T cells (Bodmer, 1995). A locus is the position on a chromosome 
at which a gene is found. Class III loci are situated between class I and class II and 
code for certain complement proteins (Meo et al., 1977), heat shock protein 70 
(Sargent et al., 1989) and for the cytokines TNFa and TNFp (Spies et al., 1986). In 
addition, several other genes are present in this region.
1.4.2 The HLA Complex and the Immune Response
The cell surface molecules of the HLA complex and the T cell receptor (TCR) play an 
important role in immune responsiveness (Baines and Ebringer, 1992; Bodmer, 1995) 
(Figure 1.2). The TCR is a membrane bound molecule composed of a  and p (or y and 
5) disulphide-linked chains. Each chain has a constant (C) and a variable region (V) 
and a joining domain (J). The p chain also has a diversity region (D). Numerous C, V, 
D and J genes exist, which are randomly rearranged to code for unique TCR molecules 
(Zadeh and Kreutzer, 1996). The variation in the V, D and J regions in the p chain, 
and the V and J regions in the a  chain, determine the specificity of the antigen-binding
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Figure 1.1 Diagrammatic representation of the human major 
histocompatibility complex showing the class I, II and III regions.
Centromere
A------
CLASS II CLASS III CLASS I
DP DQ DR COMP HSP70 LTB TNF B C A
DP, DO, DR = HLA class II loci, COMP = complement genes, HSP70 = heat shock 
protein 70 locus, LTB  = lymphotoxin p gene, TNF  = tumour necrosis factor loci, B, C 
and A = HLA class I loci. Adapted from Wilson et al. (1995) and Rink and Kirchner 
(1996).
Figure 1.2 Diagrammatic representation of antigen presentation to T helper 
cells.
Helper T cell
TCRLFA-1
CD2
CD3^
CD4
Class II HLA
LFA-3
ICAM-1 Antigen presenting cell
Adapted from Kinane and Davies (1990). See text for explanation of T cell receptor 
structure. TCR = T cell receptor, HLA = human leucocyte antigen, CD4 = cluster of 
differentiation antigen for T-helper cells, CD3 = signal transducing unit for the TCR, 
Ag = antigen, Sag = superantigen.
activation (Engel, 1996). The CD3 molecule transduces the signal received by the 
TCR to the inside of the cell (Roitt, 1994).
The HLA complex is amongst the most polymorphic regions of the human genome 
with each locus represented by multiple alleles (Bodmer, 1995). An allele is one of a 
number of possible alternative forms of a gene at a given locus. Each allele has a 
different sequence of DNA, which may code for different amino acids and thereby 
affect the structure and possibly the function of a protein product. It is assumed that 
the high degree of polymorphism displayed by the HLA complex was developed in 
order to protect the species from infection (Schwaiger and Epplen, 1995; Bodmer,
1995). Associations between particular HLA antigens and several diseases thought to 
have an autoimmune background, such as diabetes and RA, have been reported 
(Baines and Ebringer, 1992). More recently the relevance of HLA variation in 
influencing susceptibility to infection has also been determined (Hill, 1992).
1.4.3 Antigen Presentation
HLA molecules contain specialised binding sites for antigen peptides (Bjorkman et al., 
1987; Brown et al., 1993; Stem et al., 1994). These peptides are the products of 
antigen processing within the APC. Class I HLA antigens are found on the surfaces of 
most eukaryotic cells and are involved in presentation of self-antigens. They also 
present antigens derived from pathogens which invade cells, such as vimses. Class II 
HLA antigens are preferentially found on professional APC such as macrophages, B 
cells, dendritic cells and Langerhans cells. Other cell types may be stimulated to 
express class II antigens by the cytokine IFNy (Pober et al., 1983; Walsh, Seymour and 
Powell, 1986). These antigens present peptides derived from pathogens existing 
extracellularly such as most species of bacteria. The class I antigen peptide complex is 
presented at the cell surface to cytotoxic T cells. The class II antigen peptide complex 
is presented to helper T cells.
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1.4.4 The Possible Role of HLA Antigens in Periodontal Disease
Particular class II HLA genes have been associated with protection from infectious 
diseases such as malaria (Hill et al., 1991). Class II HLA antigens (DQ, DP and DR) 
have been identified on gingival Langerhans cells and have been shown to stimulate 
lymphocytes (Walsh, Seymour and Powell, 1987; 1990). Keratinocytes have also been 
shown to express HLA-DR but not -DQ (Walsh, Seymour and Powell, 1986). 
Langerhans cells correlate with the presence of Aa and Pg on the oral epithelium in 
periodontitis (Saglie et al., 1987) and numbers of Langerhans cells have been shown to 
increase in gingival inflammation (DiFranco et al., 1985; Seymour et al., 1988; 
Giinhan et al., 1996). LPS from the periodontal pathogen Fn induces differential 
expression of HLA-DR and -DQ on Langerhans cells in vitro (Walsh, Seymour and 
Powell, 1987). It is possible that the humoral response to specific periodontal 
pathogens is under the influence of HLA genes. Work in our laboratories has indicated 
a wide variation in serum antibody titre and avidity to Pg and Aa within groups of 
periodontitis patients pre- and post-treatment (Mooney et al., 1995). These varying 
responses could be associated with different HLA genotypes within a homogeneous 
population.
Molecular genetic techniques are now available to investigate in detail genetic 
polymorphisms such as those demonstrated by the HLA gene cluster (Schwartz, Felser 
and Mayr, 1995; Wade, 1996). A recent study in a population of Japanese patients 
demonstrated a significant association between an atypical BamHl restriction site 
found in the HLADQB gene and EOP (Takashiba et al., 1994; Ohyama et al., 1996). 
In addition a large-scale linkage study of 100 families with EOP carried out by Wang 
et al. (1996) identified linkage between susceptibility to EOP and the HLA region of 
chromosome six (Hart and Komman, 1997) (section 1.8.4.4).
1.4.5 Summary
Associations between the HLA complex and a number of chronic diseases have been 
established. In addition, its role in influencing susceptibility to infection has more
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recently been uncovered. It appears likely that variation in HLA genotype between 
individuals also determines response to infection in periodontal disease.
1.5 Classification of Periodontitis
1.5.1 Introduction
The classification of periodontitis has evolved over the years in an attempt to parallel 
developments in diagnosis and increased knowledge of the aetiology and pathogenesis 
of the disease process. A number of different authors have proposed varying 
classifications (Page and Schroeder, 1982; Grant, Stem and Listgarten, 1988; 
Proceedings of the world workshop in clinical periodontics, 1989; Genco, 1990; 
Ranney, 1993; Carranza, 1996; Jenkins and Allan, 1999). Some of these have 
included gingivitis as well as periodontitis. The contents have ranged from a few 
distinct categories to a more complex layout. The classification presented in this thesis 
will include only inflammatory diseases of the supporting structures of the teeth, which 
have an underlying infectious aetiology (Table 1.1).
Periodontitis is thought to be a heterogeneous group of diseases with many similarities 
in microbial aetiology, pathogenesis and clinical presentation. The characteristics, 
which distinguish the different categories, are the age of onset and the extent and 
severity of the disease. However, there is considerable overlap between the disease 
categories.
1.5.2 Measurement of Disease Status
Diagnosis of periodontal disease is based on clinical measurement of attachment level 
and radiographic analysis. Severity of diseased is referred to in terms of AL and loss 
of alveolar bone height. The latter may be described as a proportion of the optimum 
bone height, or by direct millimetric measurement.
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Table 1.1 Classification of periodontal disease.
Early-onset periodontitis
Prepubertal periodontitis (PP)
Localised PP 
Generalised PP 
Localised early-onset periodontitis (LEOP) 
Generalised early-onset periodontitis (GEOP) 
Incidental early-onset periodontitis (IEOP) 
Adult periodontitis (AP)
Refractory periodontitis (RP)
Necrotising ulcerative periodontitis (NUP) 
Periodontitis associated with systemic disease
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1.5.2.1 Attachment level and probing pocket depth
Attachment level can be assessed using a graduated probe, by measuring the distance 
in millimetres from the amelocemental junction (ACJ) to the base of the probable 
periodontal pocket. Pocket depth is measured from the gingival margin to the base of 
the pocket. Pocket depth will only coincide with measurement of attachment level 
when the gingival margin is level with the ACJ. In situations where swelling of the 
gingivae has occurred causing “false pocketing”, the attachment level measurement 
will be less than the pocket depth. The reverse will be the case when the gingival 
margin has receded apically. Recession is measured apically from the ACJ to the 
gingival margin.
Measurement of attachment level or pocket depth is not a true representation of the 
level at which the most apical cells of the JE lie (Nyman and Lindhe, 1997). 
Listgarten (1980) suggested distinguishing between the histological and clinical pocket 
depth, or in other words the actual depth and the measurement recorded by the probe. 
There are a number of factors which influence the measurement of attachment level. 
These include the thickness of the probe; the position of the probe in relation to the 
anatomical morphology of the tooth; the pressure applied during probing; and the 
degree of inflammatory cell infiltration of the tissues (Listgarten, 1980; Zappa et al., 
1991). Errors in recording probing pocket depth and attachment level can be reduced 
by using a suitable probe and by correct angulation of the probe. Variations in 
measurements due to probing pressure and the degree of inflammation of the tissues 
are more difficult to control. Pressure sensitive probes have been developed which 
enable the examiner to probe with a constant pressure (van der Velden and de Vries, 
1978; Poison et al., 1980). However these electronic probes are also subject to 
measurement errors (Robinson and Vitek, 1979; Poison et al., 1980).
Recording of attachment level and probing pocket depth will be overestimated at 
inflamed sites and underestimated at sites which have healed. The probe tip can 
penetrate beyond the most apical extent of the JE into the infiltrated connective tissue, 
when inflammation is present. After treatment and healing, with the deposition of new 
collagen, the probe tip will not reach the apical termination of the JE. From this
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discussion it can be seen that an improvement in attachment level may not represent a 
true gain of attachment but only a resolution of inflammation (Nyman and Lindhe, 
1997).
In spite of this drawback, measurement of attachment level is a useful tool for 
assessing response to treatment. In addition, AL is the most reliable method available 
of diagnosing the presence or absence of loss of periodontal support (Clerehugh and 
Lennon, 1984; Tonetti and Mombelli, 1997).
1.5.2.2 Radiographic analysis
The level and contour of the interdental alveolar bone can be assessed from 
examination of radiographs. The outline of the buccal and lingual alveolar bone may 
also be seen but will in many cases be masked by the teeth, restorations or by bone 
tissue (Nyman and Lindhe, 1997). For this reason and because radiographic evidence 
of loss or increase in bone density lags behind the clinical measurements, radiographic 
analysis must be combined with a detailed periodontal charting (Clerehugh and 
Lennon, 1986).
If the BL has progressed at a similar rate, the bone level will be even and is termed 
“horizontal bone loss”. On the other hand, if BL has progressed at different rates 
around a particular tooth angular bone defects may be evident which are referred to as 
“vertical” bone loss. Alveolar bone loss is measured from the ACJ to a point where 
the lamina dura becomes continuous with the compact bone of the interdental septum. 
It is measured on the mesial and distal surfaces of the teeth. This is not a true 
measurement of BL since in health alveolar bone surrounds the tooth to a level 
approximately one millimetre apical to the ACJ. However, this is the most accurate 
method available of estimating the degree of BL.
1.5.3 Early Onset Periodontitis
The term early-onset periodontitis encompasses a group of diseases which are 
diagnosed in patients under the age of thirty-five years (Fourel, 1972; Astemborski et 
al., 1989). The destruction of the periodontium is advanced for the age of onset of the
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condition (Baer, 1971). Early-onset periodontitis has a tendency to aggregate in 
families (Hassell and Harris, 1995).
1.5.3.1 Prepubertal periodontitis
Page et al. (1983) first described this extremely rare category of periodontitis as a 
distinct clinical entity. The onset of the disease usually occurs during or soon after the 
eruption of the deciduous teeth. Both familial clustering of PP and a higher incidence 
in females have been documented (Fourel, 1972; Page et al., 1983; Shapira, 
Schlesinger and Bimstein, 1997; Bimstein, Sela and Shapira, 1997).
Because of the rarity of this form of the disease, no strict definition of the level of AL 
and the number of teeth involved has been proposed. For this reason, no prevalence 
data exist for this condition. According to Page et al. (1983) the localised form affects 
some but not all of the primary teeth more often the molars. The associated plaque 
deposits are moderate and there is little inflammation of the gingivae, but bleeding on 
probing is present at affected sites. There are no associated systemic conditions and 
patients do not suffer from frequent upper respiratory tract infections. The destruction 
is not as rapid as in the generalised form and the condition usually responds to 
treatment.
Page et al. (1983) also described the following features of GPP. The generalised form 
affects all the deciduous teeth and sometimes also involves the permanent dentition. 
There is acute inflammation of the gingival tissues and rapid destruction of the 
periodontium often leading to premature exfoliation of the teeth. Pronounced 
recession and cleft formation are also sometimes present. The periodontitis may be 
refractory to therapy. Individuals may suffer from recurrent upper respiratory tract and 
skin infections. It has been suggested that this form of PP is only found associated 
with leucocyte adhesion deficiency syndrome (LAD) (Page et al., 1983; Page, Beatty 
and Waldrop, 1987; Meyle, 1994). However, GPP has also been reported in otherwise 
healthy children (Butler, 1969; Fourel, 1972; Shapira, Schlesinger and Bimstein,
1997).
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1.5.3.2 Localised early-onset periodontitis
This form of early-onset periodontitis is also referred to as localised juvenile 
periodontitis. There are numerous case definitions of LEOP adopted for convenience 
rather than being based on scientific evidence. The one presented here has been used 
in genetic studies of EOP. According to Hart et al. (1991) diagnosis of LEOP is based 
on AL of > 4 mm on at least two permanent first molars and incisors (one of which 
must be a first permanent molar). Not more than two other permanent teeth, which are 
not first permanent molars or incisors, should be affected. Individuals must be 
systemically healthy and under 35 years of age.
1.5.3.3 Generalised early-onset periodontitis
The term GEOP covers various forms of the disease having overlapping clinical 
presentations, which can only be distinguished at present by observational longitudinal 
assessment. These include generalised juvenile periodontitis, generalised severe 
periodontitis and rapidly progressing periodontitis (RPP). Within each of these forms 
heterogeneity exists. The Early Onset Periodontitis workshop in 1996 recommended 
concentrating on immunological, bacteriological and environmental markers of disease 
(Van Dyke and Schenkein, 1996). In addition they recommended focusing on the 
earliest stage of detectable disease. The outcome of these proposals would help to 
correctly assign diagnoses, assess disease progression and elucidate the relationship 
between the localised and generalised forms of the disease.
GEOP has its onset from puberty until 35 years of age. According to Hart et al. (1991) 
clinical diagnosis is based on AL of > 5 mm on a minimum of eight permanent teeth 
(one of which must be a first molar), at least three of which should not be first molars 
or incisors. Individuals must be systemically healthy.
1.5.3.4 Incidental early-onset periodontitis
Studies of prevalence of AL in adolescents and young adults have identified a 
substantial group of individuals who show a pattern of destruction which does not fit 
the classification of either LEOP or GEOP (Loe and Brown, 1991; Brown et al., 1996;
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Albandar et al., 1997) (section 1.6.2). It is suggested that this category should include 
individuals who do not fulfil the criteria for diagnosis of either GEOP or LEOP, but 
show > 4 mm of AL on one or more teeth. An epidemiological survey by Loe & 
Brown (1991) of early-onset periodontitis, in adolescents aged 14 to 17 years, was 
carried out in the United States. Because of the young age of the population sample 
AL of > 3 mm was used as the cut-off for diagnosis of LEOP, GEOP and IEOP. It was 
found that 71% of the IEOP group had one site affected and 97% had three or less 
affected sites. This definition is a useful way of classifying those individuals who 
have a few sites affected by abnormal AL, which is not associated with local causes 
such as proximal caries or overhanging restorations.
1.5.4 Adult Periodontitis
Adult periodontitis is probably initiated at or soon after puberty but does not manifest 
symptoms until the middle of the fourth decade (Clerehugh, Lennon and Worthington,
1990). AP is a slowly progressing form of periodontitis. However, it may at any stage 
undergo an acute exacerbation with associated AL. From prevalence studies, AP is the 
most commonly occuring form of periodontitis. Varying levels of severity of AP 
exist. It is possible that AP patients with severe generalised disease, first diagnosed 
under the age of about 45 years, would have been classified as EOP had they been 
initially examined under the age of 35 years.
1.5.5 Refractory Periodontitis
The definition of refractory periodontitis includes all cases of EOP and AP which fail 
to respond to treatment and continue to lose attachment. It has been suggested that the 
majority of refractory periodontitis patients are smokers (MacFarlane et al., 1992; 
Wolff, Dahlen and Aeppli, 1994). However, a recent study found this not to be the 
case (Colombo et al., 1998a; 1998b).
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1.5.6 Necrotising Ulcerative Periodontitis
This condition is preceeded by necrotising ulcerative gingivitis (NUG) which is an 
acute inflammatory condition associated with a fusospirochaetal microbiota. NUG is 
characterised by ulcerated and necrotic papillae and gingival margins (Holmstrup and 
Westergaard, 1997). The ulcers are covered by a grayish slough, removal of which 
causes bleeding from the exposed ulcers. The condition is painful and there is an 
associated foetor oris. As the necrosis progresses cratering appears between the buccal 
and lingual margins of the papillae. Untreated or recurrent NUG may progress to 
necrotising ulcerative periodontitis. This diagnosis follows the involvement of the 
periodontal ligament and the destruction of the interproximal alveolar bone 
(Holmstrup and Westergaard, 1997). Marked gingival recession may result and 
sequestra formation is a sequela of the rapid necrosis. In industrialised countries 
young adults in their early 20s appear to be most predisposed to this condition and a 
prevalence of 0.5% or less has been reported (Homing, Hatch and Lutskus, 1990).
1.5.7 Periodontitis Associated with Systemic Disease
Severe periodontitis of the deciduous and permanent dentitions has been associated 
with the monogenic disorders and also with Down’s syndrome (section 1.8.3.1, 1.8.4.1 
and 1.8.5.1). In addition, patients with both insulin-dependent-diabetes mellitus and 
non-insulin dependent diabetes mellitus have been shown to be at greater risk of 
developing periodontitis (Genco and Loe, 1993; Grossi et al., 1994; Oliver and 
Tervonen, 1994; Page and Beck, 1997).
Another systemic condition, which demonstrates an increased risk of developing 
periodontitis, is infection with human immunodeficiency virus (HIV). Necrotising 
ulcerative periodontitis has also been associated with the late stages of this condition 
(Holmstmp and Westergaard, 1994).
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1.6 Prevalence of Loss of Periodontal Support in Individuals less than Thirty- 
five Years of Age
1.6.1 Introduction
The following section presents a review of prevalence of loss of periodontal support in 
children, adolescents and young adults. It attempts to illustrate the rarity of severe 
generalised disease in individuals under the age of 35 years. It also demonstrates that 
mild AL (> 1 mm and < 3 mm) and marginal BL (> 2 mm) of the permanent dentition 
are relatively common in circumpubertal children and teenagers (Hansen, Gjermo and 
Bergwitz Larsen, 1984; Clerehugh, Lennon and Worthington, 1990; Neely, 1992).
Case definitions of localised, generalised and incidental EOP have been presented in 
the previous section on classification of periodontal disease. However, 
epidemiological studies in children and young adults suffer from a lack of accepted 
definitions of the various forms of the disease. Wide variation in prevalence of loss of 
periodontal support exists between studies, due to the use of different diagnostic 
criteria and overlap between the disease categories. This has confounded meaningful 
comparison of epidemiological reports.
1.6.2 Longitudinal Studies
Several longitudinal studies have highlighted the dynamic nature of periodontal AL 
(Albandar, Buishi and Barbosa, 1991; Albandar, 1993; Albandar et al., 1997; 
Gunsolley et al., 1995; Brown et al., 1996). It appears that some cases progress with 
time to involve more teeth and the deeper structures of the periodontium, whereas in 
other cases the disease arrests or healing occurs. These observations highlight the 
marked heterogeneity of the disease.
It has been proposed that the most sensitive method of diagnosis of periodontal disease 
is the measurement of AL by probing (Tonetti and Mombelli, 1997). A five year 
longitudinal study was carried out on 167 adolescents of a low socio-economic group 
who were considered likely to develop periodontitis (Clerehugh, Lennon and 
Worthington, 1990). The children were fourteen years of age at the start of the study.
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AL was measured on the mesio-buccal surfaces of first molars, first premolars and 
central incisors. The prevalence of AL of > 1 mm was calculated at 14.3 years, 16.0 
years and 19.6 years. The subject prevalence was found to be 3%, 37% and 77% and 
the site prevalence < 1%, 7% and 31%, respectively. It has been shown that AL of > 1 
mm correlates with early radiographic BL (Clerehugh and Lennon, 1986). AL of > 2 
mm < 3 mm was only found at 19 years and affected 14% of the population. 
Individuals who had evidence of AL by 16 years still had significantly more sites 
affected by the age of 19.6 years. It appears therefore that AL of > 1 mm is 
widespread in adolescents. In addition, in a significant proportion of these individuals 
AL progresses to > 2 mm by the late teens. This group may be indicative of 
prevalence of slowly progressing AP diagnosed during the fourth decade, since AL of 
1-3 mm is a valid measure of early periodontitis (Clerehugh and Lennon, 1984; 
Clerehugh, Lennon and Worthington, 1988; Albandar, 1993).
Two recent papers investigated clinical classification of periodontitis in a sample of 
adolescents and young adults from the 1986/1987 survey of 14,013 North American 
schoolchildren (Brown et al., 1996; Albandar et al., 1997). The subjects were 
examined at baseline, when aged between 13 and 20 years old, and at follow-up six 
years later to determine whether diagnoses, based on cross-sectional assessment, 
change over time. In the classification of Loe and Brown (Loe and Brown, 1991; 
Brown et al., 1996; Albandar et al., 1997) AL of > 3 mm on the mesial surface of any 
tooth, excluding third molars, was taken as evidence of significant disease. Individuals 
were classified into three groups. Subjects required at least one first molar and at least 
one incisor or second molar, and two or fewer other teeth, to be placed in the LEOP 
group. For GEOP (if the LEOP criteria were not met) the selection criteria were four 
or more teeth with AL > 3 mm, and a minimum of two affected teeth which were 
second molars, canines or premolars. Individuals who did not meet the criteria for 
either LEOP or GEOP, but showed AL of > 3 mm on one or more teeth, were included 
in the IEOP group. The results indicated that 82% of cases of GEOP remained as such 
when re-classified at follow-up and 35% of cases of LEOP progressed to GEOP. 
Twenty-eight percent of IEOP subjects progressed to either LEOP or GEOP and 30% 
either did not progress or healed. It can be seen from these data that progression of 
EOP does not occur in a straightforward linear fashion.
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1.6.3 Cross-Sectional Studies
In a recent large-scale study of periodontal status in the United States, prevalence rates 
for a minimum of one site with clinical AL of > 1 mm, > 3 mm and > 5 mm were 
recorded (Brown, Brunelle and Kingman, 1996). A total of 7,447 individuals were 
examined, representing 160.3 million civilian, non-institutionalised Americans. Only 
0.3% of individuals in the 13-17 and 18-24 year age groups were found to be affected 
by AL of > 5 mm. In the 25-34 year age group the number affected was 6.4% of the 
population. This figure appears to be unusually high. However, it should be borne in 
mind that in an earlier study, almost two-thirds of those individuals diagnosed as being 
affected demonstrated incidental AL (Loe and Brown, 1991). The bias towards this 
form of AL is probably also reflected in the 25-34 year age group.
Another recent cross-sectional survey in North America, of 5,849 individuals aged 18- 
34 years found 3.6% had AL of > 3 mm on at least eight teeth (Oliver, Brown and Loe,
1998). The authors classified this level of disease as moderate GEOP. For subjects 
aged between 25 and 35 years these criteria appear to lack precision and may overlap 
with AP. A prevalence of only 0.3% was found for advanced GEOP where AL of > 5 
mm was present on eight teeth. However, these inclusion criteria may miss potentially 
severe disease at the younger end of the age range, since an increase in frequency of 
both moderate and severe GEOP was found with age. It is also worth mentioning that 
the validity of these American studies has been questioned. Only the mesio-buccal 
and mid-buccal sites on all fully erupted permanent teeth in two randomly selected 
quadrants (one maxillary and one mandibular) were examined in each individual, 
which may underestimate severe disease.
Assessment of AL by probing may be difficult in the mixed dentition. Measurement 
from the amelocemental junction to the alveolar crest on bite-wing radiographs has 
therefore been suggested as a screening method in prepubertal children (Tonetti and 
Mombelli, 1997). Needleman et al. (1997) found median distances at primary molars 
were 0.58-1.39 mm in seven- to nine-year-old children. In another study ACJ to 
alveolar crest measurements were symmetrically distributed around the mean of 0.9 
mm with a range of 0.0 - 3.0 mm (Sjodin and Matsson, 1992). It was concluded that
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sites with ACJ to alveolar crest measurements of more than 2.0 mm showed 
pathological BL. Sjodin and Matsson (1994) conducted an epidemiological survey of 
radiographic bone levels of 2017 Swedish children of nine years of age. They found that 
4.5% showed marginal BL of > 2.0 mm from the amelocemental junction to the alveolar 
crest, affecting deciduous molars and canines. Another study carried out by the same 
group compared marginal BL > 2.0 mm in the primary dentition with the same amount 
of BL in the permanent dentition, in individuals aged 13 to 19 years (Sjodin et al., 1993). 
They found that 20% of patients with one site with BL in the permanent dentition had 
evidence of BL in the primary dentition, between the age of five and 12 years. The 
figure for individuals with more than two sites was 52%. A healthy reference group had 
5% of their subjects who showed BL in the deciduous dentition. These data indicate that 
abnormal BL in adolescents and young adults may be associated with BL in prepubertal 
children.
A study in North America of circumpubertal children aged 10 to 12 years screened bite- 
wing radiographs for evidence of interproximal BL of > 2 mm. Ten percent of children 
were selected, but a prevalence rate of only 0.45% was found for AL of > 3 mm on at 
least one first permanent molar, following clinical examination (Neely, 1992).
Saxen (1980c) found a prevalence of 0.1% for loss of periodontal support in a population 
of 8,096, 16-year-old, Finnish schoolchildren. Screening was initially performed using 
bite-wing radiographs. Individuals who displayed interdental BL of > 2 mm around 
more than one tooth were selected for a detailed clinical examination. Out of 28 cases 
selected, diagnosis was confirmed in eight individuals. Probing pocket depth 
measurements of > 3 mm and subsequently radiographic re-examination, six months to 
two years after the initial examination, ratified the diagnosis. The ethnic group studied 
was said to represent a uniform Caucasoid population. It has been suggested that bite- 
wing radiographs are a useful method of detecting early bone lesions in adolescents 
(Blankenstein, Murray and Lind, 1978; Hansen, Gjermo and Bergwitz Larsen, 1984). 
However the level at which a threshold should be set to determine only those individuals 
who will develop severe disease is uncertain. Evidence of loss of periodontal support 
from radiographic examination requires to be corroborated by clinical examination.
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1.6.4 Racial Variation in Loss of Clinical Attachment
Loss of periodontal support in adolescents and young adults occurs at least fifteen 
times more frequently in blacks than in Caucasians (Saxby, 1987; Astemborski et al., 
1989; Loe and Brown, 1991; Melvin, Sandifer and Gray, 1991). It is also more 
common in Hispanics than non-Hispanics (Ismail et al., 1987; Loe and Brown, 1991). 
Saxby (1984b; 1987) used the same diagnostic criteria as Saxen to assess loss of 
periodontal support. He found an overall prevalence of 0.1% in a mixed ethnic 
population of 7,266, 15 to 19 year-olds, from the west Midlands. When the population 
was sub-divided into its separate ethnic groups, prevalence of 0.02% was shown for 
Caucasians, 0.8% for Afro-Caribbeans and 0.2% for Asians.
Few epidemiological studies of adolescents exist where localised is distinguished from 
generalised AL. This may be because of the very low occurrence of generalised AL in 
this age group. Loe and Brown (1991) conducted a large-scale survey of 11,000 North 
American schoolchildren aged between 14 and 17 years. The diagnostic criteria have 
been previously described in section 1.6.2. They found a prevalence of 0.53% for 
LEOP, 0.13% for GEOP and 1.16% for IEOP. When the dataset was split into defined 
racial groups, prevalence of 2.05% for black and 0.14% for whites was found for 
LEOP. A prevalence of 0.59% and 0.03% respectively was found for GEOP. 
Incidental EOP was also five times more frequent in blacks than whites. In addition, 
Hispanics were 2.4 times more likely to have LEOP than non-Hispanics.
1.6.5 Sex Predilection
A number of studies have found prevalence of loss of periodontal support to be evenly 
distributed between the sexes (Saxen, 1980a; Saxby, 1984a; Melvin, Sandifer and 
Gray, 1991). However some investigators have found variations in prevalence 
between males and females in different racial groups. In a population of adolescents in 
Amsterdam a prevalence of 0.35%, with loss of attachment of > 5mm on at least one 
tooth, was demonstrated (van der Velden et al., 1989). This study showed a predilection 
for female subjects of 1.3:1.0, but no racial differences. This may have been because 
82% of the population were white Caucasians.
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Black males have been found 2 to 3 times more likely to have localised AL than black 
females (Harley and Floyd, 1988; Loe and Brown, 1991; Melvin, Sandifer and Gray,
1991). Caucasian females have an odds ratio (OR) 1 to 2.5 times that of Caucasian 
males (Saxen, 1980a; 1980c; van der Velden et al., 1989; Loe and Brown, 1991). For 
generalised loss of attachment, males manifest the disease more often than females by 
a ratio of 4.3:1 (Loe and Brown, 1991).
1.6.6 Summary
A review of the literature, on prevalence of loss of periodontal support in individuals 
under the age of 35 years, uncovers the confusion that exists regarding diagnostic 
criteria for the various forms of EOP. Bearing this point in mind, it appears that the 
prevalence of severe generalised AL is rare in this age group. The severity and extent 
of AL increases with age. Both localised and generalised loss of periodontal support is 
found between 15 and 40 times more commonly in blacks than Caucasians. Sex 
predilection varies between racial groups. Furthermore, a large proportion of teenagers 
show mild AL of > 1mm and a significant proportion show AL of > 2 mm but < 3mm 
by their late teens. The latter group probably does not represent those who have a 
predisposition to develop severe AL under the age of 35 years, but may represent the 
initiation of slowly progressing AP. Another interesting finding is the high prevalence 
of incidental AL, compared with the localised and generalised forms, in younger age 
groups.
1.7 Smoking and Periodontal Disease
1.7.1 Introduction
Dentists believed for decades that those patients who smoked showed a poorer 
standard of oral hygiene and accumulated more calculus on their teeth than non- 
smokers. Smoking was also implicated as a risk factor for acute necrotising ulcerative 
gingivitis (Pindborg, 1947). There were however, until more recently, few studies of 
the relationship between smoking and chronic inflammatory periodontal disease. In
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the past 15 years, compelling evidence has revealed a strong association between 
smoking and periodontitis. Even after adjustment for factors such as oral hygiene 
status, age, gender, education and socio-economic status, a greater risk for 
periodontitis exists among smokers. Epidemiological studies in a number of different 
countries across the world have corroborated these findings.
1.7.2 Cross Sectional Studies
Numerous cross-sectional epidemiological studies of the relationship between smoking 
status and periodontal health have been reported. A large-scale survey in North 
America of 1,426 subjects aged between 25 and 74 years assessed risk for AL and BL 
(Grossi et al., 1994; 1995). Smoking had relative risks for AL ranging from 2.05 (95% 
confidence interval [Cl]: 1.47-3.24) in light smokers up to 4.75 (95% Cl: 3.28-6.91) in 
heavy smokers (Grossi et al., 1994). For severe BL the range was from 3.25 (95% Cl: 
2.33-4.54) to 7.28 (95% Cl: 5.09-10.31) in light to heavy smokers (Grossi et al.,
1995).
Two studies in Sweden by Bergstrom and co-workers (Bergstrom and Eliasson, 1987; 
Bergstrom, Eliasson and Preber, 1991) investigated smoking and BL in individuals 
with a high standard of oral hygiene. The first study of 235 professional musicians, 21 
to 60 years of age, found alveolar bone height was significantly lower in smokers (n = 
72) compared with non-smokers (n = 163). Former smokers were excluded from the 
study. When age and oral hygiene were taken into consideration the findings were still 
unchanged (Bergstrom and Eliasson, 1987). The second study was of dental 
hygienists and included 63 current smokers, 67 former smokers and 80 non-smokers, 
aged 24 to 60 years (Bergstrom, Eliasson and Preber, 1991). Interproximal bone 
height was determined on bite-wing radiographs. BL was significantly greater for 
smokers than non-smokers. There was no significant difference in bone height 
between former smokers and non-smokers. Oral hygiene status including the presence 
or absence of calculus showed no relationship to smoking. The authors concluded that 
oral hygiene does not vary with smoking when study and control groups are matched 
for socio-economic status.
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Linden and Mullally (1994) investigated the association between smoking and 
periodontal disease in 82 regular dental attenders (21 current smokers and 61 non- 
smokers) aged between 20 and 33 years. They found that smokers had similar levels 
of plaque to non-smokers but had more interproximal subgingival calculus. In 
addition, smokers had significantly more pocketing of > 4 mm and AL of > 2 mm than 
non-smokers. Severe AL of > 6 mm was recorded in 4 (19%) smokers and 2 (3%) 
non-smokers.
The effect of smoking on periodontal health was assessed in diabetic and non-diabetic 
individuals aged between 19 and 40 years (Haber et al., 1993). In the non-diabetics, 
periodontitis was observed significantly more often among current smokers compared 
with non-smokers. Similar effects were observed in the diabetic group. Furthermore, 
half of the periodontitis in non-diabetics aged between 19 and 30 years and one third in 
31 to 40 year olds was estimated to be due to smoking. No differences were observed 
between smokers and non-smokers with regard to oral hygiene status.
Another interesting study by Haber and Kent (1992) compared the prevalence of 
smoking between patients from a periodontal practice (mean age = 51.5 ± 11.9 years) 
and general dental practice patients (mean age = 43.5 ± 13.6 years). Only patients who 
were periodontally healthy were recruited from general practice. The percentage of 
combined former and current smokers with moderate to severe periodontitis (75%) 
was higher than the percentage reported by patients from general practice (54%) across 
all age groups. The age- and sex-adjusted OR for having a positive smoking history 
among the moderate to severe periodontitis patients versus the general practice 
subjects was 2.6. Furthermore, a significantly higher number of periodontal patients 
were heavy smokers (> 10 cigarettes per day) than general practice patients (OR = 
5.7).
A case-control study of the relationship between life-events and periodontitis found 
smoking to be associated with periodontitis (p < 0.01) (Croucher et al., 1997). 
However after controlling for oral hygiene status and socio-demographic variables 
smoking was no longer significantly associated with periodontal disease. In the 
discussion the authors suggested that this may have been due to smoking being a
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confounding factor for several other variables in the model and overadjustment having 
occurred. Another recent study examined psychosocial factors, dental plaque levels 
and smoking in AP and RPP patients (Monteiro da Silva et a l , 1998). It was shown 
that no differences in oral hygiene status existed between the two groups. However, 
RPP patients smoked significantly more tobacco than AP patients (p = 0.02). These 
findings confirm earlier studies demonstrating a higher risk of disease in younger adult 
smokers (Haber et al., 1993; Linden and Mullally, 1994).
A recent large-scale epidemiological survey of the dental status and smoking habits of 
randomised samples of 35, 50, 65 and 75 year-old subjects was undertaken in Sweden 
(Axelsson, Paulander and Lindhe, 1998). The results showed that smokers had a 
higher mean AL than non-smokers across all ages. The difference between the two 
groups in mean AL increased from 0.37 in 35 year-old subjects to 1.33 in 75 year olds. 
This finding confirmed the results of other studies, which showed a cumulative effect 
of smoking (Bergstrom and Eliasson, 1987; Bergstrom, Eliasson and Preber, 1991; 
Martinez-Canut, Lorca and Magan, 1995).
It has been observed that approximately 90% of patients who are refractory to 
periodontal therapy are smokers (MacFarlane et al., 1992; Wolff, Dahlen and Aeppli, 
1994). Two recent studies by Colombo and co-workers (Colombo et al., 1998a; 
1998b) found that only a quarter of their population of refractory patients were 
smokers. However, around 40% of this population were former smokers. Another 
group suggested that former smokers often relapse and therefore self-reporting is not 
an accurate measure of smoking exposure (Bostrom, Linder and Bergstrom, 1998b) 
(section 1.7.3.3).
Taken together the findings of these studies suggest a strong association between 
smoking and periodontal health, regardless of oral hygiene status. It appears the 
misconception that arose, in which smokers exhibited poorer levels of oral hygiene, 
may have been due to a lack of consideration of confounding variables such as socio­
economic status. Cross-sectional studies of associations between possible risk 
variables and any disease can indicate factors which may increase the likelihood of a
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disease occurring (Page and Beck, 1997). In order to confirm a particular 
characteristic as a risk factor, observational longitudinal studies need to be undertaken.
1.7.3 Longitudinal Studies
1.7.3.1 Observational studies
A report of AL over five years in community-dwelling older adults found smokers to 
be at increased risk of AL (Beck et al., 1997). In another study of prognostic factors in 
periodontal disease over a one-year period, smokers were found to show greater AL 
and BL than non-smokers. Smoking was suggested to significantly increase the odds 
of showing further AL by 5.4:1.0 (Machtei et al., 1997).
1.7.3.2 Response to treatment
Studies of response to treatment have demonstrated similar findings. Clinical and 
microbiological effects of non-surgical therapy were investigated in smokers and non- 
smokers (Preber, Linder and Bergstrom, 1995). The authors found that smokers 
showed a less favourable outcome in probing depth reduction despite a similar 
decrease in the presence of periodontal pathogens in the two groups. Another study 
investigated changes in alveolar crestal height 11 to 14 months following the 
completion of hygiene phase therapy (Machtei et al., 1998). Non-smokers showed no 
change in bone height but smokers continued to lose bone at an annual rate of 0.17 mm 
(p < 0.005).
Reports of various surgical procedures including conventional surgery (Preber and 
Bergstrom, 1990), guided tissue regeneration procedures (Tonetti, Pini-Prato and 
Cortellini, 1995; Trombelli and Scabbia, 1997) and implant placement (Haas et al.,
1996), have also showed a less favourable clinical response in smokers compared with 
non-smokers.
In a recent study of a 5-year maintenance programme following surgery, smokers were 
found to exhibit less improvement than non-smokers in terms of bone height. Smokers 
were also more likely to show BL after five years of maintenance than non-smokers
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(Bostrom, Linder and Bergstrom, 1998a). An earlier report had demonstrated that 
smokers show an increased likelihood of recurrence of disease following therapy than 
non-smokers (Kaldahl et al., 1996).
1.7.3.3 Smoking Cessation
An improvement in periodontal health following smoking cessation provides further 
evidence for smoking as a risk factor in periodontitis. A study designed to assess the 
prevalence of cigarette smoking in a group of moderate to severe AP patients from a 
periodontal practice and a group of periodontally healthy patients from general dental 
practice illustrated this point (Haber and Kent, 1992). Smokers were split into former 
smokers and current smokers. The OR between the periodontal practice patients and 
the general practice subjects, for non-smokers versus former smokers and non-smokers 
versus current smokers, were 2.1 and 3.3 respectively. A longitudinal report of BL 
over ten years showed that progression of destruction was significantly slowed in 
subjects who gave up smoking during the study, compared with those who continued 
to smoke (Bolin et al., 1993).
Several studies have demonstrated more missing teeth in smokers than non-smokers 
(Bergstrom and Floderus-Myrhed, 1983; Linden and Mullally, 1994; Holm, 1994; 
Axelsson, Paulander and Lindhe, 1998). Krall et al. (1997) confirmed this finding and 
reported that current smokers had more missing teeth than either former smokers or 
never smokers. Prospective observations over six years of 1231 male veterans, aged 
between 21 and 75 years, found that the rate of tooth loss was significantly reduced in 
individuals who stopped smoking during the study. However, the rate remained higher 
than in non-smokers (Krall et al., 1997).
To summarise, the findings of longitudinal epidemiological surveys, studies of 
response to treatment and reports of smoking cessation, provide further convincing 
evidence of a strong association between smoking and periodontal health. The 
confirmation of smoking as a risk factor for periodontitis awaits the publication of 
further prospective longitudinal studies of the effects of smoking cessation on clinical 
periodontal parameters. In future studies of smoking cessation, cigarette exposure 
should be assessed by assaying serum cotinine levels. Cotinine is a metabolite of
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nicotine. This approach would improve the accuracy of smoking studies, since patient 
compliance and self-reported smoking status are unreliable (Gonzalez et al.t 1996).
1.7.4 Dose Response
The relationship between smoking and periodontal disease appears to be a dose 
response effect and is also cumulative. Most studies have measured smoking exposure 
in pack years i.e. the number of packs of cigarettes smoked per day x the number of 
years smoked. In calculating this figure it should be remembered that current smoking 
levels may not reflect past exposure. However, in spite of this drawback reports have 
consistently demonstrated a dose response for smoking in relation to periodontitis.
Grossi and co-workers (Grossi et al., 1994; 1995) found that both AL and BL 
increased with increasing pack years. They found that the healthy, low, moderate, 
high and severe AL groups showed increasing number of mean pack years from 4.3 in 
the healthy group to 28.3 in the severe group (Grossi et al., 1994). The range was 5.3 
to 26.8 mean pack years from the healthy to severe BL groups (Grossi et al., 1995). 
Another study in Sweden of dental hygienists showed most of the difference in BL 
between smokers and non-smokers appeared to be due to those who smoked more than 
10 pack years (Bergstrom, Eliasson and Preber, 1991). In addition, in the younger age 
group (<30 years) there was no difference in bone levels between smokers and non- 
smokers.
In a large scale survey of 899 Spanish periodontal patients (age range 21 to 76), of 
whom 47.4% were non-smokers and 52.6% were smokers, the influence of smoking 
on disease severity was assessed (Martinez-Canut, Lorca and Magan, 1995). There 
was no significant difference in AL between smokers of less than 10 cigarettes per day 
(AL = 3.72 mm ± 0.86) and non-smokers (AL = 3.84 ± 0.89). However, smokers who 
smoked more than 11 but less than 20 (AL = 4.36 ± 1.23) and more than 20 cigarettes 
per day (AL = 4.50 ± 1.04) showed significantly more AL than non-smokers.
Another large-scale study investigating the association between cigarette smoking and 
infection with specific periodontal pathogens was carried out in North America 
(Zambon et al., 1996a). Of the 1,426 subjects who took part, 798 were current or
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former smokers. Smokers were found to be infected by significantly higher levels of 
B f and were at significantly higher risk of subgingival infection by this organism than 
non-smokers. The risk in current smokers was 2.3 times that of former or non- 
smokers. In addition, the relative risk of infection by Bf increased 1.18 times for every 
category of smoking from very light to heavy. The authors suggested that this 
increased risk of subgingival infection with periodontal pathogens might explain in 
part, the increased risk for periodontal disease seen in smokers.
1.7.5 Clinical Effects
Smoking has pronounced effects on the gingival tissues in periodontitis, by 
suppressing the clinical signs of gingivitis. The gingivae of smokers instead of 
appearing inflamed and swollen may be pale, fibrotic and hyperkeratotic, compared 
with non-smokers exhibiting equal levels of disease. In addition, the gingival papillae 
are blunted and thickened with rolled margins, which is a characteristic feature of 
smokers with or without periodontitis. Smokers have a reduced tendency to bleed on 
gentle probing into the periodontal pocket and produce significantly less GCF 
(Bergstrom and Floderus-Myrhed, 1983; Holmes, 1990). It has been suggested that 
nicotine causes vasoconstriction of the peripheral blood vessels in the gingivae 
(Clarke, Shephard and Hirsch, 1981). Smokers also show more advanced disease 
anteriorly especially on the palatal surfaces of the incisors and canines. Destruction 
tends to be more severe and widespread in smokers compared with non-smokers of the 
same age. Finally, smokers have been shown to demonstrate more recession than non- 
smokers, whether they have periodontitis or not (Martinez-Canut, Lorca and Magan, 
1995; Gunsolley et al., 1998). However, it has been suggested that this finding could 
be due to toothbrush abrasion rather than the effects of smoking. Smokers exhibit 
more staining than non-smokers and may use harder toothbrushes to clean their teeth 
(Gunsolley et al., 1998).
As already mentioned in a previous section, evidence from studies of response to 
treatment suggests that smokers respond less well to therapy than non-smokers. One 
possible explanation for this effect may be the result of the resolution of gingival 
swelling in non-smokers, causing a more pronounced reduction in probing depth
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compared with smokers. However, this scenario would only apply to longitudinal 
studies of initial hygiene phase therapy. In reports of response to surgical treatment, 
shrinkage and recession, due to healing of the marginal gingivae, would have occurred 
prior to the start of the study. A recent paper by Biddle et al. (1998) raised the 
possibility that the smaller improvement in attachment level and probing pocket depth, 
seen in smokers, may be due to less probe tip penetration at baseline. The reduced 
inflammation and supra-bony connective tissue at the base of the pocket in smokers 
may partly explain this finding. This interpretation would apply to studies of response 
to treatment of both non-surgical and surgical therapy.
1.7.6 The Effect of Smoking on the Host Response in Periodontitis
Numerous aspects of the host response may be modified by the effects of smoking, 
tobacco and nicotine. A recent review by Barbour et al. (1997) discusses in detail the 
immune and inflammatory mechanisms affected by smoking and tobacco products, 
which may possibly play a role in periodontal disease. The following paragraphs will 
concentrate on those features of host defence for which there is some evidence of an 
association between smoking and periodontitis.
1.7.6.1 Effects on specific cell types
In vitro experiments have shown that nicotine can affect the proliferation and 
adherence of human gingival fibroblasts (Peacock et al., 1993). Chemotactic 
responses of gingival neutrophils may be enhanced or suppressed when exposed to 
nicotine (Kraal et al., 1977; Totti et al., 1984). However phagocytic function appears 
to be reduced (Kenney et al., 1977). This finding was corroborated more recently in a 
study of patients with refractory periodontitis, of whom 90% were smokers. In this 
report neutrophil adherence to and phagocytosis of periodontal pathogens was 
suppressed (MacFarlane et al., 1992; Wolff, Dahlen and Aeppli, 1994).
Smoking may also affect the recruitment of inflammatory and immune cells to the 
gingival tissues by altering expression of adhesion molecules. Smoking has been 
found to increase the amount of soluble ICAM-1 in the serum (Koundouros et al.,
1996).
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1.7.6.2 Inflammatory mediators
It has recently been shown that TNFa levels in the GCF of periodontal maintenance 
patients, five years after periodontal surgery, were significantly higher in smokers than 
non-smokers (Bostrom, Linder and Bergstrom, 1998a). A further study by this group 
assessed the same parameters in patients with untreated moderate to advanced 
periodontitis (Bostrom, Linder and Bergstrom, 1998b). It was demonstrated that in 
this disease category also, smoking was significantly associated with increased 
TNFa level in GCF (p = 0.001). In addition, 90% of current smokers, 68% of former 
smokers and 51% of non-smokers showed detectable levels of TNFa. The authors 
suggested that the increased TNFa levels exhibited by smokers may be indicative of 
more destructive disease amongst smokers. They also proposed that the increased 
levels of the cytokine among former smokers may have been due to periodical relapse 
to smoking in this group. This observation gives further credence to the use of the 
serum cotinine assay for accurately determining smoking exposure.
Another recent study examined the effect of nicotine and smokeless tobacco (ST) on 
GMC and PBMC from non-smoking AP patients (Bemzweig et al., 1998). PGE2 
secretion was found to be increased in PBMC after stimulation with nicotine and ST, 
but no effect on IL-lp was observed. Secretion of PGE2 from GMC could not be 
increased further when stimulated with nicotine, ST or LPS. This indicated that GMC 
were already maximally upregulated by the inflammation present in the periodontal 
lesion. Levels of IL-ip from GMC were decreased by exposure to nicotine compared 
with controls. The authors suggested a potential regulatory role for nicotine in 
periodontal disease of smokers (Bemzweig et al., 1998). However, the levels of 
nicotine used in these experiments (lOOpg/ml) were well above the levels found in 
serum in cigarette smokers (72 ng/ml). Furthermore, even though the nicotine levels 
in saliva of smokers have been found to be higher (1.3 pg/ml) than in serum, they did 
not approach the levels used in this study. These findings should therefore be 
interpreted with caution.
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1.7.6.3 The humoral immune response
Antibodies of the IgG2 isotype are thought to play an important role, in the protective 
humoral immune response in periodontitis. They are directed against carbohydrate 
antigens found on the surfaces of periodontal pathogens. IgG2 levels have been found 
to be significantly reduced in smokers with AP, GEOP and in those with a healthy 
periodontium, compared to non-smokers (Tew et al., 1996). More specifically, IgG2 
titres directed against Aa in black smokers are suppressed in GEOP patients but not in 
those with LEOP (Tangada et al., 1997). Furthermore, the lower IgG2 titres seen in 
black GEOP smokers may be specific to Aa. IgG2 response against antigens of other 
non-periodontal bacteria may not be lower in GEOP subjects who smoke.
Gunsolley et al. (1997) recently investigated the effects of race, smoking and 
immunoglobulin allotypes on IgG subclass concentration in various diagnostic 
categories of periodontitis and in healthy controls. In black AP patients IgGl was 
lower in smokers, while those with GEOP showed lower IgG2 levels, confirming 
earlier reports. In white subjects, complex relationships between smoking and 
allotypic markers were reported but none of these effects influenced periodontal 
diagnosis. However subsequently the same research group found white AP patients 
and healthy controls who smoked had higher mean AL and lower IgG2 levels than 
non-smokers (Quinn et al., 1998). Conversely there were no differences in these 
parameters between black AP smokers and their controls.
Recently, subgingival infection with Bf has been shown to occur significantly more 
frequently in smokers (Zambon et al., 1996a). In addition, smoking and subgingival 
infection with Prevotella intermedia (Pi), Bf and Pg were found to be significant 
prognostic indicators for future periodontal destruction (Machtei et al., 1997). Two 
earlier studies had found no significant differences in prevalence of Pg, Aa, Pi, 
Eikenella corrodens (Ec) or Fn between smokers and non-smokers (Preber, Bergstrom 
and Linder, 1992; Stoltenberg et al., 1993). Further investigations into the association 
of specific periodontal pathogens with smoking should help to elucidate these findings.
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1.7.7 Summary
Many well-designed epidemiological, cross-sectional studies carried out in the last 15 
years, have provided convincing evidence of an aetiological role for smoking in 
periodontal disease. Smokers appear to be in the region of 2.5 to 6.0 times more likely 
to develop periodontitis than non-smokers (Barbour et al., 1997). More recently, 
longitudinal observational studies and reports of response to treatment have supported 
the findings of cross-sectional data. Studies of smoking cessation also add to this body 
of evidence.
A significant dose response effect of smoking has been observed. A number of reports 
have shown that light smokers (< 5 pack years) have no increased risk of periodontal 
disease than non-smokers. However, more heavy smokers have periodontitis than a 
healthy periodontium.
The manner in which smoking affects the host defence system and increases 
susceptibility to periodontitis is unclear. Suppression of inflammatory and resident 
cells, stimulation of proinflammatory mediators and down-regulation of the humoral 
immune response have been proposed as possible mechanisms. In addition smoking, 
race and disease category appear to affect IgG2 response in periodontal patients. 
Therefore, both environment and genotype influence the severity of disease observed 
in patients with periodontal disease. Research in this area in the future will help to 
unravel the complex processes involved.
1.8 Genetic Predisposition to Early Onset Periodontitis
1.8.1 Introduction
This review of genetic predisposition to early-onset periodontitis is divided into five 
sections. The first section presents an overview of study approaches used to 
investigate the role of genetic factors in periodontal disease. The three following 
sections summarise the current status of research into the genetic basis of prepubertal 
periodontitis, localised and generalised early-onset periodontitis, and adult
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periodontitis. The final section brings together reports of genetically determined host 
response aspects which have been investigated in periodontitis patients.
1.8.2 Overview of Study Approaches
Evidence for a genetic predisposition to periodontitis comes from four areas of 
research: 1) the study of inherited diseases and genetic syndromes; 2) association 
studies; 3) twin studies; and 4) family studies. In this section the design, intent and 
interpretation of each of these four approaches to the study of genetic diseases will be 
discussed.
1.8.2.1 Study of inherited diseases and genetic syndromes
Evidence for the role of specific genes in disease may be gleaned from the study of 
inherited conditions or genetic disorders, in which the disease is pathognomonic. A 
number of monogenic syndromes with accompanying severe periodontal disease have 
been reported in the literature. Although these reports have not always distinguished 
disease categories, they have identified the striking and consistent co-occurrence of 
early-onset and severe periodontitis. Examining the underlying immunological or 
structural defects associated with the inherited conditions and genetic syndromes can 
provide insight into the pathogenesis of disease in the general population.
1.8.2.2 Association studies
Environmental or behavioural risk factors for a disease are often first detected in large 
epidemiological or population-based studies. In genetic epidemiology, similar 
approaches can be used to identify genetic risk factors for disease. The frequencies of 
polymorphisms of candidate genes, whose protein products play a role in the 
inflammatory or immune response, can be compared between unrelated cases and 
controls. A significant difference in the frequency of a specific polymorphism 
between a disease group and a control group is evidence that the candidate gene plays 
some role in determining susceptibility to disease. An association indicates that either 
the candidate gene directly affects disease susceptibility or that it is in linkage 
disequilibrium with (very close to) the disease locus. This method can help to
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elucidate the pathogenesis of a disease process, identify aetiological heterogeneity and 
ultimately identify individuals most at risk of disease (Sofaer, 1990). In population 
studies it is important to clearly define disease status. Likewise, because of the 
possibility of racial heterogeneity (Marazita et al., 1994), it is important to insure that 
patient and control groups are racially matched.
1.8.2.3 Twin studies
Studying phenotypic characteristics of twins is a method of differentiating variations 
due to environmental and genetic factors. Sir Francis Galton in 1875 was the first 
scientist to use this concept to study disease aetiology. The twin method has been 
applied to many spheres of medical research including Alzheimer’s disease (Raiha et 
al., 1996), cancer (Ahlbom et al., 1997), diabetes (Poulsen et al., 1997) and response 
to drug administration (Vojvoda et al., 1996). Monozygous (MZ) twins arise from a 
single fertilised ovum and are therefore genetically identical and always the same sex. 
Dizygous (DZ) twins arise from the fertilisation of two separate ova and share, on 
average, one half of their genes in the same way as siblings do. Any discordance in 
disease between MZ twins must be due to environmental factors. Any discordance 
between DZ twins could arise from environmental and/or genetic variance. Therefore, 
the difference in discordance between MZ and DZ twins is a measure of the effects of 
the excess shared genes in MZ twins, when the environmental influence is constant.
In studying twins reared-together it is assumed, and can be indirectly tested, that the 
environmental variances of MZ and DZ twins are similar. For a condition which is 
predominantly environmental in origin, the correlations of MZ and DZ twins would be 
expected to be similar. If host genes influence disease susceptibility, concordance 
rates would be greater in MZ than DZ twins.
Studying MZ twins separated at birth and reared-apart provides an alternative
approach to determining the concordance due to shared genes (Bouchard, 1984). 
Under the assumption that adoption is independent of related environmental factors, 
then the similarity of these twins is due solely to the effects of shared genotype. The
rarity of such twins has limited their use in medical studies.
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1.8.2.4 Family studies
Many diseases and disorders aggregate in families. The magnitude of clustering, or 
family risk, can be estimated by comparing the risk of disease in first degree relatives 
of patients to the risk of disease in the general population (Vyse and Todd, 1996). A 
risk ratio of 1.0 implies no familial clustering. Since family members share 
descendent genes and environments, data from extended families can be used to 
separate the relative influences of genetic and environmental factors on the disease or 
disorder.
Most of the evidence to date for a genetic predisposition to EOP comes from 
segregation analysis. This method is used to search for a major gene. It attempts to 
uncover a pattern in family data that corresponds to the transmission of a gene (or in 
rare cases multiple genes). The observed proportions of affected siblings and offspring 
are compared with expected proportions under specific genetic hypotheses. For 
example, an X-linked recessive hypothesis would predict that males would be 
predominantly affected. The terms pedigree analysis and segregation analysis are 
often used interchangeably. However, strictly speaking pedigree analysis is a general 
term that refers to using pedigrees for genetic analysis. Pedigree analysis may include 
segregation analysis, linkage analysis and association analysis of candidate genes.
In segregation analyses of the periodontal diseases it is important to test multifactorial 
models as well as Mendelian models of major gene effects. Multifactorial models 
incorporate environmental and/or additional genetic factors, which may modify the 
clinical expression of disease in susceptible individuals. Finally, linkage studies can 
be used to confirm some genetic predisposition to disease and to identify risk genes. 
Linkage studies combine detailed clinical analyses of family members with genome 
wide scans, using known genetic markers to search for susceptibility or linked genes. 
Linkage is the association within families of two or more non-allelic genes resulting 
from their proximity on the same chromosome.
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1.8.3 Prepubertal Periodontitis
As has been mentioned earlier, Page and colleagues have proposed that the generalised 
form of PP is an oral manifestation of the leucocyte adhesion deficiency syndromes 
(Page et al., 1983; Page, Beatty and Waldrop, 1987; Meyle, 1994) (section 1.5.3.1). 
However, both GPP and LPP have also been described in otherwise healthy children 
(Butler, 1969; Fourel, 1972; Shapira, Schlesinger and Bimstein, 1997).
It has been proposed that PP is transmitted through an autosomal dominant mode of 
inheritance (Shapira, Schlesinger and Bimstein, 1997; Bimstein, Sela and Shapira,
1997). In one study of a large kindred, affected children were otherwise healthy and 
expressed normal levels of lymphocyte surface receptors including the adhesion 
molecules CD 18 and CD1 la. The occurrence of both GPP and LPP in siblings of this 
kindred suggests a common genetic aetiology for these disease forms. The differential 
expression of the phenotype could be due to the interaction of multiple genes or to the 
effects of interaction between the genotype and the environment.
PP has also been described in the offspring of a consanguineous marriage, which 
suggests that the disease may be transmitted by recessive genes (Lopez, 1992). In this 
report, both parents had AP. Two daughters, aged 13 and 15, had LEOP. Two other 
daughters and a son were diagnosed as having GPP, while two remaining siblings were 
not affected. Again, the co-occurrence of disease in one family points towards a 
common underlying genetic aetiology. In this family, GPP patients were otherwise 
healthy, while family members with LEOP, AP and one unaffected sibling showed 
depressed PMN chemotaxis (Lopez, 1992). Depressed neutrophil chemotaxis in GPP 
patients have been reported by others (Firatli et al., 1996a), suggesting that the genetic 
determinants of neutrophil functions may affect risk for EOP.
1.8.3.1 Monogenic syndromes
GPP has often been reported in patients with certain monogenic syndromes. These 
conditions are rare, and may be divided into those manifesting defects in neutrophil 
number or function, and those with epithelial or connective tissue pathogeneses (Table 
1.2).
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Table 1.2 Inheritance of the monogenic syndromes associated with a high 
incidence of periodontal disease.
Taken from McKusick (1994) - Mendelian Inheritance in Man. A Catalog of Human 
Genes and Genetic Disorders.
Neutrophil Defects Inherited Trait
Cyclic and Chronic Neutropenia AD
Leucocyte Adhesion Deficiency AR
Chediak-Higashi Syndrome AR
Glycogen Storage Disease lb AR
Infantile Genetic Agranulocytosis AR
Cohen’s Syndrome AR
Epithelial / Connective Tissue Defects 
Papillon-Lefevre Syndrome AR
Haim-Munk Syndrome AR
Ehlers-Danlos Syndrome, Types IV and VIII AD
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Polymorphonuclear leucocytes are the first line of defence against infection. Defects 
in either their number or function can have profound effects on host susceptibility. For 
example, cyclic and chronic familial neutropenias are inherited as autosomal dominant 
traits. Children suffering from these conditions have an increased susceptibility to 
infection due to a decrease in the number of circulating neutrophils. They suffer from 
oral ulceration, angular stomatitis and severe periodontitis (Cohen and Morris, 1961; 
Andrews et al., 1965; Kyle and Linman, 1970; Deasy et al., 1980; Porter et al., 1994). 
Variations in disease within the same family are thought to be due to differences in the 
standard of oral hygiene (Deasy et al., 1980).
Leucocyte adhesion deficiency occurs in two forms (type I and type II), which are both 
inherited in an autosomal recessive manner. Although the numbers of circulating 
leucocytes may be elevated, cells have defective surface receptors and are unable to 
adhere to vascular endothelial cells. In LAD I the defect is in the CD11/CD18 family 
of receptors; in LAD II the sialyl Lewis-X receptor is abnormal. The anomalies in 
LAD I have been identified as various DNA coding irregularities, which may result in 
an abnormal three-dimensional assemblage of the receptors (Daniel and Van Dyke, 
1996). Affected homozygotes suffer from acute recurrent infections, and those who 
survive infancy, develop severe periodontitis of the deciduous dentition immediately 
after eruption of the teeth (Waldrop et al., 1987; Page, Beatty and Waldrop, 1987; 
Nagahata et al., 1994; Paller et al., 1994). In addition, examination of the root 
surfaces of teeth from children suffering from LAD I has revealed areas of hypoplastic 
cementum (Waldrop, Hallmon and Mealey, 1995). This defect may contribute to the 
manifestation of the aggressive form of periodontitis seen in these patients.
Chediak-Higashi syndrome and glycogen storage disease lb  are inherited as autosomal 
recessive traits associated with severe periodontitis (Tempel et al., 1972; Hamilton and 
Giansanti, 1974; Charon, Mergenhagen and Gallin, 1985; Page and Beck, 1997). The 
chemotactic and bactericidal functions of neutrophils are abnormal in these patients. 
The faulty carbohydrate metabolism in individuals with glycogen storage disease lb 
has been associated with low neutrophil numbers, impaired neutrophil function and 
periodontal disease (Hara et al., 1987; Beaudet and Anderson, 1987).
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Infantile genetic agranulocytosis (Kostmann syndrome) is a rare disorder, which is 
inherited in an autosomal recessive manner. This condition manifests as severe 
neutropenia and has also been associated with EOP (Kyle and Linman, 1970; Saglam 
et al., 1995). Cohen’s syndrome is another autosomal recessive syndrome and is 
characterised by non-progressive mental and motor retardation, infantile hypotonia, 
childhood obesity and numerous dysmorphic features. Neutropenia is also a feature of 
this condition. Individuals with Cohen’s syndrome show more frequent and extensive 
BL than controls matched as far as possible for the degree of mental retardation 
(Alaluusua et al., 1997). Cohen’s syndrome patients also harbour one or more 
recognised periodontal pathogens in their subgingival plaque.
The most extensively studied of the monogenic conditions is the Papillon-Lefevre 
syndrome (PLS). This disease will be discussed in some detail here, as a number of 
recent papers in the literature have improved our understanding of the genetic 
background to this condition. The classical clinical manifestations of PLS are 
hyperkeratotic lesions of the skin, affecting the palmoplantar surfaces, and EOP, 
affecting the deciduous and permanent dentitions (Papillon and Lefevre, 1924). More 
recently, the Haim-Munk syndrome has been described. This condition is similar to 
PLS with the addition of arachnodactyly and a peculiar deformity of the terminal 
phalanges (Haim and Munk, 1965; Puliyel and Sridharan Iyer, 1986; Hart et al., 1997). 
The clinical presentation of PLS can vary. Cases have been reported with no history of 
periodontitis of the deciduous dentition (Schroeder et al., 1983; Willet et al., 1985; 
Brown et al., 1993; Bullon et al., 1993; Soskolne et al., 1996). Varying degrees of 
severity of periodontitis and abnormal keratosis have been noted (Soskolne et al.,
1996).
The underlying aetiology of PLS has been the subject of considerable debate in the 
literature (Gorlin, Sedano and Anderson, 1964; Shoshan, Finkelstein and Rosenzweig, 
1970; Lyberg, 1982; Page and Baab, 1985; Preus, 1988). Defects in epithelium 
formation have been proposed (Gorlin, Sedano and Anderson, 1964; Lyberg, 1982; 
Page and Schroeder, 1982; Schroeder et al., 1983). In addition, reduced lymphocyte 
response in vitro (Haneke, Homstein and Lex, 1975; Levo, Wollner and Hacham- 
Zadeh, 1980) and decreased chemotaxis and phagocytosis of neutrophils and
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monocytes have been suggested to cause the clinical manifestations seen in PLS 
patients (Djawari, 1978). These immunological defects may also explain the increased 
susceptibility to infections of patients with this syndrome (Haneke, Homstein and Lex, 
1975; Shams El Din et al., 1984; Van Dyke et al., 1984; Rateitschak-Pluss and 
Schroeder, 1984; Tinanoff et al., 1986; Bullon et al., 1993).
The Papillon-Lefevre and Haim-Munk syndromes are inherited as autosomal recessive 
traits (McKusick, 1994). A high degree of consanguinity has been reported in families 
with these conditions (Pareek and Al Aska, 1986; Soskolne et al., 1996; Hart et al., 
1997; Laass et al., 1997; Fisher et al., 1997). Recently, three studies involving 
genome wide linkage scans of consanguineous families linked the gene for PLS with a 
marker on the long arm of chromosome 11, near to the metalloproteinase gene cluster 
(Laass et al., 1997; Fisher et al., 1997; Hart et al., 1998). These reports have identified 
additional loci for the palmoplantar keratodermas. Previously, several forms of these 
conditions had been linked with mutations in the two clusters of genes for the type I 
and type II keratin proteins, on the long arms of chromosomes 17 and 12 (Rogaev et 
al., 1993; Lind et al., 1994; Reis et al., 1994). Cells of the epidermis become 
progressively impregnated with keratin, as the continuously dividing cells of the 
germinative layer push them towards the surface. It has been suggested that junctional 
epithelium shows a different type of expression of cytokeratins from the surrounding 
epithelium (Mackenzie et al., 1991). Furthermore, it has been proposed that the 
development of junctional epithelium and palmoplantar epithelium may be affected by 
a common gene defect (Hart et al., 1997). It now seems unlikely that this is the case 
following the confirmation of linkage between PLS and a marker on chromosome 11, 
separate from the gene clusters for the keratin proteins. Separate loci for palmoplantar 
hyperkeratosis and periodontitis, in linkage disequilibrium with one another, may be 
one explanation for the genetic basis of these clinical findings. This explanation has 
been previously proposed for LEOP and dentinogenesis imperfecta (Boughman et al., 
1986). It is also possible that the variation in the severity of the clinical features of 
PLS is due to the effects of two major genes, with other modifying genes influencing 
them in an additive or epistatic manner.
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Many conditions and syndromes have been documented which are known to arise from 
different genes yet present with the same clinical manifestations (McKusick, 1994). It 
now seems clear that the early-onset periodontal diseases are genetically 
heterogeneous in nature (Potter, 1989; Sofaer, 1990; Hart, 1996). The three research 
groups who recently linked the gene for PLS with chromosome 11 may yet provide the 
first confirmation of an autosomal recessive form of early-onset periodontitis (Laass et 
al., 1997; Fisher et ah, 1997; Hart et al., 1998).
Ehlers-Danlos syndrome covers a group of connective tissue disorders that are 
characterised by a defect of collagen synthesis. Individuals with types IV and VIII 
inherit this defect in an autosomal dominant manner and have an increased 
susceptibility to periodontitis (Linch and Acton, 1979; Hartsfield, Jr. and Kousseff, 
1990; Genco and Loe, 1993; Page and Beck, 1997). Clinical characteristics of type 
VIII Ehlers-Danlos syndrome include fragility of the oral mucosa and blood vessels 
and a severe form of EOP (Apaydin, 1995).
Other hereditary conditions that may reveal an associated periodontitis have been less 
well documented. These include the enzyme and enzyme inhibitor defects acatalasia 
and alpha-1-antitrypsin deficiency, which are autosomal dominant traits, and 
congenital erythropoietic porphyria, which is an autosomal recessive trait (Page and 
Beck, 1997). Alopecia, epilepsy and mental retardation are all inherited in an 
autosomal dominant manner (Page and Beck, 1997). Early-onset periodontitis has 
been reported in association with Weary-Kindler syndrome. Clinical manifestations of 
this condition also include epidermolysis bullosa and poikiloderma congenitale. The 
mode of inheritance of this rare syndrome is uncertain (Wiebe, Silver and Laijava,
1996).
It has been suggested that PP occurs only in children suffering from hypophosphatasia 
with an associated defective cementum (Baab et al., 1986). This theory is difficult to 
accept. In individuals with hypophosphatasia, the premature loss of the primary teeth 
soon after their eruption into the mouth is not necessarily the result of a' microbial 
infection and subsequent destruction of the periodontium. The condition is inherited 
in an autosomal dominant manner and is characterised by hypoplasia or aplasia of
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cementum, which prevents the normal attachment of periodontal ligament fibres (Page 
and Beck, 1997). In a recent study, the histological appearance of the root surfaces of 
primary teeth was described in children with PP and no systemic disease (Bimstein et 
al., 1998). It was found that some features of hypophosphatasia, such as atypical root 
resorption and the composition of the associated bacterial plaque, were also common 
to PP. However, there was no evidence of cementum aplasia which is characteristic of 
hypophosphatasia; instead, only abnormalities in cementum width were reported.
1.8.4 Localised and Generalised Early Onset Periodontitis
1.8.4.1 Inherited diseases and genetic syndromes
The incidence of periodontitis is higher in teenagers and adults with insulin dependent 
(type I) diabetes mellitus (Glavind, Lund and Loe, 1968; Cianciola et al., 1982; Loe, 
1993; Firatli, 1997). Type I diabetes mellitus is assumed to be autoimmune in nature 
and has been shown to have a clear genetic susceptibility (Todd, Bell and McDevitt, 
1988; Davies et al., 1994). Despite the association of periodontal disease and type I 
diabetes mellitus, no link between periodontitis and risk genes for diabetes has been 
established (Alley et al., 1993; Gustke et al., 1998).
The monogenic syndromes have been discussed in detail in the section on prepubertal 
periodontitis. In many of these conditions the permanent dentition is also affected to a 
greater or lesser extent. However, as has been mentioned earlier, most studies do not 
differentiate between the various forms of EOP. The periodontitis affecting the 
permanent dentition in Papillon-Lefevre syndrome may appear as an acute severe 
generalised infection from the time of eruption, which is refractory to treatment 
(Haneke, Homstein and Lex, 1975; Schroeder et al., 1983; Shams El Din et al., 1984; 
Van Dyke et al., 1984; Rateitschak-Pliiss and Schroeder, 1984; £elenligil et al., 1992; 
Soskolne et al., 1996). Alternatively, it may manifest as a late-onset form of more 
moderate periodontitis (Willet et al., 1985; Brown et al., 1993; Fardal, Drangsholt and 
Olsen, 1998). Some cases respond to periodontal therapy and resolution of symptoms 
occurs (Tinanoff et al., 1986; Preus and Gjermo, 1987; Ishikawa, Umeda and 
Laosrisin, 1994).
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The frequency of infections in patients suffering from LAD I markedly decreases by 
the time they reach their late teens. It appears that other aspects of the immune 
response mature and compensate for the defective neutrophil function (Page et al.,
1997).
Trisomy 21 is a chromosomal aberration that should also be included here. Individuals 
with Down’s syndrome have a higher incidence of periodontal disease, after taking 
into account levels of oral hygiene and other environmental variables (Cutress, 1971; 
Omer, 1976; Saxen, Aula and Westermarck, 1977; Saxen and Aula, 1982; Genco and 
Loe, 1993). In this condition extra copies of normal genetic material may result in 
aberrant gene dosage. The majority of cases of Down’s syndrome are trisomic for the 
whole of chromosome 21. This chromosome contains genes encoding a number of 
functional and structural proteins (Sofaer, 1990). The Down’s syndrome phenotype 
has, however, also been found with trisomy of band 21q22.3 alone (Pellissier et al.,
1988). It seems likely that the increased susceptibility to periodontal disease seen in 
patients with this syndrome, is caused by trisomy of another part of the chromosome, 
rather than being associated specifically with trisomy of band 21q22.3. One study has 
found decreased neutrophil chemotaxis in Down’s subjects (Izumi et al., 1989). 
Patients with Down’s syndrome also suffer from frequent upper respiratory tract 
infections, indicating an immune defect in resistance to bacterial infection (Hassell and 
Harris, 1995). The gene directing synthesis of the beta subunit of the leucocyte 
adhesion molecule is found on chromosome 21 (McKusick, 1994), and may influence 
neutrophil chemotaxis in these patients.
1.8.4.2 Family studies
Many reports in the literature have documented the familial pattern of the early-onset 
periodontal diseases. In a recent North American survey of 7447 dentate individuals 
aged 13 years and older, the prevalence of EOP was low in younger age groups 
(Brown, Brunelle and Kingman, 1996). The prevalence of loss of attachment > 5 mm 
was 0.3% in the 13-17 and 18-24 year olds, and 6.4% in the 25-34 year olds in this 
racially mixed population. In contrast, 40-50% of siblings in families with EOP may 
be similarly affected (Hart, 1996). This marked aggregation of EOP within families is
75
consistent with a genetic predisposition to this disease. However, familial patterns of 
disease may reflect not only a common genetic background but also exposure to 
common environmental factors (Hassell and Harris, 1995).
When evaluating the familial risk for periodontitis it is important to consider the 
myriad of known environmental and behavioural risk factors, including oral hygiene, 
exposure to specific oral bacteria, the presence of systemic disease, the competence of 
the immune system, smoking and psychological factors such as stress. Some of these 
factors themselves may be under genetic control; for example, the intelligence quotient 
of family members may influence oral hygiene standards.
The complex interactions between genes and the environment must also be considered 
when evaluating familial risk for the periodontal diseases. Currently, smoking and the 
presence of specific periodontal pathogens in subgingival plaque, appear to be the 
most important environmental risk factors for periodontitis (Bergstrom and Floderus- 
Myrhed, 1983; Grossi et al., 1994; 1995; Page and Beck, 1997). Transmission of 
periodontal pathogens within families has been documented (Gunsolley et al., 1990; 
Alaluusua, Asikainen and Lai, 1991; Petit et al., 1993a; 1993b; Asikainen, Chen and 
Slots, 1996; Zambon et al., 1996b; Stabholz et al., 1998). A recent study by Stabholz 
et al. (1998) on a unique population of teenagers attending the same orthodox religious 
school near Jerusalem reported a high prevalence of LEOP. Ten of 15 affected 
families had more than one affected sibling. Following repeated and intensive 
questioning, only two sets of families were found to be related. However, because the 
15 families were all of the same religion there were close social ties between them. 
The authors concluded that a strong environmental aetiology exists for LEOP. The 
findings of this study are in contrast to the consensus of the current literature. Further 
microbiological and linkage studies of this population should help to elucidate the 
contribution of genes and environment to the form of LEOP seen in these children. 
Since 75% of the parents originated from the East Coast of America and share the 
same orthodox religious beliefs, it is possible they may be unaware of being distantly 
related.
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The observation of bacterial transmission within families is insufficient on its own to 
account for the familial clustering seen in EOP (Boughman, Astemborski and Suzuki, 
1992; van der Velden et al., 1993; Tinoco, Sivakumar and Preus, 1998). In addition, it 
is not clear whether the presence of specific periodontal pathogens is necessary to 
cause destruction in genetically susceptible individuals. It is possible that commensal 
bacteria in an individual with a deficient immune response may be sufficient to cause 
tissue damage (Hart, 1996). Environmental conditions in the periodontal pocket might 
then favour the growth of opportunistic or exogenous pathogens (van Steenbergen et 
al., 1993). For example, smoking has important effects on the inflammatory and 
immune response (Kenney et al., 1977; Kraal et al., 1977; Totti et al., 1984; 
MacFarlane et al., 1992; Wolff, Dahlen and Aeppli, 1994; Tew et al., 1996). Smoking 
may tip the balance towards periodontal destruction in a susceptible host by, for 
example, suppressing levels of IgG2 antibody specific for certain periodontal 
pathogens (Tew et al., 1996). There is also evidence to suggest that smoking may alter 
the composition of subgingival plaque (Zambon et al., 1996a).
Attempts to elucidate the role of inheritance in periodontal disease are complicated by 
the heterogeneous nature of these diseases. Variations in ages of onset and clinical 
presentations of the disease further complicate formal genetic studies. Finally, even 
within families, multiple forms of disease can co-exist (Spektor, Vandesteen and Page, 
1985; Lopez, 1992; Boughman, Astemborski and Suzuki, 1992). Generalised 
prepubertal periodontitis, LEOP and AP can occur in the same family (Melnick, 
Shields and Bixler, 1976; Spektor, Vandesteen and Page, 1985; Lopez, 1992). Other 
reports have documented the sequential appearance of GPP, LEOP, and/or GEOP in 
the same subject (Butler, 1969; Jorgenson et al., 1975; Shapira et al., 1994a). It 
appears likely, therefore, that the various forms of EOP (PP, LEOP and GEOP), and 
possibly AP as well, have a common underlying genetic background. For the purposes 
of segregation analyses, most investigators have grouped the various forms of EOP 
together.
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1.8.4.3 Segregation analyses
There are a number of obstacles inherent in genetic studies of EOP, not least of which 
is the difficulty in accurately diagnosing family members. Boughman et al. (1988) 
discussed this and other problems including the following findings: 1) EOP has a 
variable age of onset and in most cases is not recognised until after puberty; 2) the 
upper age limit of expression of the disease is curtailed, because loss of attachment in 
patients older than 35 years cannot always be differentiated from AP; and 3) the 
difficulty in accurately determining phenotypes of edentulous family members. 
Despite these difficulties, pedigree and segregation analyses of EOP support the role of 
a major gene. Various modes of inheritance have been postulated for EOP. These 
include X-linked dominant (Melnick, Shields and Bixler, 1976; Fretwell, Leinbach and 
Wiley, 1982; Page et al., 1985; Spektor, Vandesteen and Page, 1985), autosomal 
recessive (Saxen, 1980b; Saxen and Nevanlinna, 1984; Beaty et al., 1987; Long et al., 
1987; Boughman et al., 1988) and autosomal dominant (Boughman et al., 1986; 
Marazita et al., 1994; Shapira, Schlesinger and Bimstein, 1997; Obach and Palomino,
1997). Most family studies of EOP have been conducted in North America and have 
consisted primarily of black families (Hart et al., 1993; Marazita et al., 1994).
Melnick and colleagues (1976) presented the most complete analysis of data from 
family studies found in the dental literature to date. Data from 19 sibships suggested 
that EOP was an X-linked dominant trait with reduced penetrance. Three important 
observations were made in support of this conclusion. Firstly, the observed ratio of 
females to males among affected persons was approximately 2:1. Secondly, no father- 
to-son transmission was seen. Finally, the segregation ratio of 0.39 was consistent 
with dominant transmission with reduced penetrance. The conclusion of this report 
was supported by two other studies of large families with a high prevalence of early- 
onset periodontitis (Page et al., 1985; Spektor, Vandesteen and Page, 1985). However 
Spektor et al. (1985) noted that the disease prevalence in the immediate family was 
found to be unusually high for an assumed X-linked dominant trait.
Other researchers have disputed these conclusions. Hart et al. (1992) re-evaluated the 
evidence for X-linked dominant inheritance of EOP. They argued that early reports
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were subject to proband bias because females are more likely to seek dental care than 
males (Benjamin and Baer, 1967). The proband is the affected individual through 
whom the family is identified. Two other papers found a predominance of female 
probands but equal sex distribution among affected relatives (Saxen and Nevanlinna, 
1984; Hart et al., 1991). The reported lack of father-to-son transmission of the disease 
was suggested to be due to incomplete pedigree information, because fathers were 
often not examined in family studies. Boughman et al. (1986) clearly demonstrated 
father-to-son transmission for EOP. Lastly, the segregation ratio of 0.39 is equally 
compatible with either X-linked or autosomal inheritance.
Saxen (1980b) examined 31 families and concluded that most probably EOP was 
inherited as an autosomal recessive trait with high penetrance in homozygotes. This 
was confirmed in a further study of 30 families (Saxen and Nevanlinna, 1984). Long 
et al. (1987) compared and evaluated autosomal recessive and X-linked dominant 
(reduced penetrance) modes of inheritance for LEOP and GEOP. They examined 33 
families and concluded that the autosomal recessive model was far more likely than 
the X-linked dominant one. They did not, however, test for autosomal dominance, and 
only four families had multiple generations affected including parent-offspring pairs. 
This low frequency of vertical transmission favours recessive inheritance of this 
disease. This group also noticed that both LEOP and GEOP occurred together in 
several families, indicating a shared genetic predisposition (Long et al., 1987).
An autosomal recessive model for EOP was proposed following the analysis of 28 
kindreds (Beaty et al., 1987; Boughman et al., 1988). The effect of including age- 
limits in the diagnostic assessment of EOP was investigated. In order to reveal the 
likelihood of mistaking an autosomal dominant mode of inheritance for an autosomal 
recessive one, phenotypes were simulated for the 28 families according to an 
autosomal dominant model. All phenotypes of individuals under 12 years or over 35 
years of age were designated as unknown. Simulations were then performed in a 
model-choice analysis using samples of the same size. The authors noted that the 
dominant model was chosen 60 of 100 times. The high rate of Type II error 
demonstrates the problems resulting from the age restrictions. Since familial 
clustering might be due to some shared environmental factors the authors tested a
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sporadic model, which assumed that the distribution of disease was due to ubiquitous 
exposure to an environmental agent. The sporadic model was rejected in favour of a 
genetic model. A combination of genetic and environmental factors might indicate a 
general multifactorial model, but the observed risk to relatives (18.6% of total first- 
degree relatives were affected in the families studied) exceeded the expected 
proportion of 7.1% by a wide margin. The authors concluded that the autosomal 
recessive model was the preferred one, since it was not significantly better than a 
general autosomal model. To help overcome the problem of truncation of the affected 
phenotype, it has been suggested that more complete phenotypic information should be 
obtained for all adult relatives during the years of risk (Beaty et al., 1987; Boughman 
et al., 1988).
The most convincing evidence for autosomal dominant inheritance and race-specific 
heterogeneity in EOP was provided by Marazita et al. (1994). This large-scale 
segregation analysis included 100 nuclear families ascertained through 104 probands 
with EOP. Because many of the probands' relatives were over 35 years of age at the 
time of study, diagnoses of EOP were made using previous radiographs and dental 
histories. Progression from the localised to the generalised form of the disease was 
noted in 26 GEOP subjects. Sixteen families demonstrated co-occurrence of LEOP 
and GEOP. Although 100% fewer fathers than mothers took part in the study, the 
proportions of affected females to affected males was not significantly different among 
relatives of the probands (Hart et al., 1991). The authors concluded that the most 
likely mode of inheritance was autosomal dominant in both black and non-black 
kindreds with 70% penetrance in black and 73% in non-black. They also detected 
significant racial heterogeneity for most parameter estimates.
A recent segregation analysis of families with EOP investigated the possibility of 
Mendelian inheritance of the IgG2 response of relatives (Marazita et al., 1996). IgG2 
levels were determined in 123 affected families and in 508 unrelated unaffected 
controls. The results of the segregation analysis indicated a major autosomal co­
dominant mode of transmission for IgG2 levels, after adjusting for age, sex, race and 
LEOP status. Sixty-two percent of the variance in IgG2 levels was estimated to be due 
to the major locus, with significant spouse and parent/offspring residual correlations.
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When smoking was also investigated as a covariate in a subset of 89 families, the best 
fitting model was still an autosomal co-dominant major locus with no residual 
correlations. This result suggests that the residual correlations in the first dataset were 
due to smoking habits.
1.8.4.4 Linkage studies
Very few family linkage studies of periodontitis have been undertaken. Two of these 
have been in families with a high prevalence of LEOP. Boughman et al. (1986) 
identified an autosomal dominant form of LEOP, in a large five-generation kindred 
from the Brandywine isolate in southern Maryland, and carried out a linkage study. It 
was found that both type III dentinogenesis imperfecta (DGI) and a localised form of 
EOP were segregating as dominant traits. In this study the gene for LEOP was linked 
to the vitamin D-binding protein group-specific component (Gc) locus, situated on the 
long arm of chromosome 4. The locus for the more common type of dentinogenesis 
imperfecta (DGI-II) had previously been linked with Gc. Linkage analysis of genetic 
and chromosomal markers on chromosome 4, suggested the gene order to be 4cen— 
LEOP—Gc--DGI—MNS—qter (Cohen et al., 1986).
Another group re-evaluated the above finding by studying 19 unrelated families, each 
with two or more EOP affected individuals (Hart et al., 1993). Their results indicated 
no significant evidence of linkage to this region for any of the models tested. It was 
hypothesised that this could be due to a previous false positive report of linkage. 
Alternatively, it was suggested that genetic locus heterogeneity might exist in EOP. 
This could be due to racial differences or because the Brandywine family had a form of 
LEOP that differed from the type found in the families in the subsequent study.
A large scale linkage study of 100 families with EOP also did not confirm linkage to 
chromosome 4 (Wang et al., 1996; Hart and Komman, 1997). Linkage was found 
between susceptibility to EOP and the HLA region of chromosome six and the region 
coding for the COX-1 enzyme system on the long arm of chromosome 9. COX-1 is 
involved in synthesis of PGE2 and may be important in regulating levels of this 
inflammatory mediator in periodontal disease.
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1.8.4.5 Association studies
A study, in a population of Japanese patients, found a significant association between 
an atypical BamRl restriction site in the HLADQB gene and EOP (Takashiba et al., 
1994). More recently a French group investigated HLADR polymorphisms in patients 
with rapidly progressive disease (Bonfil et al., 1999). They found a significant 
association between alleles DRBJ*0401, 0404, 0405, 0408 and GEOP. These alleles 
had previously been found to be associated with RA.
A recent study in North America found very significant evidence of linkage 
disequilibrium between allele one of the ILIA -889 gene and allele one of the IL1B 
+3953 gene and GEOP (Diehl et al., 1999) (section 1.8.5.3). A number of multiplex 
families were used to investigate these candidate genes in EOP. In this report, both the 
transmission disequilibrium test (TDT) and the affected sib pair design were used to 
examine the association between the two IL1 polymorphisms. The TDT test compares 
the number of transmissions of specific alleles from heterozygous parents to affected 
offspring. For GEOP subjects allele one of the ILIA -889 polymorphism was 
transmitted significantly more frequently than allele two (p = 0.0065). There were 
seventeen transmissions of allele one of the IL1B +3953 gene and only two 
transmissions of allele two (p = 0.0005). Similar but non-significant trends were found 
for LEOP. Associations were observed in both smokers and non-smokers. The 
homozygous (1,1) IL1B +3953 genotype was also transmitted significantly more often 
to GEOP affected individuals than to unaffected subjects (p = 0.014). These findings 
were consistent in both African Americans and Caucasians, although the numbers in 
some categories were small. Further analyses revealed that the transmission 
disequilibrium is more strongly associated with the IL1B +3953 polymorphism. These 
results provide evidence that the IL1B +3953 polymorphism (allele one) may be in 
linkage disequilbrium with one EOP gene. Results from the affected sib pair analysis 
were less compelling.
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1.8.5 Adult Periodontitis
1.8.5.1 Monogenic syndromes
Varying degrees of periodontitis of the permanent dentition have been reported for 
some of the monogenic syndromes. In cyclic and chronic neutropenia, the neutropenia 
and associated periodontitis may be less severe in the permanent than in the deciduous 
dentition (Sofaer, 1990). In heterozygote individuals with LAD, who have half the 
amount of normal membrane glycoprotein in the cell surface receptors, less severe BL 
of the permanent dentition may be evident later in life (Waldrop et al., 1987). It is 
possible that there is coincidental development of AP, which is not related to LAD.
1.8.5.2 Twin studies
Despite the twin model being a very powerful method of providing evidence of a 
genetic predisposition to disease, there have been very few twin studies of AP. An 
early study, which investigated levels of gingival recession and crevice depth, and 
indices of gingivitis, supragingival plaque and calculus, in 26 twin pairs aged 12-17 
years, found no evidence of genetic influence (Ciancio, Hazen and Cunat, 1969). An 
explanation for this finding may have been the relatively young age of the individuals 
and the small sample size.
More recently, larger studies of older subjects have found an association between 
genetic variation and individual susceptibility to AP. Corey et al. (1993) collected 
questionnaire data of periodontal health from 4,908 twin pairs included in the 
population-based Virginia Twin Registry. Four hundred and twenty individuals (mean 
age 31.4±0.7 years), who were members of 116 identical and 233 fraternal twin pairs, 
reported a history of periodontitis. The concordance rate ranged from 0.23 to 0.38 for 
MZ twins, and 0.08 to 0.16 for DZ twins. It was concluded from these results that 
adult-onset periodontal disease has a genetic susceptibility. However, in this study no 
data on smoking status were collected for the subjects who took part and no 
adjustments were made for sex and age, which may inflate twin correlation (McGue 
and Bouchard, 1984).
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A large-scale study of twins recruited from the Minnesota Twin Registry and the 
Minnesota Study of Twins Reared-Apart was undertaken by Michalowicz and co­
workers (Michalowicz et al., 1991a; 1991b; Michalowicz, 1994; Rudney et al., 1994). 
They investigated clinical status and host risk factors for periodontal disease in 17 
pairs of reared-apart dizygous twins (DZA), 63 pairs of dizygous twins reared-together 
(DZT), 83 pairs of monozygous twins reared-together (MZT) and 21 pairs of 
monozygous twins reared-apart (MZA). Ratio of the within-pair variances of dizygous 
to monozygous twins was significantly greater than zero for mean probing depth and 
AL, for both unadjusted and adjusted values. It is important to bear in mind that the 
majority of twins in this study had mild AL. Therefore, it is possible that the small 
variance in AL, with a concurrent large measurement error, might mask an even 
greater genetic contribution. Alternatively, more severe disease may show greater or 
less genetic variability. The correlation for AL was similar between MZT and MZA 
twin groups, which indicates that a common environment does not influence AL in 
adults. In addition, MZT twins were found to be less concordant for oral hygiene 
habits than DZT twins. Therefore, the mean probing depth and attachment level scores 
were found to vary less for MZT than for DZT twin pairs, despite the reverse being the 
case for oral hygiene practices. Investigation of alveolar bone height in twins from the 
Minesota study also showed significant variation due to differences in genotype 
(Michalowicz et al., 1991b). Subgingival plaque samples from 169 twin pairs were 
also analysed for the presence of Pi, Pg, Aa, Ec and Fn using an immunoassay 
(Michalowicz et al., 1999). For all species examined, the concordance rates were not 
significantly different between MZ and DZ twin groups. These findings were apparent 
despite similar smoking histories, self-reported oral hygiene practices and antibiotic 
use in the twin groups. It was concluded that there is a genetic contribution to clinical 
and radiographical, but not microbiological, measures of disease. However, the mode 
of transmission of the trait may be a complex interaction between alleles at more than 
one locus, or between genetic and environmental and/or systemic factors.
Studies of structural or immunological features, which may have an effect on 
expression of periodontal disease, have been investigated in twins. Examination of 
salivary protein levels, in monozygous and dizygous twins, found the correlation for 
total protein, lactoferrin and total peroxidase indicative of a shared genetic and
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environmental model. However, a much more complicated genetic influence was 
suggested by data for myeloperoxidase (Michalowicz et al., 1991b). In vitro models of 
cells cultured from twins have shown that proliferation of fibroblasts from gingival 
biopsies of identical and fraternal twins are under significant genetic influence 
(Cockey et al., 1989; Hassell and Harris, 1995). In addition, the exposure of 
fibroblasts to extracts from periodontal pathogens has found a strong genetic 
susceptibility to these bacteria. This is manifested in the cytoskeletal structure of these 
cells (Hassell and Harris, 1995; Hassell et al., 1997).
1.8.5.3 Association studies
Two studies of large populations of patients and race-matched controls, have recently 
investigated associations between Fc-gamma receptor (FcyR) polymorphisms and AP 
(Kobayashi et al., 1997; Van Schie et al., 1998) (section 1.8.6.3). FcyRIIa and 
FcyRIIIb genotypes were investigated in 100 Japanese maintenance patients and 105 
healthy controls (Kobayashi et al., 1997). No associations were found between any 
specific genotype and the disease. However, in those patients with recurrence of 
disease the FcyRIIIbNA2 allele was found significantly more frequently (p < 0.05). 
Furthermore, the annual rate of recurrence was significantly higher in patients 
homozygous for NA2 and heterozygous for NA2/NA1 than in those who were 
homozygous for NA1 (p < 0.05). It is interesting to note that only six patients were 
homozygous for the FcyRIIaR131 genotype in this report and all of them showed 
recurrence of disease, although the results were not significant (p = 0.06). It has been 
demonstrated previously that a very low prevalence of the FcyRIIaR/R131 genotype 
exists in Japanese individuals (Osbome et al., 1994; Rascu et al., 1997). This may 
account for the lack of a significant finding for this genotype. The authors also 
investigated whether the following confounding factors influenced the correlation 
between the FcyRIIIbNA2 allele and disease recurrence: serum IgG subclass 
concentrations; clinical parameters at baseline and at follow-up; differences in the 
distribution of disease recurrence between mild and severe forms of AP; and smoking. 
None of these covariates were found to be responsible for the observed correlation. It 
was concluded that the FcyRIIIbNA2 allele may be a risk factor for recurrence of
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periodontitis. In addition, it was suggested that the association of the FcyRIIaR/R.131 
genotype with disease recurrence should be investigated in other ethnic populations 
(Kobayashi et al., 1997).
In another study in American Caucasians, 105 patients with moderate to severe AP and 
132 age-matched and healthy controls were examined for FcyRIIa and FcyRIIIb 
genotypes (Van Schie et al., 1998). FcyRIIaH/H131 combined with 
FcyRIIIbNA2/NA2 was found significantly more frequently in patients than controls. 
FcyRIIaR/H131 combined with FcyRIIIbNA2/NA2 was significantly reduced in 
patients compared with controls (p = 0.035). Neither genotype demonstrated any 
association when considered individually. These results are confusing in the light of 
the knowledge we have concerning the protective role of the FcyRIIaH/H131 genotype 
(Sanders et al., 1995; Wilson and Kalmar, 1996). It is possible that these combined 
genotypes are in linkage disequilibrium with other alleles and form part of an extended 
haplotype, rather than being directly responsible for immune defects themselves.
Colombo et al. (1998a) recently investigated serum levels of IgG2, Gm(23) allotype 
and FcyRIIa and FcyRIIIb genotypes in 32 refractory, 54 successfully treated and 27 
periodontally healthy subjects. The number of smokers was not significantly different 
between the groups. No significant differences in serum IgG2 levels, Gm(23) 
allotypes or FcyR genotypes were found between the three groups. These variables 
were weakly related or not related to clinical status. It is possible that no relationship 
exists between any of these factors and periodontal disease. Alternatively the 
heterogeneous and multifactorial aetiology of the disease may mask any association, 
because of the varying importance of specific factors between individuals. In addition, 
the authors did point out that specificity of IgG2 was not determined, which might 
cause confusion because of raised IgG2 levels to an infection in a different body 
system.
A recent paper has indicated an association between a composite genotype of allele 2 
of the IL1B +3953 gene and allele 2 of the ILIA -889 gene and the severe form of AP 
(Komman et al., 1997). All the patients in this study were Caucasian and of Northern 
European origin. The association was only found in non-smokers. Those non-
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smokers who were positive for the composite genotype had the same risk of disease as 
smokers who were either genotype-positive or genotype-negative. This result requires 
corroboration in larger studies of AP patients. There were only eighteen patients in the 
severe non-smoking group and although the OR between severe versus mild AP was 
large (18.90), the confidence intervals were very wide (1.04-343.05).
Another recent report of a population of Caucasian AP patients, found an association 
between allele 2 of the IL1B +3953 gene and advanced periodontitis. This genotype 
occurred more frequently in patients with advanced disease, when compared to 
patients with either mild or moderate disease (Gore et al., 1998). However, there was 
no significant difference between the advanced group and the healthy control group 
with regard to this allele. No associations were found between the ILIA -889 gene and 
any of the disease categories or between patients and healthy controls. Furthermore, 
an investigation of the composite genotype (allele 2 of the IL1B +3953 gene and allele 
2 of the ILIA -889 gene (Komman et al., 1997)), demonstrated a very significant 
association (p = 0.002, 2-tail Fisher’s exact test) between this genotype and both 
patient and control groups. These findings are difficult to interpret but do appear to 
bring into question the results of Komman et al. (1997). However, the findings of the 
more recent study should also be treated with caution, as the numbers of individuals in 
the different categories of disease severity were small (n = 10 for mild, 10 for 
moderate, 12 for severe). Because of the small size of the groups, no analysis of the 
contribution of smoking as a confounding variable could be carried out (Gore et al.,
1998).
It is also interesting to note, that the findings of both of these groups differ from those 
of Diehl et al. (1998) who studied IL1 polymorphisms in EOP (section 1.8.4.4). In 
the EOP study linkage disequilibrium was found between GEOP and allele 1 of the 
IL1B +3953 gene (p = 0.0005). Allele one of ILIA -899  was also transmitted 
significantly more frequently (p = 0.0065). This may be due to differences between 
diagnostic groups. However the latter study did investigate a much larger group of 
individuals. Twenty-eight African American families, with 94 EOP affected and 85 
unaffected subjects, and seven Caucasian families, with 31 EOP affected and 36 
unaffected subjects, were included in the analysis.
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Galbraith et al. (1998) also determined TNF genotypes in the same populations of AP 
patients and healthy controls as were investigated for IL1 polymorphisms (Gore et al.,
1998). TNFa production by oral PMN was also measured. No differences in the 
three-biallelic polymorphisms of TNF (-238, -308, +252) (Figure 4.1) were found 
between AP patients and controls, or between patients with different levels of disease 
severity. However, a significant association was noted between the level of TNFa 
production by oral PMN and the heterozygous 77,2 genotype of TNFA -308 (p =
0.037). When severity of disease was investigated in relation to level of secretion of 
TNFa, an association between the Tl,2 genotype and increased production of TNFa 
was only seen in patients with severe disease. Again the small sample size of the 
different disease categories should be noted. Furthermore only three patients in the 
severe group showed increased production of TNFa and were also heterozygous for 
the TNFA -308 gene polymorphism.
1.8.6 Aspects of the Host Response which may form the basis of Genetic 
Susceptibility to EOP
The genetic basis of a number of aspects of the host response has already been 
discussed earlier. The aim of this section is to summarise the role of these innate, 
inflammatory and immunological defects.
There are several features of the host’s innate immune system, which may contribute 
to genetic susceptibility to EOP. These include epithelial and connective tissue 
anomalies (section 1.8.3.1) and fibroblast defects (Cockey et al., 1989; Anavi et al., 
1989; Hassell et al., 1997; Aldred and Bartold, 1998). Other possible traits are 
alkaline phosphatase deficiency resulting in defective cementum (Baab et al., 1986) 
and variation in salivary protein levels (Rudney et al., 1994).
Defects in the inflammatory and humoral immune response which might predispose an 
individual to periodontitis are discussed below.
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1.8.6.1 IgG2 response
Lu et al. (1994) have shown that serum IgG2 levels are increased in LEOP patients, as 
opposed to GEOP, AP or unaffected individuals. This point is of interest because 
IgG2 is the predominant immunoglobulin subclass reactive with Aa serotype b outer 
membrane antigens. Aa is a periodontal pathogen considered important in early-onset 
periodontitis (Wilson and Hamilton, 1992; Lu et al., 1993; Wilson, Bronson and 
Hamilton, 1995). Serum IgG2 levels were shown to increase with age and there was a 
sharp rise at around puberty (Lu et al., 1994). Black subjects in all diagnostic groups 
had higher levels of IgG2 than whites. The incidence of LEOP among black 
individuals has been shown to be at least 15 times greater than among whites (Saxby, 
1987; Loe and Brown, 1991; Melvin, Sandifer and Gray, 1991). Furthermore, the 
increase in serum IgG2 levels in LEOP patients was found not to be entirely 
attributable to high anti-Aa serotype b levels which accounted for only about 10% of 
the excess IgG2 in LEOP patients’ sera. It appears that LEOP patients, particularly 
black individuals, have a tendency, perhaps a genetic predisposition, to produce 
increased levels of IgG2 (Tew et al., 1996).
A recent segregation analysis of families with EOP indicated a major autosomal co­
dominant mode of transmission for IgG2 levels, after adjusting for age, sex, race and 
LEOP status (Marazita et al., 1996) (section 1.8.4.3). Convincing evidence exists for a 
protective role of high levels of IgG2 in patients with LEOP (Tew et al., 1996). 
Smoking has been found to suppress the IgG2 response in AP and GEOP patients and 
is associated with more severe destruction. This does not appear to occur in LEOP 
patients (Tew et al., 1996). Furthermore, the lower IgG2 titres seen in black GEOP 
smokers may be specific to Aa. IgG2 response against antigens of other bacteria may 
not be lower in GEOP subjects who smoke (Tangada et al., 1997).
Definition at the gene level for this major autosomal co-dominant trait for IgG2 
response may lie within the major histocompatability complex on chromosome six 
(section 1.4).
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1.8.6.2 Gm allotypes
Another region of the genome that could determine serum levels of IgG2 is the y-2 
heavy chain gene complex situated on chromosome 14, which influences Gm allotypes 
found on IgG molecules. Only one allotype has been found to be associated with IgG2 
and this is Gm23 (G2m[n]) (Marazita et al., 1996). It has been shown that one allele 
of the Gm23 locus produces higher levels of IgG2 (Rautonen, Sarvas and Makela,
1989). Furthermore, immune response genes within the MHC interact with Gm-linked 
genes in influencing serum antibody responses to specific bacterial antigens 
(Whittingham et ah, 1980). However, in the study of Marazita et al. (1996) 
segregation of Gm23 was not found to be responsible for the co-dominant mode of 
inheritance they observed. In addition, Colombo et al. (1998a) did not find any 
association between Gm allotypes and refractory periodontitis, successfully treated 
periodontitis or a healthy periodontium.
1.8.6.3 Fey receptors
Some investigators have shown that patients with GEOP can demonstrate high 
antibody titres against Aa serotype b outer membrane antigens (Gunsolley et al., 1988; 
Wilson and Hamilton, 1995; Tew et al., 1996). It has also been suggested that the 
subclass IgG2 is a poor opsonin because it fixes complement less effectively than IgG3 
and IgGl and binds weakly to Fc receptors on the surface of phagocytes (Roitt, 1994; 
Wilson and Kalmar, 1996). These observations complicate any rationalisation of the 
proposed protective effect of high anti-Aa titres of IgG2 in black LEOP patients. More 
recently, another aspect of the immune response has been elucidated that may explain 
this phenomenon.
Fc receptors provide a critical link between the humoral and cell-mediated components 
of the immune system. FcyR on phagocytes recognise the Fc region of IgG. An 
excellent review of the possible role of FcyR in determining susceptibility to LEOP 
was recently presented by Wilson and Kalmar (1996). What follows is a brief resume. 
It has been shown that neutrophils express low-affinity FcyR (FcyRII [CD32] and 
FcyRIII [CD16]) under normal conditions. FcyRII bind all subclasses of IgG but 
FcyRIII only bind IgG3 and IgGl. Many more FcyRIII than FcyRII are expressed on
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the surface of neutrophils. However, while FcyRIII can evoke lysosomal 
degranulation they are incapable of promoting respiratory burst activity and 
phagocytosis. FcyRJI on the other hand can precipitate all three activities. It is 
possible that FcyRIII may prepare PMNs for phagocytosis mediated by FcyRII (Wilson 
and Kalmar, 1996).
It appears likely that phagocytosis of Aa opsonised with IgG2 is mediated by the 
presence of FcyRII. FcyRII and FcyRIII exist in a number of isoforms coded by genes 
situated on the long arm of chromosome 1. Both FcyRIIa and FcyRIIIb show biallelic 
polymorphism which have been shown to influence neutrophil phagocytic capacity 
(Kobayashi et al., 1997). IgG2 is bound more effectively by the HI 31 allotype of 
FcyRIIa than by the R131 allotype and opsonised particles are phagocytosed more 
efficiently (Sanders et al., 1995; Wilson and Kalmar, 1996). Thus the possibility 
exists that the perceived protective effect of a high IgG2 titre reactive against Aa is 
also dependent on the H I31 allotype of FcyRIIa. A recent study found that opsonic 
activity of affinity-purified IgG2, reactive against cell-envelope antigens of Aa, from 
patients with LEOP but not from healthy sera effectively mediated phagocytosis and 
killing by neutrophils which were homozygous for the H I31 allotype (Wilson, 
Bronson and Hamilton, 1995). Two earlier studies had found that in either the 
presence or absence of complement, opsonisation of Aa by IgG2 is enhanced by the 
presence of neutrophils that are homozygous for H I31 and inhibited by neutrophils 
homozygous for R131 (Cutler, Kalmar and Arnold, 1991).
It has been reported that the numbers of FcyRII and FcyRIII on peripheral blood 
neutrophils of LEOP patients are within the normal range (Leino et al., 1994). 
However, uncertainty exists regarding which allotype is present. Miyazaki et al. 
(1997) found that both FcyRII and FcyRIII expression and neutrophil phagocytosis 
were significantly depressed in GCF compared with peripheral blood in AP patients. 
The reduction in FcyR significantly correlated with phagocytic activity. In addition 
the mRNA level of FcyRIII was also significantly lower in GCF neutrophils than in 
peripheral blood neutrophils, but not the mRNA level of FcyRII. These findings 
indicate local suppression of FcyR expression and/or the production of Fcy-binding 
proteins by periodontal pathogens (Hillestad, Helgeland and Tolo, 1996). In this study
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individual FcyR allotypes were not examined. There have been no published reports 
of FcyR polymorphisms in LEOP or GEOP patients but three research groups have 
investigated FcyR polymorphisms in AP patients (Kobayashi et al., 1997; Van Schie et 
al., 1998; Colombo et al., 1998a) (section 1.8.5.3). Research in the future aimed at 
defining which allotypes are present on both peripheral and gingival neutrophils in 
relation to genotype, in different categories of periodontal disease and different racial 
groups, may yield interesting results.
1.8.6.4 Neutrophil chemotactic defects
Another possible mechanism whereby genetic associations are translated into an 
increased susceptibility to EOP are through chemotactic defects of neutrophils. A high 
percentage of members of families with a background of LEOP show abnormal 
neutrophil chemotaxis (Van Dyke et al., 1985). Analysis of 22 families with LEOP 
demonstrated that in 19 of these families the proband and all affected siblings 
manifested neutrophil chemotaxis disorders. In the families investigated the 
chemotactic defect was found in almost 50% of the siblings, indicating a dominant 
mode of inheritance (Van Dyke et al., 1985). Whether the trait is due to an intrinsic 
defect of neutrophils or is caused by extrinsic factors in the sera is controversial 
(Agarwal et al., 1996). If the neutrophil chemotactic defect is the manifestation of a 
major gene locus, heterogeneity of LEOP exists because a significant number of 
patients and families with LEOP do not show evidence of the defect (Kinane et al., 
1989; Page and Beck, 1997).
Reports of decreased neutrophil chemotaxis in LEOP have been associated with a 
lower number of receptors for chemoattractants such as N-formyl-methyl-leucyl- 
phenylalanine (FMLP), complement fragment C5a, leukotriene B4 and interleukin-8 
(De Nardin et al., 1990; Daniel and Van Dyke, 1996). A cell surface glycoprotein 
(gpllO) possibly involved in neutrophil movement and secretion is reduced in LEOP 
patients (Van Dyke et al., 1987). In addition, several other post-receptor defects have 
been identified (Daniel and Van Dyke, 1996). Recently De Nardin (1996) investigated 
decreased FMLP binding in relation to variations in FMLP receptor DNA from 
patients with LEOP and from healthy controls. Initial results indicated a base change
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in the FMLP receptor DNA from LEOP patients with decreased FMLP binding. This 
resulted in a different amino acid in a region of the receptor molecule which has been 
shown to influence ligand binding. An LEOP patient and healthy controls with normal 
receptor binding showed no changes in DNA. These preliminary results indicate a 
possible role for a FMLP receptor alteration in neutrophil chemotaxis. However, the 
author points out in the discussion that many of the molecules related to neutrophil 
dysfunction in LEOP patients belong to the same family of surface receptors and have 
similar morphogenic characteristics. Similarities in signal transduction mechanism 
between cell surface components also exist. De Nardin (1996) hypothesised that a 
common underlying defect, at either the cell surface receptor or post-receptor level, 
contributed to the alteration in neutrophil function seen in patients with LEOP.
1.8.6.5 Inflammatory mediators
It has been demonstrated that sera from LEOP patients with decreased neutrophil 
function can modify the activity of healthy neutrophils (Agarwal et al., 1996). The 
serum factors responsible for these effects have been identified as being inflammatory 
mediators such as prostaglandins and cytokines. Small quantities of bacterial 
lipopolysaccharide (12.5 pg/ml) can induce the secretion of TNFa, IL-1 and PGE2 
from monocytes. The production of IL-1-TNFa and TNFa-PGE2 are strongly 
correlated (Molvig et al., 1988). Very small increases in serum cytokine levels can 
alter neutrophil function. PGE2 and cytokines also stimulate fibroblasts to release 
MMPs, which break down the extracellular matrix. In addition, IL-1, TNFa and PGE2 
are potent stimulators of bone resorption. Adherent mononuclear cells from LEOP 
patients have been found to secrete higher levels of PGE2 and TNFa than GEOP 
patients or healthy controls (Shapira et al., 1994c). More recently, insulin-dependent 
diabetic patients with periodontitis have been reported to manifest excessive levels of 
inflammatory mediators (Salvi et al., 1997a; 1997b; Salvi, Beck and Offenbacher,
1998). It has been suggested that these observations indicate an underlying immune 
defect of monocytes in certain diagnostic groups (Offenbacher, 1996). However, there 
are dissenters from this theory (Kjeldsen et al., 1995; Shapira, Soskolne and Van 
Dyke, 1996).
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A genetic basis for the concept of excessive production of inflammatory mediators by 
monocytes has recently begun to appear in the literature. Early investigations of 
genetic polymorphisms of cytokines have attempted to identify a possible link between 
different periodontal categories and specific alleles (Komman et al., 1997; Diehl et al., 
1998; Galbraith et al., 1998; Gore et al., 1998) (section 1.8.5.3). In addition, a family 
linkage study of EOP linked the disease with the region encoding the COX-1 enzyme 
system on the long arm of chromosome 9 (section 1.8.4.4). This system acts as a 
catalyst for the breakdown of arachidonic acid, one of the products of which is PGE2 
(Gemmell, Marshall and Seymour, 1997).
1.8.7 Summary
It is important to highlight the use of clear diagnostic criteria in the investigation of 
hereditary diseases. Genetic analyses must be underpinned by reliable clinical 
diagnoses within heterogeneous populations; otherwise genetic transmission 
assessments will be erroneous.
A number of aspects of the inflammatory and immune response that are suspected to 
play a role in the development of periodontal disease have a clearly defined genetic 
basis (Malo and Skamene, 1994; Wilson, di Giovine and Duff, 1995; Vyse and Todd, 
1996). Possible associations between several of these aspects of immune defence and 
genotype have been discussed in the context of both family and population studies.
One hypothesis of the complex multifactorial background to EOP is that mutations 
exist that cause general defects in immune responsiveness, whereas other genes cause 
specific defects in the periodontium. The genes controlling immune regulation could 
interact in an additive, synergistic or epistatic manner with genes of major effect 
inherited in a Mendelian fashion (Hart, 1996). Furthermore, environmental factors 
might affect the phenotypic expression of the genotype of different individuals in a 
diverse manner. This explanation would allow for the variation in age of onset and 
extent and severity of disease seen in patients with EOP.
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1.9 Aims and Objectives
1.9.1 Genetic Markers of Susceptibility to Periodontitis
As mentioned earlier, no host-based biochemical or cellular markers of periodontitis 
have so far been identified. Many candidate aetiopathogenic factors have been 
proposed as possible disease markers but no single entity has emerged as 
pathognomonic for any of the periodontal diseases. Several factors appear to be 
useful. However, doubts exist as to their role in aetiopathogenesis and considerable 
technical difficulties prevail in their application. Investigations of cytokine levels or 
the humoral response in serum, gingival tissue cell supernatants and GCF have 
produced conflicting results from different research groups. This is due to the 
following reasons: the reverse-transcriptase polymerase chain-reaction (RT-PCR) 
which is one method of measuring cytokine levels lacks quantitation (Gemmell and 
Seymour, 1998); because of the short half-life of some cytokine mRNAs, such as IL-4, 
measurements do not reflect actual cytokine production; large individual variation 
exists in antibody titres and avidities among patients and controls, there is very 
probably cross-reactivity between antigens of periodontal bacteria and those of the 
gastro-intestinal tract; during tissue remodelling, increased levels of both 
proinflammatory and anti-inflammatory cytokines are found; tissue breakdown 
products such as alkaline phosphatase and glycosaminoglycans can also be found 
during remodelling; and finally, bacterial proteases may breakdown antibodies and 
cytokines in the tissues and GCF. Assessing the numbers of immune and 
inflammatory cells and differences in their intracytoplasmic cytokine synthesis 
patterns in gingival tissues is probably more informative. Immunohistochemistry, in 
situ hybridisation and flow cytometry techniques are methods of investigating 
variations between diseased and healthy tissues and among different categories of 
periodontitis. However, due to wide individual variation and the dynamic nature of the 
disease process, no markers of disease status have yet come to light.
Considering the problems outlined above, the identification of a stable marker of 
periodontal disease susceptibility which is independent of the immune response would 
be appealing. Recently, researchers have investigated associations between genetic
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markers and certain autoimmune and infectious conditions. Molecular biological 
techniques can be used to differentiate polymorphisms of candidate genes, which have 
been selected because their protein products play a role in the inflammatory or immune 
response. Two techniques employed to distinguish the different polymorphisms 
include PCR and RFLP analysis.
1.9.1.1 Genetic polymorphisms
A genetic polymorphism is the long-term occurrence in a population of two or more 
genotypes, which could not be maintained by recurrent mutation (Connor and 
Ferguson-Smith, 1997). Usually if one in fifty of the population have the rare 
genotype then the condition is polymorphic. Recent research has indicated that most 
genes are polymorphic. Variations in DNA may result in no change to the protein 
product if the polymorphism is found in a non-coding region of the genome (intron), or 
if they still code for the same amino acid. Alternatively, the polymorphic alleles may 
result in an altered protein product which affects the function of the protein and its 
electrophoretic mobility. Polymorphisms occur because of frequent selection of 
mutations in particular habitats. They may also arise as a result of random genetic 
drift.
1.9.1.2 Polymerase chain reaction
The PCR technique involves the amplification of a specific segment of DNA from the 
candidate gene under investigation. In the first step, genomic DNA is denatured by 
heating to 94°C. Two synthetic oligonucleotide primers anneal to their complementary 
coded sequences either side of the target segment on separate strands of DNA, at their 
optimum annealing temperature (usually 50-60°C). After annealing, the primers are 
extended at 72 °C, in the presence of deoxyribonucleotide triphosphates (dNTPs), a 
reaction catalysed by a thermostable DNA polymerase enzyme. The three stages of 
denaturation, annealing and extension constitute one cycle of PCR and the resulting 
product serves as a template for the next cycle. Further cycles result in exponential 
accumulation of the target sequence. The PCR product can then be digested using an
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appropriate restriction enzyme and the fragments separated using gel electrophoresis 
and visualised under UV light when stained with ethidium bromide.
1.9.1.3 Restriction fragment length polymorphism analysis
Restriction enzymes are found in many bacteria and serve to prevent the incorporation 
of foreign DNA (Connor and Ferguson-Smith, 1997). More than 400 restriction 
enzymes have been identified and they are named after the bacterium which produces 
them. Each enzyme will only cleave at a particular recognition site, which is usually 4 
to 6 base pairs in length. Digestion yields fragments with either blunt or sticky 
(staggered) ends. There are about 100 different recognition sites throughout the 
human genome. Restriction enzymes can be used to differentiate allelic
polymorphisms, by the presence or absence of a specific recognition site.
1.9.1.4 Aims and objectives
Using the techniques described above the studies of candidate genes presented in this 
thesis sought to answer the following questions:
1. Is the HLADQB1 polymorphism associated with GEOP in a Japanese population, 
also associated with the disease in a Caucasian population?
2. Is GEOP associated with specific polymorphisms in the IL10G and IL10R 
microsatellites?
3. Is GEOP associated with specific polymorphisms in the TNFa and TNFd 
microsatellites?
4. Are there any differences in the frequency of these polymorphisms between GEOP 
smokers and non-smokers?
1.9.2 Clinical and Genetic Analysis of GEOP
Many difficulties arise when studying delayed onset hereditary traits. In some 
conditions, such as Huntington’s chorea and also in periodontal disease, the diagnosis
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is only possible relatively late in life. The problems of genetic model testing in EOP 
have been highlighted previously (Boughman et al., 1988): 1) EOP has a variable age 
of onset and in most cases is not recognised until after puberty; 2) the upper age limit 
of expression of the disease is curtailed, because loss of attachment in patients older 
than 35 years cannot always be differentiated from AP; and 3) it is difficult to obtain 
accurate phenotypic information for edentulous family members. These factors create 
substantial problems for genetic studies of EOP.
To help overcome the problem of truncation of the affected phenotype, it has been 
suggested that more complete phenotypic information should be obtained for all adult 
relatives during the years of risk (Beaty et al., 1987; Boughman et al., 1988).
1.9.2.1 Aims and objectives
The aim of the final study in this thesis was to develop a system in which documented 
clinical evidence and reported histories could be used to accurately diagnose untreated 
disease, in an equivalent manner to full periodontal chartings. This index could then be 
used for the current and retrospective diagnosis of EOP relatives. A method is presented 
which objectively addresses the difficulties encountered in defining affected and 
unaffected categories. Using this index, the results of the segregation analysis on an 
extended North European Caucasian kindred with 14 affected individuals is presented, to 
determine whether this family is suitable for a linkage study.
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Chapter 2 General Materials and Methods
2.1 Introduction
The following chapter describes materials and methods used routinely during the 
studies presented in Chapters Three and Four. Methods which apply specifically to 
work covered in individual chapters are detailed in the materials and methods section 
of the relevant chapter.
2.2 Materials
The following list comprises the consumables used for the DNA analysis presented in 
this thesis and their sources.
2.2.1 DNA
Oligonucleotide primers: Cruachem Ltd, Glasgow, UK.
Markers: ’k-HindllHEcoBl: Appligene, Oncor, Watford, UK.
100-bp DNA ladder: Pharmacia Biotech Ltd, Milton Keynes, UK.
Life Technologies Ltd, Paisley, UK.
2.2.2 Modifying Enzymes
Dynazyme: Flowgen Instruments Ltd, Lichfield, UK.
Taq polymerase: Pharmacia Biotech Ltd, Milton Keynes, UK.
Primezyme: Biometra, Gottingen, Germany.
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2.2.3 Restriction Enzyme
BamHl restriction endonuclease: Promega Corporation, Southampton, UK.
Ncol restriction endonuclease: Promega Corporation, Southampton, UK.
Taql restriction endonuclease: Promega Corporation, Southampton, UK.
2.2.4 Chemicals
Tris base, boric acid, ethidium bromide, orange G, xylene cyanol FF, bromophenol 
blue, sodium chloride, mineral oil, sodium perchlorate, ammonium persulphate, 
tetramethylethylenediamine (TEMED), Triton X-100, spermidine: Sigma Chemical 
Co Ltd, Poole, UK.
Formamide, agarose, acrylamide (19:1 with bis-acrylamide, ‘Ultrapure’): Life 
Technologies Ltd, Paisley, UK.
Chloroform, ethanol, amberlite resin, bromophenol blue, sodium acetate, sucrose,
magnesium chloride, sodium hydroxide, ethylene diamine tetraacetic acid (EDTA),
sodium dodecyl sulphate (SDS): BDH Ltd, Poole, UK.
Urea: Appligene, Oncor, Watford, UK.
Sodium chloride: Fisher Scientific UK, Loughborough, UK.
Dynawax: Flowgen Instruments Ltd, Lichfield, UK.
Ultrapure dNTPs: Pharmacia Biotech Ltd, Milton Keynes, UK.
1.5 mM MgCl2 optimised buffer for Dynazyme: Flowgen Instruments Ltd,
Lichfield, UK.
1.5 mM MgCl2 optimised buffer for Taq polymerase: Pharmacia Biotech Ltd,
Milton Keynes, UK.
1.5 mM MgCl2 optimised buffer for Primezyme: Biometra, Gottingen, Germany.
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2.2.5 Radioisotope
a 32 P-radiolabelled dCTP: Amersham International pic, Buckinghamshire, UK.
2.2.6 Miscellaneous Items
Polaroid film type 667: HA West, Clydebank, UK.
Kodak x-ray film: HA West, Clydebank, UK.
2.2.7 DNA Purification Systems
QIAamp® Blood Kit: QIAGEN Ltd, Crawley, UK
Nucleon II Kit: Scotlab Biosciences, Coatbridge, UK
Nucleon BACC 2 Kit: Scotlab Biosciences, Coatbridge, UK
2.3 Methods
2.3.1 Patient Selection
Unrelated patients referred to the periodontal department of Glasgow Dental Hospital 
for treatment were recruited for the study of genetic polymorphisms in GEOP. They 
were white and of European origin. The Glasgow Dental Hospital Ethics Committee 
approved the studies undertaken in this thesis and all the participants gave informed 
consent.
The clinical diagnosis of the patients was based on the following classification for 
GEOP (Hart et a l, 1991):
- the patient should be aged 35 years or less at diagnosis and should be systemically 
healthy
- interdental AL of > 5 mm should be present on at least eight permanent teeth, at least 
three of which should not be first molars or incisors.
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Clinical diagnoses were confirmed by evidence of interproximal BL on fill mouth 
periapical radiographs taken using the parallel technique.
2.3.2 Control Groups
The control groups are distinctive to the particular studies and will be discussed in the 
relevant sections.
2.3.3 Blood Samples
10 ml of venous blood was collected from the ante cubital fossa in vials containing 
Potassium EDTA. The blood was stored in 50 ml polypropylene tubes at -70°C, until 
DNA separation could be carried out.
2.3.4 DNA Purification
Extraction of whole genomic DNA from nucleated peripheral blood cells was carried 
out using the Nucleon II protocol a and the more recently developed Nucleon BACC 2 
protocol. These methods include the following steps: cell lysis; deproteinisation with 
sodium perchlorate; extraction with chloroform and the proprietary resin; and DNA 
precipitation. The extracted DNA was stored at 4°C until required. These protocols 
were performed according to the manufacturer’s instructions as summarised below:
1. 40 ml of Reagent A was added to 10 ml of whole blood in a 50 ml polypropylene 
centrifuge tube. The tube was rotary-mixed for 4 min at room temperature and 
then centrifuged at 1300 x g for 4 min. The supernatant was discarded without 
disturbing the cell pellet.
2. 2 ml of Reagent B was added and the mixture was briefly vortexed to resuspend 
the cell pellet.
3. 500 |il of sodium perchlorate was added to the mixture and the tube was incubated 
in a shaking water bath at 65°C for 25 minutes.
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4. 2 ml of chloroform (stored at 4°C and kept on ice) was added to the tube. The 
tube was rotary mixed for 10 min and then centrifuged at 800 x g for 1 min.
5. 300 jal of Nucleon silica suspension was added. The tube was centrifuged at 1300 
x g for 3 min.
6. Only the DNA containing phase above the Nucleon layer was transferred into a 
fresh centrifuge tube of appropriate volume.
7. The tube was centrifuged briefly at 1300 x g to pellet any residual Nucleon silica 
and the supernatant carefully decanted to a fresh tube.
8. Two equal volumes of cold absolute ethanol at 4°C was added to the aqueous DNA 
containing phase. The tube was inverted gently to precipitate the DNA.
9. The DNA was pelleted, the supernatant decanted and the pellet air-dried.
Alterations to the above protocol for the Nucleon® BACC 2 DNA extraction kit were 
as follows. At stages 3 and 4 the contents of the tube were mixed by inverting at least 
7 times by hand, rather than being incubated in a shaking water bath or rotary-mixed 
and centrifuged. After stage 8 the DNA precipitate was removed from the absolute 
alcohol and immersed in 70% ethanol.
2.3.5 Agarose Gel Electrophoresis
Agarose was dissolved in 1 x TBE buffer (Table 2.1) to a concentration of 0.8% w/v 
by heating in a microwave oven. Ethidium bromide (3 mg/ml) was added to the 
molten gel (15 pi to 100 ml 1 x TBE buffer). The cooled mixture was poured into a 
gel electrophoresis tank, the well-forming comb inserted and the gel allowed to set. 
Once the gel had solidified, the comb was removed carefully. The gel slab was 
submerged in 1 x TBE buffer. Sample DNA was mixed with 0.1 volume of gel 
loading dye (Table 2.1) before loading into the wells. A constant voltage of 70V was 
applied to the gel until the dye front had migrated to the bottom of the gel. DNA was 
visualised on a UV TM-40 transilluminator (UVP inc, USA) at 302 nm and 
photographed using Polaroid type 667 film.
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Table 2.1 General stock solutions and buffers.
10 x TBE
Tris base 108 g
Boric acid 55 g
0.5M EDTA [pH 8.0] 40 ml
dH20  to 1 litre
Use at a final concentration of 1 x. Sterilise by autoclaving.
Reagent A
Adjust to pH 8.0 using 40% NaOH
Autoclave prior to use.
Reagent B
400mM Tris-HCl [pH to 8.0 using 40% NaOH] 48.4 g 
60mM EDTA 22.3 g
150mM NaCl 126.6 g
1%SDS 10 g
(add SDS after autoclaving)
dH20  to 1 litre
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Ethidium Bromide (3 mg/ml)
Ethidium bromide 30 mg
dH20 to 10 ml
Store away from light. Use at a final concentration of 0.5 jig/ml.
TE buffer (pH 8.0)
lOmMTris pH 8.0 
ImMEDTA pH 8.0
0.5M EDTA (pH 8.0)
EDTA 186.1 g
dH20  900 ml
Adjust to pH 8.0 with NaOH. Make up volume to 1 litre with dH20 . Sterilise by 
autoclaving.
1M Tris-HCl (pH 8.0)
Tris base 121 g
dH20  900 ml
Adjust to pH 8.0 with HC1. Make up volume to 1 litre with dH20 . Sterilise by 
autoclaving.
1% SDS
Sodium dodecyl sulphate 1 g
dH20  900 ml
Dissolve on heated stirer. Adjust to pH 7.2 with HC1. Make up volume to 1 litre with 
dH20 .
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Bromophenol blue loading dye
Bromophenol blue 
Glycerol
Orange G loading dye
Orange G 
Glycerol
0.05% w/v 
50%
0.05% w/v 
50%
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Chapter 3 DNA Analysis of HLADQB1 Polymorphism in 
Generalised Early Onset Periodontitis
3.1 Introduction
Immune response genes are found on various chromosomes and although their site of 
expression may be different they all have a similar phenotypic outcome i.e. they 
determine ability to respond to antigenic stimuli (McDevitt and Chinitz, 1969; Rihova,
1995). Some investigators accept that HLA genes are immune response genes rather 
than markers linked to disease susceptibility genes found nearby on chromosome six 
(Hill, 1992).
Most of the polymorphisms found in the HLA complex are associated with the amino 
acids, which make up the antigen binding sites (Bjorkman et al., 1987; Brown et al., 
1988; 1993; Stem et al., 1994). Therefore, theoretically different polymorphisms 
should determine the binding of different antigens. Furthermore, certain infectious 
diseases have been associated with a particular HLA type. Hill et al. (1991) found a 
protective effect of HLA-Bw53 against both severe malarial anaemia and cerebral 
malaria in African children. In addition, on examination of class II haplotypes 
composed of HLA-DR and -DQ antigens they also found another protective 
association with HLA-DRwl3.02. However, the latter was only statistically 
significant for individuals suffering from severe malarial anaemia.
It appears possible that variations in frequency of HLA allelic polymorphisms may 
determine susceptibility to EOP through their ability to bind immunodominant 
antigens of periodontal pathogens. The primary immune response to a 65 kDa protein 
of Aa has been demonstrated to be controlled by genes in the IA subregion of the H2 
complex (MHC) in inbred strains of mice (Nitta and Ishikawa, 1993). It is also 
possible that class I and II HLA alleles are markers rather than mutant genes (Riley and 
Olerup, 1992). In certain diseases mutant alleles in the TNF cluster have been shown 
to be in linkage disequilibrium with alleles spanning the whole of the HLA complex 
(Pociot et al., 1993; Monos et al., 1995). Considering the importance of TNF in the
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in the pathogenesis of periodontitis, a mutant gene in the TNF complex might show 
linkage disequilibrium with a marker allele in the HLADQ or DR regions in EOP. 
Other genes involved in processing and transport of HLA antigens may also be linked 
to the class II gene cluster.
Over the past 20 years, researchers have periodically reported associations between the 
different forms of periodontitis and HLA antigens (Terasaki et al., 1975; Kaslick et al., 
1975; Kaslick, West and Chasens, 1980; Saxen and Koskimies, 1984; Goteiner and 
Goldman, 1984; Cogen et al., 1986; Klouda et al., 1986; Katz et al., 1987; Amer et al., 
1988; Shapira et al., 1994b). Until recently, no convincing association between HLA 
type and any category of periodontitis had been demonstrated. These studies 
investigated polymorphisms defined serologically using the complement-dependent 
microlymphocytotoxicity test assay of the HLA antigens displayed on the cell surface 
(Terasaki and Singal, 1969; Terasaki et al., 1978). The disadvantage of this technique 
was that it relied on alloantibody and monoclonal antibody reactive with specific 
antigens and was therefore difficult to standardise between laboratories. In addition, 
reagents were not available for all antigens. It was also not possible to distinguish 
between a “blank” antigen and a homozygous antigen without typing an entire family 
(Wade, 1996).
Despite the drawbacks of this technique, three independent research groups have 
reported similar findings. A study in Israel found a significant association between 
HLA-DR4 and GEOP (Katz et al., 1987), but the patient sample size was small (n = 
10). Alley et al. (1993) supported this finding in a Caucasian population. They 
investigated HLA-D phenotypes in individuals with or without IDDM and moderate to 
severe periodontitis. They observed a significantly elevated frequency of HLA-DR4 in 
diabetics and periodontitis patients. The association was stronger in periodontitis (p =
0.001) than diabetes (p = 0.05) and followed a similar pattern in HLA-DR53 and HLA- 
DQ3 which are in linkage disequilibrium with HLA-DR4. Firatli et al. (1996b) more 
recently reported a significant association between LEOP and GEOP and HLA-DR4 in 
a Turkish population.
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In order to investigate HLA allelic polymorphisms in more detail molecular genetic 
techniques can be employed. A recent study in France confirmed the association 
between HLA-DR4 and GEOP. Sequence-specific oligoprobe hybridisation after PCR 
(PCR.SSO) was used and a more specific association, with DRB1*0401, 0404, 0405 
and 0408 alleles, was found for the -DR4 subgroup (Bonfil et al., 1999). Another 
study in a population of Japanese patients found no association between class II HLA 
antigens and EOP using the complement-dependent microcytotoxicity method. 
However, a significant association was found between an atypical BamHl restriction 
site in the HLADQB1 gene and EOP (Takashiba et al., 1994; Ohyama et al., 1996) 
(Figure 3.1). This site was identified, following RFLP analysis, with cDNA probes for 
the HLADRB1 and HLADQB1 genes. The genes were digested into fragments of 
various lengths by the restriction enzymes BamHl, EcoBl, Mspl and Pstl. The 
HLADQB1 gene was split into a common fragment of 10.0 kb and uncommon 
fragments of 7.0 kb and 3.0 kb by BamHl (Figure 3.1). The atypical site was 
concluded to be in the intron downstream of the third exon, after examination of 
fragments resulting from digestion of the 10.0 kb and 7.0 kb fragments with EcoBl and 
Smal.
In the study presented here, the atypical BamHl site was investigated in a population of 
European Caucasian GEOP patients.
3.2 Materials and Methods
3.2.1 Patient Selection
Forty-five patients were recruited to this study based on the criteria described 
previously (section 2.3.1). There were six patients recruited to the study who were 
over the age of 35 years when they presented in the periodontal department of 
Glasgow Dental Hospital and School. However, these patients had a clear history of 
having symptoms of the disease prior to the age of 35 years. In addition they were 
referred to the department by their general dental practioners for treatment of severe
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Figure 3.1 Diagrammatic representation of the human HLADQB1 gene.
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Adapted from Jonsson et al. (1987), Larhammar et al. (1983) and Takakshiba et al. 
(1994). The one kilobase region which was amplified by PCR is magnified. The atypical 
BamHl site is illustrated by a blocked arrow. The oligonucleotide primers correspond to 
the sequence reported by Larhammar et al. (1983). B = BamHl, E = EcoBl, S = Smal 
restriction sites.
H I  Translated exon □  Untranslated exon — —  Intron
progressive periodontitis. They had BL > 50% around most of the affected teeth.
3.2.2 Control Group
The control group included 44 volunteers from the staff of Glasgow Dental Hospital with 
no evidence of GEOP. They were all white and of European origin. It was not 
considered to be important to match the controls for age. However, no individual under 
the age of 21 was recruited because 20 years was thought to be the lower limit at which 
signs of GEOP would be evident (Albandar et al., 1997).
Demographic data for the patient and control groups are presented in Table 3.1.
3.2.3 DNA Purification
DNA separation from the EOP patients’ blood was carried out using the Nucleon II 
protocol a and the more recently developed Nucleon BACC 2 protocol as previously 
described (section 2.3.4).
Extraction of whole genomic DNA from the control bloods was accomplished using 
the QIAamp ® Blood Kit. This is a rapid method of DNA extraction. It involves one 
step cell lysis, deproteinisation and extraction. The DNA is then precipitated, washed 
and eluted. Extracted DNA was stored at 4°C until required. This protocol was 
performed according to the manufacturer’s instructions with some minor modifications 
as follows:
1. 200 pi of sample was pipetted into a 1.5 ml microfuge tube.
2. 25 pi QIAGEN Protease stock solution and 200 pi of Buffer AL were added
and mixed immediately by vortexing.
3. The mixture was incubated at 70°C for 10 min.
4. 210 pi of 100% ethanol was added to the tube and the contents were mixed
again by vortexing.
I l l
Table 3.1 Demographic data.
Total3 Male3 Female3 Smokers3 Non-smokers3 Meanageb
Patients 45 (100) 19(42) 26(58) 23 (51) 22(49) 31.36(16-38)
Controls 44(100) 18 (41) 26(59) 12(27) 32(73) 33.07(22-53)
3 Numbers of individuals in each group; percentages in parentheses. 
b Mean age and range in parentheses, in years.
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5. A QIAamp spin column was placed into a 2 ml collection microtube 
(provided). The mixture from step 4 was carefully added to the QIAamp spin 
column without moistening the rim. The cap was closed and the tube was 
centrifuged at 8000 rpm (6000 x g) for 1 min. The QIAamp spin column was 
placed into a clean 2 ml collection microtube (provided) and the tube 
containing the filtrate was discarded.
6. The QIAamp spin column was carefully opened and 500 pi of Buffer AW was
added. The tube was centrifuged at 8000 rpm (6000 x g) for 1 min. The 
filtrate was discarded and the QIAamp spin column was replaced into the same 
collection microtube.
7. The QIAamp spin column was carefully opened and another 500 pi of Buffer
AW was added. The tube was centrifuged at full speed for 3 min.
8. The QIAamp spin column was placed into a clean 1.5ml microcentrifuge tube
(not provided) and the collection microtube containing the filtrate discarded.
9. The QIAamp spin column was carefully opened and the DNA was eluted with
200 pi of Buffer AE (provided) preheated to 70°C.
10. The tube was incubated at 70°C for 5 min and centrifuged at 8000 rpm (6000 x 
g) for 1 min.
11. The DNA was then ready for further processing as required.
DNA integrity was checked and DNA quantitated using agarose gel electrophoresis
(section 2.3.5). One microlitre of sample was added to 8 pi of molecular biology
grade water (MBG) and 1 pi of bromophenol blue loading dye before loading into the
gel.
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3.2.4 Screening of Subjects for the Atypical BamHl Restriction Site
3.2.4.1 PCR
In order to screen subjects for the atypical BamHl site, PCR amplification of a 1.0 kb 
region corresponding to nucleotide residues 4001-5000 of the HLADQB1 gene, was 
carried out (Larhammar et al., 1983) (Figure 3.1).
The following synthetic HLADQB1 specific oligonucleotide primers were used 
(Takashiba et al., 1994):
primer 1: 5’-GAGTGCCTTTTAATTGGGGTG-3’
primer 2: 5’-GTAGACGTCTCCACGCTGGGG-3’
A master mix containing all the reagents minus the sample DNA was set up on ice as 
shown in Table 3.2. Primers were supplied as lyophilised pellets. They were 
resuspended in MBG H20  at a concentration of 1 pg/pl and aliquoted. Hot start PCR, 
where the primers are separated from other components of the PCR by 50 pi of 
prewarmed wax (Dynawax), was used in this study. The wax prevents the reaction from 
starting until melting of the wax occurs on commencement of thermal cycling. The hot 
start method improves the specificity and yield of PCR products. One microlitre of 
sample DNA was added to the upper layer. Negative PCR controls contained 1 pi of 
MBG water instead of sample DNA. An Omnigene thermal cycler (Hybaid Ltd, 
Teddington, UK.) was employed for the PCR reactions. An initial denaturation step at 
94°C for 5 minutes was followed by 35 cycles of denaturation at 94°C for 1 minute, 
annealing of primers at 60°C for 2 minutes and primer extension at 72°C for 2 minutes. 
A final extension step at 72°C for 10 minutes completed the cycling. Ten microlitres of 
each PCR product were mixed with 1 pi of bromophenol blue loading dye and 
electrophoresed on a 2% agarose gel as described in section 2.3.5, with a 100-bp DNA 
ladder being used as a size marker.
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Table 3.2 Upper and lower master mixes used in ‘hot start’ PCR.
1. Upper master mix
Reaction
component
Concentration 
in final volume
Vol per 100 pi 
(per reaction)
Primer 1 0.2 pM 0.2 pi
Primer 2 0.2 pM 0.2 pi
Template DNA — 1.0 pi
MBG H20 — 48.6 pi
2. Lower master mix
Reaction
Component
Concentration 
in final volume
Vol per 100 pi 
(per reaction)
PCR Buffer (10 x) 1 X 10.0 pi
Dynazyme/Tag
polymerase
2 units 1.0 pi
dNTPs (20mM) 0.2 mM 1.0 pi
MBG H20 — 38.0 pi
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3.2.4.2 Purification of PCR product
The volume of PCR product was made up to 100 pi. DNA was precipitated by the 
addition of one-tenth volume (10 pi) of 3M sodium acetate and two volumes of 
ethanol (220 pi), followed by mixing and storage at -70°C for 30 min. The mixture 
was then centrifuged for 10 min at 13,000 rpm in a microcentrifuge to precipitate the 
DNA pellet. The supernatant was carefully removed and the DNA pellet air dried for 
10 min and finally the DNA product was resuspended in 15 pi of MBG water.
3.2.4.3 Restriction endonuclease digestion of the PCR product
Amplified DNA was digested with BamHl in a volume of 20 pi. Six microlitres of 
sample DNA were added to the digestion mixture which comprised 2 pi of 
recommended 10 x restriction enzyme buffer (supplied by the enzyme manufacturer), 
0.5 pi BamHl (10 units/pl), 0.4 pi 2mM spermidine and MBG water to 20 pi. 
Digestion reactions were thoroughly vortex-mixed and incubated at 37°C for a 
minimum of three hours. The digested samples were subjected to electrophoresis on 
2.0 % agarose gels as described previously (section 2.3.5).
3.2.4.4 Contamination controls
Separate rooms were used for PCR and post-PCR analysis and a one-way system 
operated from the PCR laboratory. Laboratory coats were changed on entering and 
leaving the different rooms. These measures were imposed to prevent contamination 
of the PCR laboratory with extraneous products.
Equipment and reagents used in PCR were separated into batches and aliquoted for 
storage to prevent contamination of stock solutions. Aliquoting of reagents and all 
PCR experiments were carried out in a UV-irradiated laminar flow cabinet. All 
equipment was irradiated before use for 10 min with 1200 pJ min'1 at 254 nm in a UV 
crosslinker. All reagents were handled using filter tips to prevent aerosol 
contamination of the inside of the pipette. Gloves were changed whenever the 
operator’s hands re-entered the flow cabinet having left to use the microcentrifuge or 
collect reagents. Negative controls were included with every PCR experiment to
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check for contamination. Template DNA was added using positive displacement tips 
in a Template Tamer cabinet (Oncor, Appligene, Watford, UK).
3.2.5 Statistical Analysis
Statistical analysis of the data was carried out using the chi-squared test. This test 
compares the two sets of data in a 2 x 2 table and returns a probability value of the 
difference between them. The level of significance for this test is set at 0.05.
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Table 3.3 Stock solutions and buffers.
QIAGEN Protease
Lyophilized QIAGEN protease 25 mg
M BGH20  1.4 ml
Store at -  20°C in 200 pi aliquots.
Buffer AL
Reagent AL 1 1 part
Reagent AL 2 4 parts
Store at room temperature in 5 ml aliquots.
N.B. Do not add QIAGEN Protease directly to Buffer AL.
Buffer AW
Buffer AW concentrate 17 ml
Ethanol (96-100%) 40 ml
Store at room temperature in 10 ml aliquots.
20 mM dNTPs (2’ deoxynucleotide 5’ triphosphates)
dATP (lOOmM) 200 pi
dTTP (lOOmM) 200 pi
dGTP (lOOmM) 200 pi
dCTP (lOOmM) 200 pi
MBG H20  to 1 ml
Store at -20°C in 50 pi aliquots.
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10 x Optimised PCR Buffer
lOmM Tris-HCl [pH 8.8 at 25°C]
1.5mM MgCl2
50mM KC1
0.1% Triton X-100
Store at -20°C in 200 pi aliquots.
3M NaOAc
NaOAc 273.4 g
dH20  900 ml
Adjust to pH 5.5 with HC1. Make up to 1 litre with dH20 . Sterilise by autoclaving.
Spermidine (lOOmM)
Spermidine 145.2 mg
MBGH20  10 ml
Use at 2mM final concentration.
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3.3 Results
3.3.1 Purified Genomic DNA
DNA integrity was tested by running genomic DNA samples and marker fragments on 
0.8 % agarose gels to check for shearing (Figure 3.2). Sheared samples would have 
appeared as a smear on the gel. The marker used in this example was X-Hindlll which 
is visible as bands of 23.5-, 9.4-, 6.7-, 4.3-, 2.3-, 2.0- and 0.6-kb on the gel.
3.3.2 PCR Products
To confirm amplification of the 1.0 kb product samples were run on 2.0 % agarose gels, 
an example of which can be seen in Figure 3.3. A 100-bp marker was used to verify the 
size of the products.
3.3.3 PCR Digests
In order to investigate the presence or absence of the atypical restriction site, digests 
were run on 2.0 % agarose gels. Figure 3.4 shows a photograph of a typical gel. 
Fragments of 1000 bp (allele 2) and approximately 700 bp and 300 bp (allele 1) are seen 
for patients and controls with the atypical BamHl restriction site, which demonstrates 
heterozygosity for the site. The size of the digested fragments differed from those 
reported by the Japanese researchers. They found intact fragments of 1000 bp but 
digested fragments of 650 and 350 bp. This may be due to differences in size estimation 
from the gels. It is also possible that the restriction site is in a slightly different position 
in Caucasians. The presence of an intact 1000 bp fragment indicates lack of the atypical 
BamHl site. None of the patients or controls was homozygous for allele 1. Twenty-three 
patients (51%) and 23 controls (52%) showed evidence of the restriction site (Table 3.4). 
Data for smokers is shown separately from non-smokers. No statistically significant 
differences were found between patients and controls (p = 0.91). When smoking status 
was included in the analysis as a covariate there was still no significant difference
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Figure 3.2 0.8% Agarose gel showing purified genomic DNA.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
17 18 19 20 21 22 23 24 M M 
Lanes 1 and 3-24 demonstrate successful DNA purification. M = AHindlll marker.
Figure 3.3 2.0% Agarose gel showing PCR products.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 M
15 16 17 18 19 20 21 22 23 24 25 26 27 28 M
PCR products o f 1000 bp can be seen in lanes 1-26. Lane 27 was left empty and 
lane 28 was the negative control. M = 100 bp marker.
Figure 3.4 2% Agarose gel showing digested PCR products.
M 1 2 3 4 5 6 7  8 9  10 11 12 M
Lanes 1, 2, 3 and 12 show undigested 1000 bp product (homozygous for allele 2). 
Lanes 4-11 show undigested 1000 bp product and DNA fragments of approximately 
300 bp and 700 bp (heterozygous). M = 100 bp marker. The 800bp fragment shows 
up more strongly than the other marker fragments.
Table 3.4 Distribution of HLADQB1 alleles in GEOP patients and controls.
Allele Patients n (%) Controls n (%)
S NS T S NS T
1/2 12(52) 11 (50) 23 (51) 6(50) 17(52) 23(52)
2/2 11 (48) 11 (50) 22(49) 6(50) 15(47) 21 (48)
S = smokers, NS = non-smokers, T = total, n = number in each group.
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between the patient and control groups (smokers - p = 0.90, non-smokers -  p = 0.82).
3.4 Discussion
3.4.1 Natural Selection
The results of this study do not support the finding of an association between an 
atypical BamHl restriction site in the HLADQB1 gene and GEOP in a population of 
Caucasian patients of European origin. It has been shown that variations in HLA 
allelic frequencies exist between different races and populations (Riley and Olerup, 
1992). These variations may be reflected in associations between certain diseases and 
HLA type within different races (Baines and Ebringer, 1992; Awata and Kanazawa, 
1994; Firatli et al., 1996b). An explanation of this phenomenon is provided by studies 
of human evolution. The evolution of the MHC differs from that of most other single 
copy genes. Whereas mutations of single copy genes are driven by chance (genetic 
drift) those in the MHC are dominated by natural selection, specifically positive 
selection (Erlich and Gyllensten, 1991; Klein et al., 1993; Hughes and Hughes, 1995).
Elucidation of the structure of HLA molecules provides evidence for the theory of 
natural selection. In addition, the serotype HLA-Bw53 which has a protective effect 
against malaria is common only among sub-Saharan Africans where it is found at 
levels of up to 40% (Hill et a l, 1991). The protective class II antigen (HLA- 
DRwl3.02) is also found more frequently in African populations. It thus seems likely 
that geographical variation in exposure to Plasmodium falciparum has contributed to 
the development of protective HLA polymorphisms.
There appear to be differences in the prevalence of certain bacteria in subgingival plaque 
in patients from different countries and ethnic groups. One study in a Chilean population 
showed a high prevalence and high levels of Pg and Pi at diseased sites, contrary to many 
previous North American and European studies of LEOP (Lopez, Mellado and Leighton.
1996). However, Aa was only found in about one-third of patients and one-quarter of 
diseased sites. Another study in a group of Chinese patients with LEOP found no
125
evidence of Aa in the sites they examined. The predominant species cultured included 
Gram positive rods (Naiming et al., 1991). Schenkein et al. (1993) found that Pg was 
more significantly associated with black AP patients and Fn was associated with white 
AP- and EOP-affected individuals.
Crossover of pathogenic species between the different diagnostic categories of 
periodontitis and periodontally healthy individuals has also been recorded. These 
phenomena may be partly due to researchers investigating evidence of a bacterial species 
rather than attempting to isolate a particular strain or serotype in a population. For 
example, specific genetic variants of Aa were found to correlate with disease and health 
in LEOP families from West Philadelphia (DiRienzo et al., 1994). Haubek et al. (1995) 
also provided evidence for the absence in North European Caucasians of especially 
virulent clones of Aa in patients with AP and LEOP. In contrast, a highly virulent clone 
of Aa producing increased quantities of leucotoxin has been isolated from a number of 
LEOP patients, from families of African origin living in geographically widespread 
locations (Haubek et al., 1996). More recently another group found a significant 
association between the detection of a high-leucotoxin-producing strain of Aa and the 
development of disease in children from African American families with LEOP (Bueno, 
Mayer and DiRienzo, 1998). Gunsolley et al. (1991) found that higher levels of antibody 
titres to Aa serotypes b and c were found in black GEOP patients and non-periodontitis 
subjects than in whites. This relationship between IgG levels and race appeared to be 
restricted to Aa. In another study, Fn subspecies nucleatum showed a strong association 
with AP; however, Fn subspecies polymorphum was isolated mainly from healthy sites 
(Gharbia et al., 1990).
These investigations suggest that differences in HLA genotype between racial groups 
may influence susceptibility to infectious periodontal diseases. They may explain the 
lack of association between the atypical BamHl site in the HLADQB1 gene and GEOP 
in Caucasian patients reported in this study.
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3.4.2 Linkage Disequilibrium
In addition to linkage between the TNF complex and class II MHC alleles, strong 
linkage disequilibrium has been demonstrated between the DR and DQ subregions of 
HLA class II genes (Inoko et al., 1986; Jonsson et al., 1987; Pociot et al., 1993). A 
disease-associated allele at one of the DR loci could be detected by linkage to a 
polymorphism in the DQ subregion. This is interesting considering the finding of an 
association between HLA-DR4 and severe periodontitis in three racially distinct 
populations, using HLA serotyping techniques (Katz et al., 1987; Alley et al., 1993; 
Firatli et al., 1996b). Furthermore, a very recent study confirmed this association 
using molecular genetic techniques (Bonfil et al., 1999). The sequencing of the 
promoter regions of class II loci has also revealed marked polymorphisms for DRA, 
DRB, DQA and DQB. The latter show strong linkage disequilibrium with the 
corresponding HLA class II alleles (Schwartz, Felser and Mayr, 1995).
Recently a number of genes have been identified within the HLA complex which code 
for proteins involved in processing and transport of class I and II HLA glycoproteins. 
For example, TAP (transporter associated with antigen processing) genes located 
within the HLA class II gene cluster code for transporter proteins (Momburg, Neefjes 
and Hammerling, 1994; Rfhova, 1995). These proteins are involved in transport of 
antigenic peptides from the cytosol into the endoplasmic reticulum where they are 
combined with class I antigens, which will eventually be presented at the cell surface 
to cytotoxic T cells. TAP genes also show polymorphism, which may be responsible 
for disease susceptibility (Powis et al., 1993; Aoki, Isselbacher and Pillai, 1993). This 
would be dependent on which pathogenic peptides are allowed to gain access to the 
endoplasmic reticulum and eventually be presented to T cells (Rfhova, 1995). Strong 
linkage disequilibrium has been found between TAP2 and HLADR, DQ and DO 
(Schwartz, Felser and Mayr, 1995). In other words an association between an HLADQ 
allele and a particular disease could be indicative of a defect in class I peptide uptake 
into the endoplasmic reticulum.
Other genes found in the class II cluster code for proteins, which are important for 
antigenic loading of class II peptides. These are known as HLA-DM molecules
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(Pieters, 1997). The HLADM  genes are much less polymorphic than classical HLA 
class II genes (Bodmer, 1995). However, class II loading is defective in cells not 
expressing these genes (Mellins et al., 1990; Denzin et al., 1994).
This discussion highlights the many genes within the HLA complex which may be 
responsible for causing susceptibility to infection. If HLA class II genes are markers 
for immune response genes found nearby on chromosome six, the marker allele might 
vary between different populations and racial groups (Baines and Ebringer, 1992). 
This would provide an explanation for the findings of the study reported here.
3.4.3 Cell-Surface Trimming of Class II MHC Bound Peptides
The importance of intracellular processing in MHC antigen presentation has been well 
documented (reviewed by Pieters (1997)). In addition, aminopeptidase-N (CD13) 
mediated cell-surface trimming of MHC class II bound peptides has been 
demonstrated in mice lymphoma cell lines (Larsen et al., 1996). The aminopeptidase- 
N can digest the NH2-terminal end of the bound peptide modifying antigen 
recognition by the TCR. The authors suggested that the surface of the APC could alter 
the MHC class II bound peptides if intracellular processing yields products which are 
too long to fit within the binding groove. They also hypothesised that peptide 
carboxy-terminals protruding from the groove might be digested by a 
carboxypeptidase, with equally important effects on the sensitivity and specificity of 
the T-helper cell response. The complexity of the pathways involved in antigen 
processing and presentation, and in T cell recognition, allows the reader to understand 
the difficulty of associating a particular HLA allele with EOP.
3.4.4 Periodontitis Is a Mixed Infection
In the Japanese study (Takashiba et al., 1994), the atypical HLADQB gene variation 
was found in 10 of 30 EOP patients, one of 24 AP patients and three of 42 healthy 
controls. The authors suggested that the atypical site might be useful as an indicator 
for a subpopulation of EOP patients and may affect immune reactions such as antigen 
recognition.
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Periodontitis is believed to be a mixed infection caused by a small group of specific 
Gram negative bacteria. It is possible that different subgroups of EOP patients are 
susceptible in the first instance to different species of bacteria and that this is reflected in 
their serum antibody response to these bacteria (Mooney et al., 1995). These varying 
responses could be associated with different HLA genotypes within a homogeneous 
population. Hart and co-workers (Hart et al., 1995; Hart, 1996) investigated the 
association of HLA-D allotypes with antibody response and periodontal disease 
category. Seventy-six black subjects (39 EOP, 22 AP and 15 controls) were typed for 
specific HLA class II antigens (DR4, D53, DQ3). These antigens had previously been 
found to be associated with periodontitis in a group of early-onset diabetics (Alley et al., 
1993). No association between any specific HLA type and any disease category was 
found. However, when 19 individuals were analysed according to IgG2 antibody titre to 
Aa and the presence of a specific antigen, DR53 was found to be associated with the 
ability to mount a high antibody titre.
Separation of the GEOP population investigated here into groups defined by, for 
example, antibody titre, cytokine levels or disease severity might have revealed an 
association with the HLADQB gene.
3.4.5 Immunodominant Antigens
One of the major problems of associating a particular HLA genotype with periodontal 
disease is the uncertainty that still exists regarding which species or strains of bacteria are 
pathogenic for particular disease categories (Schenkein, 1998). Evidence of associations 
of individual species and mixed bacterial infections with different diagnostic categories 
of periodontal disease has been reported (Socransky and Haffajee, 1997). However, 
which of the bacteria identified in microbiological studies are pathogenic and which are 
merely opportunists is still not clear. In addition, there is also uncertainty regarding 
which are the immunodominant antigens of these bacteria. The following suggestions 
have been made; an Mab 1A1 epitope common to multiple gene products of Pg (Curtis et 
al., 1996); the fimbrial proteins of Pg and Aa (Evans et a l, 1992; Harano, Yamanaka and 
Okuda, 1995; Sojar, Hamada and Genco, 1997); lipopolysaccharide of Gram negative
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bacteria (Vasel et al., 1996); and heat shock protein 60 (HSP60) of Pg and Aa (Maeda et 
al., 1994; Nakano et al., 1995).
It should be emphasised that there is marked homology between HSP60 of Aa and 
several such proteins of other species of Gram negative bacteria. Nakano et al. (1995) 
found that rabbit polyclonal antibodies to the 64 kDa protein cross-reacted with the 
HSP60 of Haemophilus aphrophilus, Haemophilus influenzae, Haemophilus 
paraphrophilus, Escherichia coli and Ec. The HSP60 of Aa also cross-reacted with 
other bacteria and human HSP60. It is possible that human antibody responses to the Aa 
protein are in fact cross-reactive with HSP60 of other bacteria or self-antigens. Of 
interest was the lack of any cross-reactivity between the 64 kDa protein of Aa and any 
cellular proteins of Pg, Pi and Fn, other suspected periodontal pathogens. Cross­
reactivity has also been demonstrated between LPS of Pg and Bf (Vasel et al., 1996). 
Furthermore, investigators looking at the effects of LPS from non-oral bacteria have 
found cross-reactivity of an epitope in the Lipid A portion of the LPS molecule in a 
number of Gram negative bacteria (Seifert et al., 1996). This immunodominant epitope 
would not be recognised by HLA class II molecules, which only present peptides.
The problem identified here is that there are many possible antigens implicated in 
periodontal disease. There must therefore be thousands of possible epitopes and 
combinations of epitopes on these antigens, and any of these may be important in antigen 
peptide presentation by HLA molecules. Until the microbial aetiology of periodontal 
disease is better understood and patient populations better defined, with regard to 
infecting microorganisms and immunodominant epitopes, it will be difficult to identify 
associations between the HLA complex and periodontitis.
3.4.6 Superantigens
An individual peptide, which forms a complex with an HLA molecule, will stimulate a 
specific clone of T cells. Recently new peptide molecules have been identified known 
as superantigens. These molecules are capable of activating T cells non-specifically 
without being presented in the peptide-binding groove of the HLA-D molecule (Zadeh 
and Kreutzer, 1996) (Figure 1.2). Superantigens interact directly with the Vp region of
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the T cell receptor and can therefore stimulate a much larger proportion of the T cell 
pool. Staphylococcus aureus enterotoxins have been identified as being superantigens. 
It is also possible that some periodontal pathogens produce superantigens (Mathur et 
al., 1995; Zadeh and Kreutzer, 1996; Getka et al., 1996). If this is the case, HLA alleles 
may not play an important role in determining susceptibility to periodontitis, which may 
explain the lack of an association between GEOP and the HLADQB1 gene in this study.
3.4.7 HLA Genes May Modify the Immune Response in Periodontitis
In a subsequent study by the Japanese group (Ohyama et al., 1996), DNA typing of 24 
EOP patients and 47 controls was performed. The results of this study were 
inconclusive. A significantly increased frequency of HLADQB1 (*0503 and *0602) 
alleles was found in EOP patients. However, the atypical BamHl site was only found in 
relation to DQB1 *0602 and not DQB1 *0503. The site was also detected in all but one 
individual who carried alleles DQB1 *0604 and DQB1 *0605, which were not found to be 
associated with EOP (Ohyama et a l, 1996). An additional level of polymorphism has 
been demonstrated by PCR amplification and sequencing of alleles detected by RFLP. A 
single RFLP may be associated with more than one sequence (Riley and Olerup, 1992). 
The authors (Ohyama et ah, 1996) stated in their discussion that the lack of strong 
linkage between HLADQ alleles and EOP is probably due to the multifactorial aetiology 
of the disease. No reference was made to the influence of smoking on susceptibility to 
EOP. In the present study no differences were observed between the presence of the 
atypical BamHl site in smokers and non-smokers. It is possible that the genes of the 
HLA complex are not major susceptibility genes for EOP. They may instead have a 
modifying effect (Marazita et al., 1996; Hart, 1996). This would explain the difficulty in 
finding convincing associations between HLA alleles and EOP, particularly in studies of 
small numbers of patients.
3.4.8 Concluding Remarks
The lack of an association between the atypical BamHl site and GEOP in a European 
Caucasian population could reflect racial genetic variation in HLA allelic frequencies 
which could be due to natural selection. Variation in exposure to periodontal
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pathogens between different racial groups and linkage disequilibrium between EOP 
and different alleles of the HLA complex are other explanations. HLA genes are 
probably not major susceptibility genes for EOP but may instead have a modifying 
effect. If this is the case, interactions could occur between the modifying gene and 
environmental factors, which vary between the populations studied.
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Chapter 4 DNA Analysis of IL10 and TNF Polymorphisms in 
Generalised Early Onset Periodontitis
4.1 Introduction
Cytokines are regulatory proteins of low molecular weight, which are active in very 
small amounts (femtomolar to picomolar concentrations). They transmit information 
between cells and form a complex network of interactions. They may act 
synergistically or may inhibit the action of another cytokine. Most cytokines are 
pleotropic. They are produced by activated cells and mainly exert their effects locally 
by binding to high affinity receptors on the surface of immune cells. The 
proinflammatory cytokines, IL-1 and TNFa, play a central role in the pathogenesis of 
many autoimmune and infectious diseases including periodontitis. Control of the 
production and function of these inflammatory proteins is accomplished by soluble 
receptors, high-affinity autoantibodies and anti-inflammatory cytokines such as IL-lra 
and IL-10 (Bendtzen, 1994; Symons, Young and Duff, 1995). Interleukin-1 receptor 
antagonist regulates IL-1 function by binding to the same high affinity receptors as IL- 
1 without activating the cell. In contrast IL-10 suppresses cytokine synthesis both at 
the mRNA and protein levels (De Waal Malefyt et al., 1991; De Waal Malefyt, Yssel 
and de Vries, 1993). Transcription of mRNA can be influenced by the binding of 
regulatory proteins to the promoter or enhancer regions of a particular gene (Connor 
and Ferguson-Smith, 1997; Knolle et al., 1998). Gene activity may also be regulated 
later in the process of protein synthesis for example at the mRNA splicing stage 
(Howells, 1995). Alternatively the rate of translation may be altered.
Stable interindividual differences in cytokine secretion patterns have been reported 
(Molvig et al., 1988). It has also been demonstrated that allelic variation at cytokine 
loci, and in genes regulating their expression, may affect cytokine responses between 
individuals (Pociot et al., 1991; 1993; Messer et al., 1991; Derkx et al., 1995; Eskdale 
et al., 1998a). In addition, associations between polymorphisms of candidate cytokine 
genes and certain diseases have been documented (Pociot et al., 1991; 1993; McGuire 
et al., 1994; Wilson et al., 1994; Eskdale et al., 1997).
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Microsatellite loci are marker motifs consisting of non-coding dinucleotide repeats 
(Jacob, Mykytyn and Tashman, 1993). The number of repeats rather than the 
nucleotide sequence differentiates the allelic polymorphism. Although microsatellites 
have no known function, they are useful as markers of cytokine gene expression. 
Some microsatellites lie close to cytokine genes and are in linkage disequilibrium with 
them and their promotor and enhancer region.
The TNF gene cluster is 12 kb in length and lies within the HLA gene complex (Figure 
1.1). It contains five polymorphic microsatellites (Figure 4.1) (Jongeneel et al., 1991; 
Nedospasov et al., 1991; Udalova et ah, 1993). In addition, several bi-allelic RFLP 
polymorphisms have been described; some of these are illustrated in Figure 4.1 
(Partanen and Koskimies, 1988; Messer et al., 1991; Wilson et al., 1992; Ferencik et 
al., 1992; D'Alfonso and Momigliano Richiardi, 1994). Polymorphic alleles within the 
TNF region have been found to correlate with TNFa and TNFp production (Pociot et 
al., 1991; 1993; Messer et al., 1991; Braun et al., 1996; Kroeger and Abraham, 1996; 
Wilson et al., 1997). An increase in TNFa levels has been suggested to be due to up- 
regulation of the TNFA gene. Regulation of LPS induced secretion of IL-1 and TNFa 
has also been associated with particular HLA-DR subtypes (Molvig et a l, 1988; 
Santamaria et al., 1989; Jacob et al., 1990). These findings suggest that class II HLA 
genes are in linkage disequilibrium with the TNF locus (Jongeneel et al., 1991; Pociot 
et al., 1993; Wilson et al., 1993; Plevy et al., 1996). However, it has also been shown 
that TNF alleles can influence levels of TNFa and the outcome of infection 
independently of the HLA complex (Molvig et al., 1990; McGuire et al., 1994; 
Galbraith et al., 1998). Gallagher et al. (1997) screened a large cohort from the West 
of Scotland for TNF polymorphisms and MHC serotypes. They found that the alleles 
at the TNF locus were in some cases an integral part of the entire HLA complex, in 
others alleles at particular loci varied between different ethnic populations. It was 
suggested that the identification of TNF alleles as disease markers independent of the 
MHC may require matching of patient and control groups at both class I and II loci.
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Figure 4.1 Diagrammatic representation of the human TNFA and TNFB (LTA)
genes.
Centromere
The position of the five microsatellite loci TNFa -  TNFe (Udalova et al., 1993) are 
illustrated together with the following RFLP biallelic polymorphisms: TNFA -238 
(NlaiV) (D'Alfonso and Momigliano Richiardi, 1994); TNFA -308 (Ncol) (Wilson et al., 
1992); EcoBl (Partanen and Koskimies, 1988); TNFB +252 (Ncol) (Messer et al., 1991); 
and (Ferencik et al., 1992).
0 Microsatellite w^ ^ mm Intron H  Exon
TNFA TNFB
- 238 -308 EcoBl +252 AspYR
Untranslated exon Interruption
Adapted from Wilson et al. (1995) and Rink and Kirchner (1996).
Recently Galbraith et al. (1998) demonstrated a significant association between 
increased TNFa production by oral PMN in AP patients and the heterozygous 77,2 
genotype of TNFA -308 (p = 0.037) (Figure 4.1). When disease severity was also 
taken into account a significant association between the 77,2 genotype and increased 
production of TNFa was only seen in patients with severe disease. These findings 
need further corroboration, as the numbers of individuals in the different categories of 
disease severity were small (n = 10 for mild, 10 for moderate, 12 for severe). In 
addition, only three patients in the severe group showed increased production of TNFa 
and were also heterozygous for the TNFA -308 gene polymorphism. Because of the 
small size of the groups, no analysis of the contribution of smoking as a confounding 
variable could be carried out. Despite these drawbacks the results of this study are 
interesting, since a large-scale family linkage analysis of over a hundred families with 
EOP had previously indicated linkage for the HLA region of chromosome six (Wang et 
al., 1996; Hart and Komman, 1997). Many similarities exist in the pathogenesis of AP 
and EOP and the importance of TNF in mediating the destructive process has been 
highlighted (Roberts et a l, 1997). It seems possible therefore that TNF production in 
patients with EOP may be influenced by allelic polymorphisms in the TNF gene 
cluster.
Two micro satellites found within the promoter region of IL10 have recently been 
elucidated (Figure 4.2) (Eskdale and Gallagher, 1995; Eskdale, Kube and Gallagher, 
1996). Eskdale et al. (1998a) examined the occurrence of polymorphic alleles at these 
loci and IL-10 secretion levels. They found IL10R3 was associated with lower 
production of IL-10 more often than any other allele at the same locus. In addition, the 
haplotype IL10R2/IL10G14 was associated with highest IL-10 secretion and 
IL10R3/IL10G7 was associated with lowest IL-10 secretion. The same group reported 
a higher frequency of IL10R2 and a lower frequency of IL10R3 in three geographically 
and racially diverse groups of RA patients compared with controls (Eskdale et al., 
1998b). Since patients with RA demonstrate higher levels of IL-10 in serum and 
synovial fluid it was suggested that IL-10 production may be under direct genetic 
control. An association was also found between the combined genotype 
(reduced IL10G9 and increased IL10G13) and systemic lupus erythematosus
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Figure 4.2 Diagrammatic representation of the human IL10 promoter region.
IL10R IL10G ATG1
-4004....-3978 -1193....-1151
V
Illustrated are the IL10R and 1L10G microsatellites. ATG1 represents the start of the IL10
gene. Microsatellite Intron
Adapted from Eskdale et al. (1997).
(Eskdale et a l, 1997). Recently a role for IL-10 in the pathogenesis of periodontal 
disease was proposed (Stein and Hendrix, 1996; Stein et a l, 1997). It is possible that 
polymorphic alleles in the IL10 microsatellites influence susceptibility to EOP.
This study presents data from the analysis of polymorphisms at TNF and IL10 
microsatellite loci in a population of GEOP patients compared with a control 
population. These microsatellite loci consist of dinucleotide repeats. The 
microsatellites examined were TNFa, comprising 14 alleles, and TNFd with seven 
alleles (Figure 4.1). The two microsatellites found within the IL10 promoter region 
were also examined (Figure 4.2). IL10R (5 alleles) and IL10G (16 alleles) lie 
approximately 4 kb and 1.2 kb respectively from the IL10 transcription initiation site 
(Eskdale and Gallagher, 1995; Eskdale, Kube and Gallagher, 1996).
4.2 Materials and Methods
4.2.1 Patient Selection
Seventy-five unrelated GEOP patients were recruited for the study of TNF and IL10 
microsatellite loci, according to the criteria previously described (section 2.3.1). 
Demographic data are presented in Table 4.1. Thirteen patients in this group were > 
35 years of age when they presented in the periodontal department of Glasgow Dental 
Hospital and School. The reasons for their inclusion have already been described in 
section 3.2.1.
4.2.2 Selection of Controls
The control group comprised unrelated healthy blood donors whose samples were 
provided by the tissue-typing laboratory at Glasgow Royal Infirmary. This group did not 
include any individuals with autoimmune or malignant disease or relatives of individuals 
with these diseases. They were ethnically-matched with the patient group. No 
demographic data were available for the control population. In addition, their 
periodontal status was not determined. However, this was not considered to be
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Table 4.1 Demographic data of GEOP patient population.
Total3 Male3 Female3 Smokers3 Non-smokers3 
Patients 75 (100) 23 52 35 (46.67) 40(53.33)
3 Numbers of individuals in each group; percentages in parentheses. 
b Mean age and range in years, in parentheses.
Mean ageb 
31.84(16-43)
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important since the frequency of GEOP in the general population (0.3%) is low (Oliver, 
Brown and Loe, 1998).
The control population for the TNFa, IL10R and IL10G microsatellites was previously 
presented as follows: TNFa (n = 91) by Gallagher et al. (1997); IL10R (n = 94) by 
Eskdale et al. (1996) and; IL10G (n = 102) by Eskdale and Gallagher (1995).
4.2.3 DNA Purification
DNA was extracted from the patients’ blood using the BACC2 Nucleon kit (section 
2.3.4). The resulting DNA samples were stored at 4°C until required. DNA integrity 
was checked and DNA quantitated using agarose gel electrophoresis (section 2.3.5). 
Two microlitres of DNA were added to 6.2 pi of TE buffer and 4 pi of orange G 
loading dye before loading into the gel. A constant voltage of 60V was applied to the 
gel for 30 to 60 minutes.
4.2.4 PCR Reactions
The microsatellite PCR reactions each required a different pair of primers (Table 4.2) 
and thermocycling conditions (see below). The thermocycler used was a Biometra 
Uno Thermoblock (Biometra, Gottingen, Germany).
Equipment and reagents used in PCR were separated into batches, and aliquoted for 
storage to prevent contamination of stock solutions. All reagents were handled using 
filter tips to prevent contamination of the inside of the pipette with aerosol. Negative 
controls were included with every PCR experiment to check for contamination. 
Positive controls from previous studies were used in the PCR reactions.
Template DNA was added to the thin-walled tubes and overlaid with mineral oil. The 
operator then moved to another bench where the master mix was prepared and added 
to the tubes. The master mixes for the different PCR reactions are detailed in Table 
4.3.
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Table 4.2
Name 
TNF. 2
TNFA
TNF. 12
TNF. 11
IL10.1
IL10.2
IL10.3
IL10.4
Sequences and positions of primers used in PCR reactions.
Region Approximate Position Sequence 5’ -  3’
5’ NCR 3.5 kb from TNFB
5’ NCR 3.5 kb from TNFB
3 ’ NCR 8-10 kb from TNFA
3 ’ NCR 8-10 kb from TNFA
5’ NCR 1.2 kb from IL10
5’ NCR 1.2 kb from IL10
5’ NCR 4 kb hom IL10
5’ NCR 4 kb from IL10
GCC.TCT.AGA.TTT.CAT.CCA.
GCC.ACA
CCT.CTC.TCC.CCT.GCA.ACA.
CAC.A
CAT.AGT.GGG.ACT.CTG.
TCT.CCA.AAG
AGA.TCC.TTC.CCT.GTG.
AGT.TCT.GCT
GTC.CTT.CCC.CAG.GTA.
GAG.CAA.CAC.TCC
CTC.CCA.AAG.AAG.CCT.
TAG.TAG.TGT.TG
CCC.TCC.AAA.ATC.TAT.TTG.
CAT.AAG
CTC.CGC.CCA.GTA.AGT.
TTC.ATC.AC
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Table 4.3 PCR master mixes.
1. TNFa and TNFd master mixes
Reaction Component Stock concentration Concentration in 
final volume
Vol per 20 pi 
(per reaction)
Primers
TNF.2/TNF.12
10 pM 1.0 pM 2.0 pi
Primers
TNF.4/TNF.11
10 pM 1.0 pM 2.0 pi
cc32P.dCTP — — 0.02 pi
dCTP 2mM 0.2 mM 2.0 pi
dATP, dTTP, dGTP 20 mM 2.0 mM
PCR Buffer 10 x 1 X 2.0 pi
Primezyme — 0.4 units 0.2 pi
Template DNA — — 1.0 pi
m b g h 2o — — 10.78 pi
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Table 4.3 PCR master mixes (continued).
1. IL1OG master mix
Reaction Component Stock concentration Concentration in Vol per 25 pi
final volume (per reaction)
Primer IL10.1 10 pM 1.0 pM 2.5 pi
Primer IL10.2 10 pM 1.0 pM 2.5 pi
ct32P.dCTP — — 0.02 pi
dCTP 2 mM 0.2 mM 2.5 pi
dATP, dTTP, dGTP 20 mM 2.0 mM
PCR Buffer 10 x 1 X 2.5 pi
Primezyme — 0.5 units 0.25 pi
Template DNA — — 2.0 pi
MBG H20 — 12.73 pi
2. IL10R master mix
Reaction Component Stock concentration Concentration in Vol per 20 pi
final volume (per reaction)
Primer IL10.3 10 pM 1.0 pM 2.0 pi
Primer IL10.4 10 pM 1.0 pM 2.0 pi
a 32P.dCTP — — 0.02 pi
dCTP 2 mM 0.2 mM 2.0 pi
dATP, dTTP, dGTP 20 mM 2.0 mM
PCR Buffer 10X IX 2.0 pi
Primezyme — 0.5 units 0.25 pi
Template DNA — — 2.0 pi
m b g h 2o — — 9.73 pi
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Following PCR, 8 pi of formamide loading buffer was added to each sample and the 
samples were stored at -20°C until required.
4.2.4.1 TNFa and TNFd PCR
The TNFa primers, TNF.2 and TNFA (Table 4.2) are adjacent to the TNFa CA(n) 
microsatellite repeat sequence. The TNFd primers, TNF. 12 and TNF. 11 (Table 4.2) 
are adjacent to the TNFd CT(n) microsatellite repeat sequence.
Thermocycling was carried out as follows; an initial denaturation step at 94°C for 5 
minutes was followed by 5 cycles of denaturation at 94°C for 25 seconds, annealing of 
primers at 65°C for 30 seconds and primer extension at 74°C for 30 seconds. Thirty 
cycles of 94°C for 15 seconds, 60°C for 20 seconds and 74°C for 30 seconds and a final 
extension step at 72°C for 10 minutes completed the PCR.
4.2.4.2 IL10G PCR
The IL10G primers, IL10.1 and IL10.2 (Table 4.2) complement bases -1254 to -1228 
and -1117 to -1042 from the transcription start site of the IL10 gene. These are 35 bp 
and 10 bp, respectively, from the ends of the IL10G micro satellite CA(n) repeat 
sequence.
Thermocycling was carried out at 94 °C for 5 minutes followed by 29 cycles of 94 °C for 
15 seconds, 65°C for 1 minute, 72 °C for 1 minute and 72 °C for 5 minutes.
4.2.4.3 IL10RYCK
The IL10R primers, IL10.3 and IL10.4 (Table 4.2) complement bases -4058 to -4035 
and -3967 to -3943 from the transcription start site of the IL10 gene. This is 1 bp and 
41 bp from the ends of the IL10R microsatellite CA(n) repeat sequence.
Thermocycling was carried out at 94 °C for 5 minutes followed by 30 cycles of 94 °C for 
15 seconds, 61°C for 15 seconds, 72 °C for 15 seconds and 72 °C for 5 minutes.
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4.2.5 Denaturing Polyacrylamide Gel Electrophoresis
The amplified PCR products were run on high resolution gels in order to differentiate 
the alleles by size in relation to control DNA of known genotype rather than size 
markers.
The polyacrylamide gel mix contained 6% acrylamide deionised with Amberlite resin, 
and urea. For TNFa and TNFd gels the urea concentration was 7.65M, otherwise it 
was 7M. The total volume of each gel mix was 100 ml. A volume of 750 pi 10 % w/v 
ammonium persulphate and 50 pi TEMED was added to the gel to initiate 
polymerisation. The gel was left overnight to polymerise before use.
The electrophoresis buffer was 1 x TBE. PCR samples were denatured at 80 °C, and 
cooled immediately on ice to prevent renaturation, before loading onto the gel. The gels 
had been preheated and were run at 75W on Stratagene BaseAce sequencing rigs 
(Stratagene, Cambridge, UK) for three hours. Xylene cyanol loading dye added to the 
samples migrates with fragments of 110 bp on a 6% acrylamide gel. Therefore this 
gave a visual indication of when separation of products was nearing completion.
The gels were allowed to dry and then exposed to X-ray film.
4.2.6 Statistical Analysis
Statistical analysis of the TNF and IL10 polymorphisms was performed using the 
CLUMP programme devised by Sham and Curtis (1995). This programme is designed 
for use in genetic case-control studies where multiple alleles are being considered and 
where the numbers observed for some alleles are small. The significance of 
differences in allele frequencies is assessed in a 2 x N table using Monte Carlo 
simulations. The number of times that a chi-squared value associated with the 
observed data is achieved by simulated data sets is the measure of significance. This 
programme is designed to maximise the chi-squared value by “clumping” the columns 
together into a new 2 x 2  table. The statistic produced is the T4 value, which is 
equivalent to the chi-squared value of the difference in frequencies of all the alleles 
clumped together. The use of the Monte Carlo method avoids the need for a
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Bonferroni correction and the difficulty of assessing the significance of rarer alleles. 
One thousand simulations were performed for each set of microsatellite data. A p- 
value of < 0.05 was taken to be statistically significant.
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Table 4.4 Reagents and buffers.
Formamide loading buffer
95% Formamide 
20mM EDTA 
0.05% Bromophenol blue 
0.05% Xylene cyanol FF
10 x Optimised PCR Buffer
lOmM Tris-HCl [pH 8.8 at 25°C]
1.5mM MgCl2
50mM KC1
0.1% Triton X-100
Store at -20°C in 200 pi aliquots.
20 mM dNTPs (2’ deoxynucleotide 5’ triphosphates)
dATP (lOOmM) 200 pi
dTTP (lOOmM) 200 pi
dGTP (lOOmM) 200 pi
MBG H20  to 1 ml
Store at -20°C in 50 pi aliquots.
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4.3 Results
The results of the analysis of TNFa, TNFd, IL10G and IL10R polymorphisms are 
displayed in Figures 4.3 to 4.10. The PCR for TNFd was unsuccessful for one patient 
who was a smoker; for IL10G it was unsuccessful for two smokers and two non- 
smokers and for IL10R for three smokers and two non-smokers.
The results of the statistical analysis were as follows:
TNFa comparison of EOP and control populations: T4 = 10.23
p = 0.14
TNFa comparison of EOP smokers and non-smokers: T4 = 4.58
p = 0.75
TNFd comparison of EOP and control populations: T4 = 1.87
p = 0.72
TNFd comparison of EOP smokers and non-smokers: T4 = 1.30
p = 0.80
IL10G comparison of EOP and control populations: T4 = 10.07
p = 0.09
IL10G comparison of EOP smokers and non-smokers: T4 = 7.71
p = 0.16
IL1 OR comparison of EOP and control populations: T4 = 1.10
p = 0.57
IL1 OR comparison of EOP smokers and non-smokers: T4 = 2.19
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Figure 4.3 Frequency of TNFa microsatellite alleles in GEOP and control
populations.
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Control Population (n = 91) GEOP Population (n = 75)
Allele Number Observed Frequency (%) Number Observed Frequency (%)
1 2 1.10 0 0.00
2 37 20.3 46 30.67
3 3 1.65 1 0.67
4 17 9.34 9 6.00
5 12 6.59 4 2.67
6 33 18.13 25 16.67
7 12 6.59 11 7.33
8 1 0.55 0 0.00
9 3 1.65 8 5.33
10 16 8.79 11 7.33
11 38 20.88 28 18.67
12 1 0.55 3 2.00
13 7 3.85 3 2.00
14 0 0.00 1 0.67
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Figure 4.4 Frequency of TNFa microsatellite alleles in GEOP smokers and
non-smokers.
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GEOP Smokers (n = 35) GEOP Non-smokers (n — 40)
Allele Num ber Observed Frequency (%) Number Observed Frequency (%)
1 0 0.00 0 0.00
2 21 30.00 25 31.25
3 1 1.43 0 0.00
4 5 7.14 4 5.00
5 1 1.43 0 0.00
6 11 15.71 14 17.50
7 5 7.14 6 7.50
8 0 0.00 0 0.00
9 5 7.14 3 3.75
10 2 2.86 9 11.25
11 16 22.86 12 15.00
12 1 1.43 2 2.50
13 2 2.86 1 1.25
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Figure 4.5 Frequency of TNFd microsatellite alleles in GEOP and control
populations.
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Figure 4.6 Frequency of TNFd microsatellite alleles in GEOP smokers and
non-smokers.
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Figure 4.7 Frequency of IL10G microsatellite alleles in GEOP and control
populations.
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I L 1 0 G  m i c r o s a t e l l i t e  a l l e l e s
Control Population (n = 102) GEOP Population (n = 71)
Allele Number Observed Frequency (%) Number Observed Frequency (%)
1 1 0.49 0 0.00
2 0 0.00 0 0.00
3 0 0.00 0 0.00
4 0 0.00 0 0.00
5 1 0.49 0 0.00
6 0 0.00 0 0.00
7 5 2.45 2 1.41
8 7 3.43 2 1.41
9 103 50.49 55 38.73
10 14 6.86 13 9.15
11 20 9.8 13 9.15
12 9 4.41 13 9.15
13 33 16.18 32 22.54
14 10 4.9 10 7.04
15 0 0.00 2 1.41
16 J_ 0.49 _0_ 0.00
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Figure 4.8 Frequency of ILJOG microsatellite alleles in GEOP smokers and
non-smokers.
I L 1 0 G  m ic r o s a t e l l i t e  a l l e l e s
GEOP Smokers (n = 33) GEOP Non-smokers (n = 38)
Allele Number Observed Frequency (%) Number Observed Frequency (%)
7 1 1.52 1 1.32
8 0 0.00 2 2.63
9 21 31.82 34 44.74
10 7 10.61 6 7.89
11 7 10.61 6 7.89
12 4 6.06 9 11.84
13 20 30.30 12 15.79
14 4 6.06 6 7.89
15 2 3.03 0 0.00
16 _0_ 0.00 _0_ 0.00
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Figure 4.9 Frequency of IL10R microsatellite alleles in GEOP and control
populations.
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Figure 4.10 Frequency of IL10R microsatellite alleles in GEOP smokers and
non-smokers.
■  Smokers 
11 Non-smokers
IL10R microsatel l i te al leles
GEOP Smokers (n = 32) GEOP Non-smokers (n = 38)
Allele Number Observed Frequency (%) Number Observed Frequency (%)
1 0 0.00 0 0.00
2 44 68.75 43 56.58
3 19 29.69 30 39.47
4 1 1.56 3 3.95
5 JL 0.00 _0_ 0.00
64 100 76 100
p = 0.29
No significant associations were found between any of the microsatellite loci 
individually and GEOP. In addition, there were no significant differences in frequency 
of any alleles between GEOP smokers and non-smokers. A trend towards a decrease 
in IL10G9 and an increase in G13 between GEOP patients and controls was noticed 
(Figure 4.7). When the patient group was split into smokers and non-smokers it 
became evident that this difference was due to the smokers (Figure 4.8). There was 
also a trend towards an increase in TNFa2 in GEOP (Figure 4.3), although there were 
no differences in frequency between GEOP smokers and non-smokers for this 
microsatellite (Figure 4.4).
The trend in TNFa2 in GEOP has been found to be significant in other studies of 
chronic inflammatory diseases, often as part of a haplotype which in one report of 
Crohn’s disease also included an increased frequency of TNFd4 (Pociot et al., 1993; 
Plevy et al., 1996; Field et al., 1997). The data was therefore also analysed for 
frequency of the TNFa2TNFd4 allelic combination.
The combined genotype was found to be more frequent in the patient group (33.8%) 
than in the control group (21.2%). This difference between the two populations was 
statistically significant (p = 0.047). There was however no difference in the combined 
genotype between GEOP smokers and non-smokers (p = 0.82).
4.4 Discussion
4.4.1 Advantages of Dinucleotide Repeats as Genetic Markers
A useful way of differentiating allelic polymorphisms at the DNA level is to employ 
the PCR-RFLP method. This is especially helpful in highly polymorphic areas of the 
genome, such as the MHC, where haplotypes extend across the entire region (Pociot et 
al., 1991; Wilson et al., 1993). In addition, linkage of certain diseases to various 
cytokine genes has been demonstrated using this method (Pociot et al., 1992; McGuire 
et al., 1994; McDowell et al., 1995).
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The use of micro satellite motifs as genetic markers has been developed more recently 
(Weber, 1990). This is a much more informative method of gene mapping. 
Microsatellite loci consist of variable lengths of tandem repeats of untranslated DNA, 
which are locus specific. The size of the tandem repeats has been shown to remain 
constant and it appears therefore that they are stable markers which are interspersed 
throughout the genome (Jacob, Mykytyn and Tashman, 1993). These short sequences 
are much more polymorphic than RFLP and are multiallelic. Normally only two 
alleles are identified using RFLP (Botstein et al., 1980) which has a maximum 
polymorphism information content (PIC) value of 0.375. For dinucleotide repeats this 
value may be doubled (Weber, 1990; Jongeneel et al., 1991).
Microsatellite loci lie in close proximity to immune response genes, such as cytokine 
genes and also their promoter and enhancer regions (Jacob, Mykytyn and Tashman, 
1993; Danis et al., 1995). Therefore they may play a part in regulating genes encoding 
protein products which have a role in the immune and inflammatory response. Only a 
small number of cytokine genes show polymorphism using restriction enzymes. Until 
the discovery of microsatellite loci a low degree of sequence polymorphism of the 
TNF locus had been demonstrated using RFLP (Udalova et al., 1993). Typing of TNF 
microsatellites and one RFLP defined by the restriction enzyme Ncol (TNF +252) 
(Figure 4.1) has revealed at least 35 distinct haplotypes (Wilson, di Giovine and Duff, 
1995). Since microsatellite loci are more informative as genetic markers than RFLP, 
their use in examining associations with heterogeneous diseases such as EOP may be 
more rewarding.
4.4.2 Analysis of the TNF Microsatellite Loci
No significant association was found between the TNFa locus or the TNFd locus and 
GEOP in the present study. There was however a trend towards an increase in allele 2 
of TNFa in GEOP patients compared with controls (Figure 4.3). When the data for 
GEOP smokers and non-smokers was analysed there was no difference between the 
two groups (Figure 4.4). The trend towards an increase in TNFa2 observed in GEOP 
has been found to reach significance in other chronic inflammatory diseases including 
RA and Crohn’s disease (Plevy et al., 1996; Hajeer et al., 1996; Field et al., 1997). In
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these studies the association was found to be part of an extended haplotype including 
other TNF markers and also previously described HLA allelic combinations. These 
conditions share in common with periodontitis high levels of proinflammatory 
cytokines, such as IL-1 and TNFa, at sites of tissue destruction. Raised TNFa 
secretion has been found to be predictive of acute relapses, following steroid induced 
remission for one year, in Crohn’s disease (Schreiber et al., 1999). In addition, anti- 
TNFa monoclonal antibody administered to patients with both RA and Crohn’s 
disease results in a dramatic improvement in clinical symptoms (Elliott et al., 1994; 
van Dullemen et al., 1995). Recently a highly significant association between sulcus 
bleeding index, probing depth and clinical AL, and longstanding active RA (p =
0.0001) was reported (KaBer et al., 1997). The RA patient group and the control group 
were comparable for age, sex, smoking and oral hygiene status.
Insulin-dependent diabetes mellitus is another condition, which shows a strong 
association with MHC loci, namely HLADR4 and TNFa (Davies et al., 1994; Gustke et 
al., 1998). Patients with IDDM have an increased susceptibility to periodontitis 
(Cianciola et al., 1982; Firatli, 1997). Alley et al. (1993) found significant 
associations between HLA-DR4, -DR53 and -DQ3 and diabetes and periodontitis. The 
association with peridontitis was highly significant (p = 0.001) whereas the association 
with diabetes was moderately significant (p = 0.05). These findings were recently 
confirmed in another study, which examined antibody responses to cell antibody- 
proteins of Capnocytophaga species (Dyer et al., 1997). Serum IgG responses and 
HLA-DR4 were found to be significantly correlated with diabetes and periodontitis. 
The authors suggested that both IDDM and periodontitis patients have a reduced 
antibody response to Capnocytophaga, which may predispose to infection with this 
bacteria. Furthermore, they proposed that the HLA-D type and altered immune 
function might play a more important role in susceptibility to periodontitis in IDDM 
than diabetes itself. Three other groups have also reported a significant association 
between HLA-DR4 and EOP (Katz et al., 1987; Firatli et al., 1996b; Bonfil et al., 
1999). The studies by Katz et al. (1987) and Bonfil et al. (1999) were in small groups 
of patients (n = 10 and n = 11 respectively). However, the latter group typed patients 
and controls using PCR.SSO and found a significant association with the HLADR4 
subtypes DRB1*0401, *0404, *0405 and *0408. This group of alleles had previously
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been implicated in RA (Bonfil et al., 1999). Pociot et al. (1993) found an increased 
frequency of the TNFa2 microsatellite allele in IDDM. This was part of an extended 
haplotype including HLA-DR4 and allele two of the TNFB +252 RFLP (Figure 4.1). 
Individuals carrying this haplotype had an increased TNFa secretory capacity.
Recently an association between an increased frequency of the combined 
TNFa2TNFd4 genotype and Crohn’s disease was reported (Plevy et al., 1996). 
Neither allele was associated individually with Crohn’s disease. The finding in this 
study of a significant association between the TNFa2TNFd4 allelic combination and 
GEOP is therefore interesting in the light of the foregoing discussion. However, the 
association is only marginally significant and requires further investigation and 
corroboration in cases and controls also typed for HLA class I and II antigens.
Taken together, the results of these studies raise the possibility of an underlying 
disease genotype, or a few genotypes, which predispose to a number of chronic 
inflammatory conditions. These genotypes might contribute to defects in one or more 
aspects of the immune response, which have a generalised effect. Susceptibility to 
disease could be governed by interaction between the disease genotype and a mutant 
gene for a particular body system. Alternatively, environmental factors such as 
smoking or infection acting both locally and systemically might cause manifestation of 
a disorder in a host carrying a defective immune response genotype.
4.4.3 Analysis of the IL10 Microsatellite Loci
No significant associations were found between the IL10 microsatellite loci and GEOP 
in this study. However, a trend towards an association between polymorphisms at the 
IL10G microsatellite and EOP was seen. Figure 4.7 demonstrates the distribution of 
alleles for this locus between the EOP and control populations. Allele nine is 
decreased and allele 13 increased in EOP patients compared with controls. A recent 
paper by Eskdale et al. (1997) found a similar association between systemic lupus 
erythematosus (SLE) and this locus. It was suggested that this finding might relate to 
the increased levels of IL-10 seen in patients with SLE (Llorente et al., 1994). IL-10 is 
a potent stimulator of B cell proliferation and differentiation (Rousset et al., 1992; Itoh
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and Hirohata, 1995) and can prolong B cell survival by preventing apoptosis (Levy and 
Brouet, 1994). It has been shown that IL-10 stimulates the production of 
autoantibodies in SLE (Llorente et al., 1995). In addition, an increasing IL- 
lOiIFNy-secreting-cell ratio with increasing disease severity has been demonstrated in 
SLE, indicating a Th-2 type of response. This finding is of interest since a number of 
investigators have found a predominantly Th-2 response in periodontitis lesions 
(Wassenaar et al., 1995; Tokoro et al., 1997). It has recently been demonstrated that 
increased production of IL-10 by GMC from AP lesions and from peripheral blood 
monocytes of diabetics stimulated with Pg occurs (Stein and Hendrix, 1996; Stein et 
al., 1997). It was suggested that autoimmune reactions against gingival tissues may be 
triggered by IL-10 (Stein et al., 1997).
A subsequent study by Eskdale et al. (1998a) found the haplotype IL10R2/IL10G14 
was associated with highest IL-10 secretion and IL10R3/IL10G7 was associated with 
lowest IL-10 secretion. This group also demonstrated a significant association 
between RA and a high frequency of IL10R2 at the expense of IL10R3 in three 
geographically diverse patient populations (Eskdale et al., 1998b). Serum and 
synovial fluid collected from RA patients contain significantly elevated levels of IL-10 
(Cush et al., 1995). It was suggested that the increased production of IL-10 may 
contribute to the reduced T cell response and increased antibody and rheumatoid factor 
titres in RA patients. These findings indicate that the decreased frequency of IL10G9 
and increased frequency of IL10G13 in SLE, and the trend in GEOP, may not have a 
direct relationship with IL-10 levels. Another group found significant associations 
between IL10G and bcl2 microsatellite loci and SLE in Mexican Americans (Mehrian 
et al., 1998). The bcl2 gene codes for a molecule that inhibits or delays apoptosis, 
(Levy and Brouet, 1994) and is found on chromosome 18. Susceptibility alleles of 
IL10 and bcl2 were found to act synergistically and the occurrence of these alleles 
together increased the risk of developing SLE by at least 40-fold. It is possible that the 
IL10G susceptibility alleles identified in the study of SLE by Eskdale et al. (1997) 
may interact with other loci which influence aspects of the immune response related to 
the function of IL-10.
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When the GEOP population was split according to smoking status, the trend towards a 
reduction in allele nine and an increase in allele 13 in the GEOP patients was found to 
be due to the smoking group (Figure 4.8). It has been demonstrated that smoking can 
have profound effects on the immune response in periodontitis (section 1.7.6). In 
addition, smoking may influence subgingival infection by specific periodontal 
pathogens (Zambon et al., 1996a). A general consensus exists to the effect that some 
autoimmune diseases may be initiated by infection (Baines and Ebringer, 1992). It is 
possible therefore that smoking interacts with the IL10 genotype to exacerbate the 
destruction seen in patients with GEOP. Alternatively, the increased IL-10 levels in 
the gingivae may normally be protective in nature (Mertz et al., 1994). In this case 
smoking may interact in a deleterious manner with other aspects of the immune or 
inflammatory response and override the anti-inflammatory effect of 11-10. The IL10 
locus may be in linkage disequilibrium with another immune response locus situated 
nearby on chromosome one. Unfortunately no comparison between smoking status 
and distrubution of IL10G alleles could be made between EOP patients and controls, 
since no demographic data were available for the control population. However, the 
trend observed in the patient group is worthy of further investigation.
4.4.4 Concluding Remarks
As previously mentioned, EOP constitutes a group of diseases which may be 
genetically and environmentally heterogeneous. Although overriding evidence now 
exists for a genetic predisposition to EOP, unravelling the detail at the gene level is a 
complicated and time-consuming process. Within populations of patients subgroups 
very probably exist with different aetiologies of disease, increasing the difficulty of 
finding associations between genetic markers and GEOP. One of the major criticisms 
of studies of candidate genes in periodontitis is the lack of sample size (Komman et 
al., 1997; Galbraith et al., 1998; Gore et al., 1998). This makes interpretation of 
significant results unreliable. The data presented in this report represented a 
population of 75 GEOP patients, which is a substantial cohort compared with previous 
studies. In addition, a careful and conservative statistical analysis has been undertaken 
to ensure no bias or over-reporting of the significance of the findings. However, the
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results of this study will require further investigation and verification before any 
conclusions are reached concerning the elucidation of the genetic basis of GEOP.
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Chapter 5 Clinical and Genetic Analysis of a Large Family with 
Generalised Early Onset Periodontitis
5.1 Introduction
Since the 1920s researchers have recorded histories of families with more than one 
individual affected by periodontitis (Hassell and Harris, 1995). However, most of the 
evidence for a genetic predisposition to EOP comes from segregation analyses 
performed over the last 20 years. The majority of reports have not defined the criteria 
used for diagnosis of the affected and unaffected family members. Clearly, a better 
understanding of the pathological and genetic processes involved in EOP would occur if 
a biochemical or cellular marker that could be assayed without age restrictions could be 
identified. Until such a marker is found, it is necessary to use reported histories in a 
methodical manner.
In a recent study, autosomal dominant inheritance and race-specific heterogeneity in 
EOP was proposed (Marazita et al., 1994). This was a large-scale segregation analysis 
using 100 nuclear families ascertained through 104 probands with EOP. The authors 
concluded that for each subset, the most likely mode of inheritance was autosomal 
dominant in both black and non-black families, with 73% penetrance in blacks and 
70% in non-blacks. Because many of the probands' relatives were over 35 years of age 
when first examined, the study clinicians reviewed the radiographs and dental histories 
of all the individuals concerned. Any AP or edentulous subject with more than a 50% 
chance of having had EOP was re-categorised as affected. In this report, the criteria 
for reviewing an individual's radiographs and dental history were not documented. It 
is essential to adopt strict criteria in reviewing histories. This avoids major errors in 
the clinical and genetic analyses by over or under-estimating disease.
Both X-linked dominant and autosomal recessive inheritance of EOP have been 
proposed in earlier studies (Melnick, Shields and Bixler, 1976; Saxen, 1980b; Saxen and 
Nevanlinna, 1984; Page et al., 1985; Spektor, Vandesteen and Page, 1985; Beaty et al., 
1987; Long et al., 1987; Boughman et al., 1988). The X-linked dominant theory is
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based on a high female:male ratio among affected individuals, and lack of father-to-son 
transmission (Benjamin and Baer, 1967; Melnick, Shields and Bixler, 1976; Spektor, 
Vandesteen and Page, 1985). The preponderance of females in genetic studies of EOP is 
probably due to an ascertainment bias (Saxen, 1980b; Beaty et al., 1987; Hart et al., 
1991). In addition, only a few fathers have participated in studies of EOP (Boughman et 
al., 1988; Hart et al., 1992). Earlier studies were based on an average of 25 pedigrees, 
which is a relatively small number. However, even in the recent large-scale study of 100 
families there were almost half as many fathers compared with mothers who took part 
(Marazita et al., 1994).
One group of investigators (Long et al., 1987) concluded that an autosomal recessive 
model fitted significantly better than an X-linked dominant one, but they did not test an 
autosomal dominant model (Marazita et a l, 1994). Others (Beaty et al., 1987; 
Boughman et al., 1988) also found the best fitting model to be an autosomal recessive 
one but identified problems with the upper age-limit for diagnosing EOP. Marazita et al. 
(1994) analysed a large number of families compared with earlier studies of EOP and 
favoured an autosomal dominant mode of inheritance with reduced penetrance.
The study reported here presents a method for current and retrospective diagnosis of 
relatives of EOP probands when the ideal clinical data is not available. The index 
developed was then applied to the segregation analysis of a large pedigree with GEOP. 
In addition, the power of the large pedigree to detect linkage was investigated.
5.2 Materials and Methods
5.2.1 Ascertainment and Diagnosis of the Proband.
The proband was a patient who first presented at Glasgow Dental Hospital in 
September 1994. A full medical history was recorded to rule out any condition that 
might predispose to periodontal disease.
The clinical diagnosis of the proband used the classification for GEOP already 
described in section 2.3.1 (Hart et al., 1991).
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5.2.2 Diagnosis of Family Members - Assessment Procedures
Comprehensive medical and social histories were recorded for all relatives included in 
the analysis.
The full mouth periodontal charting is the most accurate method available of diagnosis 
of periodontitis. Measurements of attachment level and probing depth are recorded at 
six points round each tooth. Using this method, three categories were defined 
according to reliability of diagnosis of EOP (Table 5.1). The extent and severity of 
disease for age was also taken into account. Relatives fewer than 25 years of age with 
at least four teeth exhibiting > 5 mm AL were classified as definitely affected. 
Individuals between 25 and 29 years old required at least six teeth to be placed in this 
category. Family members falling into the “probably affected” and “possibly affected” 
groups required the same number of teeth in each age group but showing AL of > 4 
mm and > 3 mm, respectively.
Information from the clinical examination that stopped short of a full periodontal 
charting (Table 5.2) and from the reported case histories and anamnestic information 
(Table 5.3) was carefully analysed according to diagnostic value and attributed points. 
Age was also taken into consideration in the analysis. The total number of points 
scored by each individual was then compared with the values allocated, according to 
severity and extent of disease, from full mouth chartings (Table 5.1). This was in 
order to determine in which of the three categories an individual should be placed. A 
diagnostic flow diagram is illustrated in Figure 5.1.
A summary of the methods used for retrospective diagnosis of the proband’s relatives 
is shown in Table 5.4. One family member, who was available for a full periodontal 
assessment but was 38 years old when he was examined, had interdental AL of 
between five and 14 millimetres around half of his remaining teeth.
Three models with different degrees of diagnostic reliability for GEOP were 
considered. A pedigree of the large family was constructed showing all three 
categories.
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Table 5.1 Diagnostic categories for genetic analysis of family members (up to 
35 years of age). Assessed using full mouth periodontal chartings -  
number of teeth required in each age group with a given level of AL.
AL (mm) Age (years) Points Category
<25 25-29 30-35
> 5 mm 4 6 8 5 definitely affected
> 4  mm 4 6 8 4 probably affected
> 3 mm 4 6 8 3 possibly affected
Table 5.2 Any documented clinical evidence of periodontal disease (when 
aged < 45 years).
Signs of disease Points
Radiographic BL >1/3 root length on > 2 teeth 1
One sextant with at least one tooth with a pocket of > 5 mm 1
measured apically from the ACJ
One sextant with at least one tooth with a pocket of > 3.5 mm XA
measured apically from the ACJ
Interproximal recession > 3 mm on more than one tooth 1
Five missing teeth (excluding third molars) 1
Age of patient at examination - 20s 2
30s 1
40s 0
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Table 5.3 Evidence of periodontal disease - reported histories (for period 
encompassing up to 45 years of age).
Symptoms Points
Pyorrhoea (periodontal disease)/loose teeth 1
Bleeding on brushing 1
Multiple tooth loss without decay 1
Recurrent abscesses/bad taste/bad breath 1
Teeth appearing longer/spaced/exposed roots (sensitivity) 1
Age of reported tooth loss - 20s 3
30s 2
40s 1
Table 5.4 Summary of methods used for current and retrospective diagnosis 
of relatives of large kindred - number of relatives in each group.
Age Full mouth charting Documented clinical Reported histories
(Table 5.1) evidence (Table 5.2) (Table 5.3)
<35 3 8 0
35-45 1 3 3
>45 0 1 13
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Figure 5.1 Diagnostic flow diagram.
Family member
^  Categorise to: definitely affected 
probably affected 
possibly affected
Full clinical examination 
<35 years (Table 1)
Documented clinical --------- ► Derive score
evidence and <45 years 
(Table 2)
Dental histories for  ► Derive score
period encompassing 
up to 45 years of age 
(Table 3)
Declare diagnosis uncertain
Smoking status was measured in pack years. For affected individuals, the period of 
smoking was measured up until the age of diagnosis. In edentulous subjects, this was 
taken to be the age at which tooth loss occurred. In unaffected individuals, the number 
of pack years was calculated up to 35 years of age.
5.2.3 Validation of the Points System
The validity of the ‘points system’ was assessed. Diagnoses of individuals classified 
using full mouth periodontal chartings (Table 5.1) were compared with the results 
obtained using documented clinical evidence (Table 5.2) or reported histories (Table 
5.3). The data for 12 relatives of EOP probands, including four relatives of the large 
kindred, was used for the comparison of Table 5.1 and Table 5.2. The documented 
clinical evidence was standard clinical information recorded during an initial visit to 
Glasgow Dental Hospital. Full periodontal chartings were then recorded at an interval 
of between two days and two months following the primary visit, apart from one 
individual who did not attend to have the charting recorded for 14 months.
Eight patients, who had lost multiple teeth and had removable dentures, were assessed 
using specific criteria from reported histories (Table 5.3). These diagnoses were then 
compared to the results obtained using previously recorded clinical data (Table 5.1) or, 
failing this, using documented clinical evidence (Table 5.2).
5.2.4 Statistical Methods
5.2.4.1 Validation of the points system
Kappa values were calculated using the SPSS statistical package.
5.2.4.2 Segregation analysis
Due to the high percentage of affected individuals in generations II and III, it was clear 
that the mode of inheritance of the disease trait in this family was not autosomal 
recessive. Autosomal dominant and X-linked dominant models were considered using
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the chi-squared test. Individuals who had married into the family were not included in 
the segregation analysis.
5.2.4.3 Analysis of the power of the pedigree to detect linkage
Simulations were performed using the SIMLINK program (Boehnke, 1986; 
Ploughman and Boehnke, 1989). This program was used because the ultimate aim of 
this project is to carry out linkage analysis of the large kindred. The SIMLINK 
program is designed to estimate the power of a linkage study. It calculates the 
probability of detecting linkage for a given recombination fraction and indicates 
whether the pedigree provides sufficient information to demonstrate linkage. 
Recombination is the formation of new combinations of linked genes by crossing over 
between loci. The recombination fraction (0) is the fraction of meiotic events that 
show a recombination between two loci. The program assumes Hardy-Weinberg 
equilibrium and no chromosomal interference. It employs the program MENDEL 
(Lange, Weeks and Boehnke, 1988) to calculate likelihoods. Replicates of each 
pedigree are simulated by SIMLINK for a given recombination fraction. MENDEL 
calculates a maximum lod score for each of the desired number of replicates (250 in 
the present case). The lod score is a base 10 logarithm of the odds favouring linkage. 
A lod score of +3 (1000:1 odds) is taken as proof of linkage; a score of -2 (100:1 odds 
against) indicates no linkage. SIMLINK uses the replicates to estimate the expected 
maximum lod score (and its standard error). It also derives the probability that a 
maximum lod score will exceed a particular value. Furthermore, maximum lod scores 
can be estimated for fixed marker distances when no linkage is assumed. This 
procedure permits the estimation of exclusion regions (over which the lod score is less 
than -2.0).
The SIMLINK program was applied to the pedigree with the three categories of GEOP 
considered separately and assuming different allele frequencies. For the purposes of 
the analysis the category with the least stringent diagnostic criteria (possibly affected) 
included the largest number of affected relatives. Therefore, the three groups consisted 
of:
1. all possibly affected cases (including probably and definitely affected individuals);
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2. all probably affected cases (including definitely affected individuals);
3. all definitely affected cases.
The model assumed 75% penetrance up to 25 years of age and 97% thereafter. 
Penetrance is the observable expression of the mutant gene. The existence of two 
unrelated affected spouses is difficult to reconcile with the low frequency of the 
disease. In order to take account of the possible effect of environmental factors on the 
expression of GEOP in this pedigree, simulations were carried out with increasing 
phenocopy rates. A phenocopy is a phenotype due to environmental factors that 
mimics a genetically determined trait.
5.2.4.4 Analysis of smoking as a contributory factor
Analysis of variance was performed to estimate the relationship between smoking and 
GEOP. Adjustments were made in the analysis for the differences in smoking level 
between the six families of the siblings in generation II.
5.3 Results
5.3.1 Validation of the Points System
A comparison of the diagnoses of individuals from full mouth periodontal chartings 
(Table 5.1) with the results that would have been obtained if only documented clinical 
evidence (Table 5.2) had been available, achieved a kappa value of 0.8. This value 
indicates excellent agreement between these scoring methods (Fleiss, 1981). In all 
cases where reported histories (Table 5.3) were compared to the results obtained using 
previously recorded clinical data (Table 5.1) or, failing this, documented clinical 
evidence (Table 5.2), there was complete agreement between the scoring methods.
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5.3.2 Segregation Analysis
The kindred consisted of 14 definitely affected, three probably affected, two possibly 
affected and 14 unaffected members (Figure 5.2). There were seven individuals for 
whom a diagnosis could not be made for one reason or another. Included in the 
analysis were two definitely affected spouses who had married into the family.
Assuming an autosomal dominant model (Table 5.5), of the 12 at risk male 
individuals, the expected number of affected subjects for the definitely affected 
category was 6.25, and unaffected subjects was 5.75. Among the 14 at risk females,
7.00 were expected to be affected and 7.00 unaffected. For the probably affected and 
possibly affected categories, the expected figures for males were 6.75 affected and 
5.25 unaffected, and for females 7.50 affected and 6.50 unaffected. The small bias 
toward affected individuals in the expected category was due to the family where both 
parents were affected. There was no significant difference between the expected and 
observed values for the autosomal dominant model (Table 5.5).
Assuming an X-linked dominant model (Table 5.6) for the definitely affected category, 
out of the 12 males, the expected number of both affected and unaffected individuals 
was 6.0. For the 14 females, 7.0 were affected and 7.0 unaffected. For the probably 
and possibly affected categories, the expected figures for males were 6.5 affected and
5.5 unaffected and for females 7.5 affected and 6.5 unaffected. There was no 
significant difference between the expected and actual values for the X-linked 
dominant model (Table 5.6).
5.3.3 Simulation Results
The simulations were carried out assuming autosomal dominant inheritance since most 
studies of EOP have favoured autosomal inheritance. Table 5.7 shows the results of 
simulations in which the markers were placed at a fixed distance apart; the maximum 
multipoint lod scores are estimated for the trait at a number of positions between 
adjacent markers. In this analysis, a phenocopy rate of 1% was assumed. The 
estimates of the lod scores were above 3.0 for all positions of the trait gene and for all 
categories of disease. The probability of a maximum lod score of 3.0 (Table 5.8) at a
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Table 5.5 Autosomal dominant model. 
Definitely affected
Affected
(expected)
Unaffected
(expected)
Total
Male 4 (6.25) 8 (5.75) 12
Female 8 (7.00) 6 (7.00) 14
Total 12 14 26
X = 1.976 with 2 degrees of freedom p = 0.372
Probably affected (including severely affected)
Total
Male
Female
Total
Affected Unaffected
(expected) (expected)
6 (6.75) 6 (5.25)
9 (7.50) 
15
5 (6.50) 
11
12
14
26
X = 0.836 with 2 degrees of freedom p = 0.638
Possibly affected (including severely and probably affected)
Total
Male
Female
Total
Affected Unaffected
(expected) (expected)
7 (6.75) 5 (5.25)
10 (7.50) 
17
4 (6.50) 
9
12
14
26
X2 = 1.816 with 2 degrees of freedom p = 0.403
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Table 5.6 X-linked dominant model.
Definitely affected
Affected
(expected)
Unaffected
(expected)
Total
Male 4 (6.0) 8 (6.0) 12
Female 8 (7.0) 6 (7.0) 14
Total 12 14 26
%2= 1.619 with 2 degrees of freedom p = 0.445
Probably affected (including severely affe<
Affected
(expected)
Unaffected
(expected)
Total
Male 6 (6.5) 6 (5.5) 12
Female 9(7.5) 5 (6.5) 14
Total 15 11 26
%= 0.730 with 2 degrees of freedom p = 0.694
Possibly affected (including severely and probably affected)
Affected Unaffected Total
(expected) (expected)
Male 7 (6.5) 5 (5.5) 12
Female 10(7.5) 4 (6.5) 14
Total 17 9 26
%2= 1.878 with 2 degrees of freedom p = 0.391
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Table 5.7 Expected maximum multipoint lod score at true map distances 
(cM) - based on 250 simulations.
Map distance from one Multipoint lod scoreb,c
marker to mutant genea
P o s s ib ly  A ffe c te d  +  P ro b a b ly  A ffe c te d  +  D e f in ite ly A ffe c te d  
P ro b a b ly  A f fe c te d  +  D e f in ite ly  A ffe c te d  
D e f in ite ly  A ffe c te d
2 3.80 (±0.09)d 3.69 (±0.08) 3.66 (±0.08)
6 3.29 (±0.08) 3.35 (±0.09) 3.42 (±0.09)
10 3.21 (±0.09) 3.31 (±0.08) 3.29 (±0.08)
14 3.27 (±0.08) 3.22 (±0.09) 3.20 (±0.09)
18 3.83 (±0.08) 3.65 (±0.08) 3.69 (±0.08)
INFINITE 0.03 (±0.01) 0.01 (±0.01) 0.04 (±0.01)
T w o  f la n k in g  m a rk e rs  a t f ix e d  2 0 c M  m a p  d is ta n c e . 
bP e n e tra n c e  in c re a s in g  f ro m  0 .7 5  to  0 .9 7  a t  2 5  y e a rs  o ld . 
T h e n o c o p y  ra te  0 .0 1 .
dF ig u re s  in  p a re n th e s e s  a re  s ta n d a rd  e r ro r  o f  th e  m e a n .
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Table 5.8 Estimated probability of a maximum multipoint lod score > 3 for 
two markers at a fixed map distance (cM) -  based on 250 
simulations.
Map Distance from one Probability1’0
Marker to Mutant Genea
P o s s ib ly  A ffe c te d  +  P ro b a b ly  A ffe c te d  +  
P ro b a b ly  A ffe c te d  +  D e f in ite ly  A ffe c te d  
D e f in ite ly  A ffe c te d
2 0.70 (±0.03)d 0.73 (±0.03)
6 0.60 (±0.03) 0.60 (±0.03)
10 0.59 (±0.03) 0.60 (±0.03)
14 0.62 (±0.03) 0.58 (±0.03)
18 0.74 (±0.03) 0.68 (±0.03)
INFINITE 0.00 (±0.00) 0.00 (±0.00)
aT w o  f la n k in g  m a rk e rs  a t f ix e d  2 0 c M  m a p  d is ta n c e . 
bP e n e tra n c e  in c re a s in g  fro m  0 .7 5  to  0 .9 7  a t 2 5  y e a rs  o ld . 
° P h e n o c o p y  ra te  0 .0 1 .
dF ig u re s  in  p a re n th e s e s  a re  s ta n d a rd  e r ro r  o f  th e  m e a n .
D e f in i te ly A f fe c te d
0.72 (±0.03) 
0.60 (±0.03)
0.60 (±0.03)
0.58 (±0.03)
0.68 (±0.03)
0.00 (±0.00)
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true marker recombination rate (Table 5.9) was at least 0.68, close to a flanking 
marker, and at least 0.59, at the midpoint between them. The probability of a type I 
error, i.e. obtaining a maximum lod score of 3.0 when there is no linkage was zero. 
The lod score was always below -3.78 when both flanking markers were considered to 
be unlinked (Table 5.10). A lod score of less than -2.0 allows exclusion of linkage for 
the whole interval between the markers (Table 5.11).
There was very little variation between lod scores for the three separate groups (Table 
5.7). Therefore only the definitely affected group was re-examined using increasing 
phenocopy rates (Table 5.12). A phenocopy rate of 15% is consistent with two out of 
14 affected individuals being phenocopies. The results at this rate still provide 
evidence of linkage (expected maximum lod score = 3.0). The probability of finding a 
lod score of more than or equal to 3.0 is greater than 0.5. In addition, a satisfactory 
negative lod score for two unlinked markers is also evident.
5.3.4 Results of Smoking Analysis
Analysis of variance of the effect of smoking on the occurrence of GEOP showed no 
evidence of an increasing trend in pack years with severity of disease (p = 0.476) 
(Table 5.13). Although all four non-smokers in generations III and IV were unaffected 
(Figure 2, 111:15, IV: 1,3,4), there were five severely affected individuals who had 
smoked less than 5 pack years (11:4, 11:8, 111:13, 111:14, 111:21) and two severely 
affected (111:3, 111:9) against three unaffected subjects (11:1, 11:11, 111:4) who had 
smoked more than 15 pack years.
5.4 Discussion
There are no family studies of EOP published in the dental literature which precisely 
define the criteria used for the diagnosis of relatives, other than the proband. The 
study presented here has attempted to address this problem. It was essential that as 
many of the relevant family members as possible were included in the segregation 
analysis. Excluding individuals over the age of 35 years could result in a dominant 
form of the disease appearing to be recessive due to lack of parent-offspring
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Table 5.9 True map distances and recombination fractions between each 
marker and the mutant gene.
Marker 1 Marker 2
Distance Recombination Distance Recombination
(cM) fraction (cM) fraction
2 0.02 18 0.15
6 0.06 14 0.12
10 0.09 10 0.09
14 0.12 6 0.06
18 0.15 2 0.02
INF 0.50 INF 0.50
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Table 5.10 Expected lod score for a pair of unlinked markers -  based on 250 
simulations.
Test map distance from Multipoint lod scoreb,c
marker to mutant genea
P o s s ib ly  A ffe c te d  +  P ro b a b ly  A ffe c te d  +  D e f in i te ly  A ffe c te d  
P ro b a b ly  A ffe c te d  +  D e f in ite ly  A ffe c te d
D e f in ite ly  A ffe c te d
2 -5.61 (±0.17)d -5.76 (±016) -5.58 (±0.17)
6 -4.12 (±0.13) -4.22 (±0.13) -4.08 (±0.14)
10 -3.83 (±0.12) -3.90 (±0.13) -3.78 (±0.13)
14 -4.17 (±0.13) -4.23 (±0.13) -4.13 (±0.14)
18 -5.75 (±0.17) -5.80 (±0.17) -5.72 (±0.18)
“T w o  m a rk e rs  a t  f ix e d  2 0 c M  m a p  d is ta n c e . 
bP e n e tra n c e  in c re a s in g  f ro m  0 .7 5  to  0 .9 7  a t 25  y e a rs  o ld . 
cP h e n o c o p y  ra te  0 .0 1 .
dF ig u re s  in  p a re n th e s e s  a re  s ta n d a rd  e r ro r  o f  th e  m ea n .
Table 5.11 Approximate map distances (cM) at which the location score equals 
-2.0 (interpolated):
Marker 1: 20
Marker 2: 20
Proportion of interval excluded (%): 100
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Table 5.12 Expected maximum lod score, estimated probability, and expected 
lod score for unlinked markers, with increasing phenocopy rate -  
based on 250 simulations.
Phenocopy 
rate (%)
Max lod score 
for 2 markers 
equidistant at 
lOcM
Probability of a lod 
score of > 3.0 with 
2 markers equidistant 
at lOcM
Lod score for 
a pair of un­
linked markers
1 3.29 (±0.08)a 0.60 (±0.03) -3.78 (±0.13)
10 2.98 (±0.09) 0.52 (±0.03) -4.08 (±0.12)
15 3.00 (±0.09) 0.53 (±0.03) -4.13 (±0.14)
20 2.89 (±0.09) 0.51 (±0.03) -3.82 (±0.12)
“F ig u re s  in  p a re n th e s e s  a re  s ta n d a rd  e r ro r  o f  th e  m ea n .
Table 5.13 Number of relatives who smoked increasing levels of pack years 
and the mean pack years smoked for each diagnostic category.
Possibly Probably Definitely
Pack years Unaffected Affected Affected Affected
(n = 14) (n = 2) (n = 3) (n = 14)
0-5 8 0 3 5
5-10 3 2 0 3
10-15 0 0 0 4
>15 3 0 0 2
Mean Pack Years 6.09 8.75 1.99 9.35
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transmission. However, individuals under the age of 20 were not included; it was 
considered that the disease phenotype had not developed sufficiently at this age to 
reliably differentiate healthy from diseased subjects (Albandar et al., 1997).
5.4.1 Clinical Analysis
An index was required for the current and retrospective diagnosis of relatives of EOP 
probands. The first stage in the development of such an index was to decide on the 
diagnostic criteria for the affected relatives under the age of 35, who were willing to 
allow a full periodontal assessment to be carried out (Table 5.1). Some investigators 
have used the same diagnostic criteria as for the proband (Hart et al., 1991; Marazita et 
al., 1994). However, in these studies a reduced threshold of clinical AL for the 
affected family members was applied. This was set at a minimum of 2 mm at affected 
molars and incisors in LEOP and a minimum of 3 mm in GEOP. It is suggested that 
these criteria are not stringent enough to distinguish between EOP affected individuals 
and AP subjects. AP also appears to be initiated during the teenage years (Clerehugh, 
Lennon and Worthington, 1990). Therefore, it was decided that AL of > 5 mm, which 
is evidence of established disease, must be present in order for an individual to be 
classified as definitely affected by EOP. However, the age of the patient at 
examination i.e. between 20 and 35 years should be factored into the assessment. 
Fewer teeth with AL of > 5 mm were required in the 25- to 29-year and the under 25- 
year age groups for the family member to be classified as definitely affected. The 
criteria used for any documented or clinical evidence of periodontal disease (Table 5.2) 
were carefully weighted. This was done as a conservative measure of the diagnostic 
value of each criterion, in reflecting the severity and extent of disease from full mouth 
periodontal chartings (Table 5.1). The age of the patient at examination up to 45 years 
was also taken into consideration.
The symptoms of the disease prior to, or the reasons for, tooth loss as reported in the 
histories (Table 5.3) are well established in the literature (Benjamin and Baer, 1967; 
Fourel, 1972; Jorgenson et al., 1975; Melnick, Shields and Bixler, 1976; Saxen, 
1980b). The age of reported tooth loss up to a limit of 45 years was also included and 
weighted in the analysis. Any individual who had suffered multiple tooth loss without
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decay, between the ages of 35 and 45, and who reported other symptoms of the 
disease, almost certainly had periodontal disease (Allen, 1944). In addition, a family 
history of the disease made it more likely that an individual between 35 and 45 years 
who had documented clinical evidence of disease (Table 5.2) or a reported history of 
periodontal disease (Table 5.3) was affected by EOP.
5.4.2 Segregation Analysis
The results of the segregation analysis are consistent with a gene of major effect for 
GEOP inherited in either an autosomal dominant or an X-linked dominant manner. 
Genetic disorders having an X-linked dominant mode of inheritance are very rare. The 
majority of these traits are lethal in hemizygous males (McKusick, 1994; Connor and 
Ferguson-Smith, 1997). Furthermore, many previous family studies of EOP have 
indicated an autosomal pattern of inheritance (Saxen, 1980b; Saxen and Nevanlinna, 
1984; Page et al., 1985; Spektor, Vandesteen and Page, 1985; Boughman et al., 1986; 
1988; Beaty et al., 1987; Long et al., 1987; Hart et al., 1992; Marazita et al., 1994).
5.4.3 Analysis of the Power of the Pedigree to Detect Linkage
There was no systematic difference between the lod scores for the three categories of 
disease (definitely, probably and possibly affected) in the three-point simulations, 
using two flanking markers (Table 5.7). The SIMLINK analysis indicated that the 
pedigree provides sufficient information for a linkage study. Multipoint linkage would 
be able to confirm or reject linkage of a trait gene in the interval between markers, 
placed at an average separation of 20 cM. In addition there was no systematic 
difference between the lod scores for the three groups in two-point simulations, using a 
single marker (data not shown). It should be borne in mind that the penetrance levels 
used for this analysis were conservative.
The phenocopy rate was increased in order to take account of possible environmental 
aetiological factors. It was found that even with a phenocopy rate of 15% the pedigree 
would still be informative for linkage analysis.
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5.4.4 Specific Environmental Risk Factors
It has been proposed that the two most important environmental risk factors for 
periodontitis are smoking and the presence of specific periodontal pathogens (Grossi et 
al, 1994; 1995; Genco, 1996; Barbour et al., 1997). It was not possible to carry out 
microbiological analysis because several of the affected relatives were edentulous. 
However, despite evidence for transmission of periodontal pathogens within families 
(Petit et al., 1993a; Asikainen, Chen and Slots, 1996), this observation on its own is 
insufficient to account for the familial clustering seen in EOP (Boughman, 
Astemborski and Suzuki, 1992; van der Velden et al., 1993; Tinoco, Sivakumar and 
Preus, 1998).
When smoking was considered as an independent variable, it was not found to be 
associated with GEOP in this family (Table 5.9). Of interest were the five relatives who 
were definitely affected by GEOP but were very light smokers (< 5 pack years). It has 
been shown that very light smokers (< 5 pack years) have no increased risk for 
periodontitis above non-smokers (Bergstrom, Eliasson and Preber, 1991; Grossi et al., 
1994; 1995; Martinez-Canut, Lorca and Magan, 1995). In addition there were three 
unaffected family members who were moderate to heavy smokers (> 15 < 2 0  pack 
years). Therefore, it appears that genotype overrides any effect due to smoking in the 
manifestation of the disease in this family.
54.5 Concluding Remarks
An autosomal dominant hypothesis is proposed against a low background prevalence 
of the disease in the general population. Unfortunately no epidemiological studies 
exist for EOP in a Scottish population. However, a recent report of periodontal status 
ir. the USA between 1988 and 1991 in 7447 dentate individuals aged 13 years and 
oder showed low prevalence of established disease in the younger age groups (Brown, 
Brunelle and Kingman, 1996). This study reported a prevalence of AL > 5 mm of 
03% in the 13-17 and 18-24 age groups and 6.4% in the 25-34 age group. 
Iiterpretation of these results must take into account the inclusion of LEOP, GEOP 
aid IEOP in the data-set. Another recent survey of 5,849 individuals aged 18-34 years
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found a prevalence of only 0.3% for GEOP where AL of > 5 mm was present on eight 
teeth (Oliver, Brown and Loe, 1998). In neither of these studies was race considered 
separately for these age groups. Caucasians have a much lower reported prevalence of 
EOP than blacks and Hispanics (Saxby, 1984b; 1987; Ismail et al., 1987; Loe and 
Brown, 1991). Therefore, these prevalence statistics may overestimate the levels of 
disease in Caucasians.
The large kindred studied here is unusual in present times because most of the family 
were bom and remained within two neighbouring villages in South-West Scotland. 
The two affected spouses in generation II who married into the family also came from 
the same community. No evidence could be found of kinship between the spouses and 
the large family when their lineage was traced back through two generations. 
However, it is possible that the spouses were in fact distant relatives of the proband.
In conclusion:
1. A system has been developed which can be used for the diagnosis of relatives of 
EOP probands when ideal clinical data is not available.
2. The index has been carefully validated.
3. The work presented here supports the autosomal dominant theory of genetic 
transmission in GEOP.
4. This large kindred is suitable for a genetic linkage study with the aim of identifying 
the location of a susceptibility gene(s).
iij
i
i
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Chapter 6 General Conclusions
6.1 Summary and Conclusions
For many years heredity has been suspected to play a part in the aetiology of 
periodontal disease. The findings presented in this thesis contribute to the 
accumulating evidence for a genetic predisposition to EOP.
Major advances in the understanding of the pathogenesis of the periodontal diseases 
have come to light during the last decade. It is now possible to identify potential 
defects in aspects of the immune and inflammatory response, which may increase 
susceptibility to the pathogens in the subgingival microbiota. Using recently 
developed molecular genetic techniques these defects can be investigated at the gene 
level.
Analysis of genetic polymorphisms in the HLA complex and the IL.10 promoter 
region were undertaken. No significant associations were found between any of the 
candidate genes and EOP. However, trends were noted in the occurrence of alleles at 
the IL.10.G and TNFa microsatellites. When smoking was included as a covariate for 
the patient group, the trend seen at the IL.10.G locus was found to be due to the 
smokers. In addition, a significant association (p = 0.047) was found between the 
TNFa2TNFd4 allelic combination and GEOP, which had previously been identified as 
a disease genotype in Crohn’s disease. These observations warrant further 
investigation. However, they also highlight the problems of examining candidate 
genes in EOP. Since EOP is a genetically and environmentally heterogeneous group 
of diseases, finding convincing associations with specific polymorphisms in 
populations of unrelated individuals is extremely difficult.
One of the problems of genetic model testing in families with an increased frequency 
of EOP is the confusion that exists between different research groups with regard to 
diagnosis of relatives of EOP probands. An index has been defined and validated 
which is suitable for the current and retrospective diagnosis of family members. The
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application of this index to a large family with GEOP supports the autosomal 
dominant theory of inheritance of this disease.
6.2 Suggestions for Future Research
6.2.1 Candidate Genes
The transmission disequilibrium test and the affected sib-pair design are other ways of 
studying candidate genes in large populations. These methods ensure that the disease 
population and the controls are genetically homogeneous and are useful for 
investigating diseases such as periodontitis, which have a multifactorial aetiology.
Another possible method of unravelling the role of candidate genes in periodontitis is 
to study the frequency of specific polymorphisms in a control group consisting of 
individuals who are resistant to disease.
6.2.1.1 Proinflammatory cytokines
It would be interesting to analyse a control group for the IL.10.G locus including 
smoking as a covariate. In so doing any possible association between GEOP smokers 
and the combined IL.10.G9 and G13 genotype would be revealed.
Because of the problems of heterogeneity of EOP described above, it would be 
worthwhile investigating IL-10 levels in the gingival tissues of patients and controls in 
combination with the IL.10 microsatellites. Eskdale et al. (1998a) recently 
demonstrated that IL-10 secretion can vary according to different haplotypes within 
the IL.10 promoter region. This approach would be a useful way of defining groups of 
individuals who are more homogeneous. It could also be applied to the analysis of 
TNF and other cytokine polymorphisms in EOP.
6.2.1.2 Anabolic cytokines
Research into the genetic basis of periodontal disease could be usefully directed 
towards investigating the anabolic cytokines. These include PDGF, fibroblast growth
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factor, insulin-like growth factor, transforming growth factors and the bone 
morphogenic proteins (Offenbacher, 1996). Many cell types including monocytes, 
platelets and fibroblasts secrete these molecules during tissue repair. Fibroblasts, 
periodontal ligament cells and bone precursor cells are attracted to areas of growth 
factor secretion and stimulated to undergo mitosis and proliferate. Growth factors may 
also promote the secretion of collagen and glycosaminoglycans by their action on 
maturing connective tissue mesenchymal cells. Variation in growth factor expression 
exists between different individuals. For example diabetics and smokers have a 
reduced capacity for monocytic growth factor secretion. This finding may be 
important since both smokers and diabetics demonstrate impaired wound healing.
6.2.1.3 Regulation of proinflammatory cytokines
Without doubt the proinflammatory cytokines IL-1 and TNF play a key role in 
precipitating the destructive processes seen in periodontal disease. However, 
important regulatory molecules such as soluble receptors and IL-lra have also been 
identified. Howells (1995) proposed that periodontitis may be due to decreased levels 
of these cytokine regulators rather than overproduction of IL-1 or TNF. An increased 
frequency of allele 2 in the IL-lra gene (IL.1RN) has been found in individuals with 
increased production of IL-lra protein and decreased production of IL-1 a  by 
monocytes (Danis et al., 1995). However, the same allelic polymorphism has also 
been associated with a number of chronic inflammatory diseases including ulcerative 
collitis and SLE, when the reverse might be expected (Mansfield et al., 1994; 
Blakemore et al., 1994). A subsequent study in patients with inflammatory bowel 
disease found a significant association with a combined genotype (an increased 
frequency of IL.1RN2 and a reduced frequency of allele 2 of IL.1B +3953) and both 
Crohn’s disease and ulcerative collitis (Bioque et al., 1995). Since allele 2 of IL.1B 
+3953 represents a high secretor phenotype the authors suggested that the combined 
genotype might interact to influence the biological outcome of chronic inflammatory 
bowel disease. Alternatively, this haplotype could be a genetic marker in linkage 
disequilibrium with other alleles nearby. A study of AP patients (mild, moderate and 
severe) found no association between IL.1RN and severity of disease (Komman et al.,
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1997). An investigation of phenotypic and genetic associations between cytokines, 
cytokine regulators and EOP might yield interesting results.
6.2.2 Family Studies
The ultimate aim of the clinical and genetic analysis of the large kindred presented 
here is to carry out a family linkage study. During the process of identifying the large 
family a number of nuclear families with a history of EOP were discovered (Appendix 
Three). It would be worthwhile to continue collecting data from smaller pedigrees 
since they could be useful for future linkage analysis and investigation of genetic 
polymorphisms as already mentioned above.
6.3 Concluding Remarks
The future identification of genetic markers of susceptibility to periodontal disease 
could have wide-ranging health and economic implications. Targeting preventive 
measures at individuals most likely to benefit from them, instead of employing a 
broad-based approach to the treatment of periodontitis would preserve valuable 
financial and healthcare resources. During the last five years a number of researchers 
have suggested that periodontal disease may predispose to atherosclerosis and 
coronary heart disease (Beck et al., 1996; Seymour and Steele, 1998). If these initial 
findings are corroborated, the identification of risk markers for periodontal disease will 
become increasingly important in the prevention and treatment of cardiovascular 
disorders.
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Appendix 1 DNA Analysis of IL1 Polymorphisms in
Generalised Early Onset Periodontitis
A l.l  Introduction
Cytokines are regulatory proteins of low molecular weight, which are active in very 
small amounts (femtomolar to picomolar concentrations). They transmit information 
between cells and form a complex network of interactions. Most cytokines are 
pleotropic. They may act synergistically or may inhibit the action of other cytokines. 
They are produced by activated cells and mainly exert their effects locally by binding 
to high affinity receptors on the surface of a variety of cell types. Stable 
interindividual differences in cytokine secretion patterns have been reported (Molvig 
et ah, 1988). It has also been demonstrated that allelic variation at cytokine loci, and 
in genes regulating their expression, may affect cytokine responses between 
individuals (Pociot et ah, 1991; 1993; Messer et ah, 1991; Derkx et ah, 1995; Bailly et 
ah, 1996; Eskdale et al., 1998; Hurme and Santtila, 1998; Santtila et al., 1998). In 
addition, associations between polymorphisms of candidate cytokine genes and certain 
diseases have been documented (Pociot et ah, 1991; 1993; McGuire et al., 1994; 
Wilson et ah, 1994; Eskdale et al., 1997).
The proinflammatory cytokine, IL-1, plays a central role in the pathogenesis of many 
autoimmune and infectious diseases including periodontitis (Roberts et al., 1997). The 
genes encoding IL-1 a  and IL -lp lie on the long arm of chromosome two, 
approximately 70 kilobases apart (Figure A l.l). They are also closely linked with the 
gene for their endogenous inhibitor IL-1 receptor antagonist (IL1RN). Variations in in 
vitro production of IL-1 between individuals suggests a hereditary interindividual 
influence (Molvig et al., 1988; Endres et al., 1989). It has been suggested that 
polymorphisms influencing transcription of IL-1 a  and IL-1 P may give rise to 
differential production of these cytokines. Bi-allelic polymorphisms within the 
promotor regions of the IL1 genes {ILIA -889, IL1B -511) have been identified (di 
Giovine et ah, 1992; McDowell et ah, 1995). In addition, variable number of tandem
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Figure A l.l Diagrammatic representation of the human ILIA and ILIB genes
5’
The position o f the following biallelic polymorphisms are illustrated: ILIA  -8 8 9  
(NcoY) (Tarlow et al., 1993); IL IB  -511 (Aval) (di Giovine et al., 1992); IIIB  +3953 
(Taql) (Pociot et al., 1992). In addition a polymorphism due to a variable num ber o f 
the 46 bp tandem repeat ( VNTR) within intron six o f ILIA  is also illustrated (Bailly et 
al., 1993)
Intron I Exon Untranslated exon
Adapted from Nicklin et al. (1994), Furutani et al. (1986) and Bensi et al. (1987).
repeats {VNTR) (section 5.4.1) in the sixth intron of the ILIA gene and the second 
intron of the IL1RN gene and a further bi-allelic polymorphism in the fifth exon of the 
IL IB  gene {ILIB +3953) have been described (Pociot et al., 1992; Tarlow et al., 1993; 
Bailly et al., 1993). Allele two of ILIB +3953 has been associated with significantly 
higher secretion of IL-1 p in  individuals homozygous for this allele (Pociot et al., 
1992). Associations have also been found between specific alleles of these 
polymorphisms and a number of chronic inflammatory diseases (Pociot et al., 1992; 
Mansfield et al., 1994; Blakemore et al., 1994; McDowell et al., 1995). In one study 
of inflammatory bowel disease, a significantly higher frequency of allele two of the 
VNTR in the second intron of IL1RN together with allele one of ILIB +3953 was found 
in patients with both ulcerative colitis and Crohn’s disease (Bioque et al., 1995). More 
recently, it has been suggested that these polymorphisms may be markers of disease 
severity rather than susceptibility (Nemetz et al., 1999; Jouvenne et al., 1999; 
Schrijver et al., 1999).
A recent paper has indicated an association between a composite genotype of allele 2 
of the ILIB +3953 gene and allele 2 of the ILIA -889  gene and the severe form of AP 
(Komman et al., 1997). The patients in this study were Caucasian and of north 
European origin. The association was only found in non-smokers. The aim of the 
present study was to investigate the ILIA -889  (McDowell et al., 1995) and ILIB  
+3953 (Pociot et al., 1992) polymorphisms in Caucasian EOP patients.
A1.2 Materials and Methods
A l .2.1 Patient Selection
Fifty-six patients were recruited to this study based on the criteria described previously 
(section 2.3.1). There were seven patients recruited to the study who were over the 
age of 35 years when they presented in the periodontal department of Glasgow Dental 
Hospital and School. The inclusion criteria were as described in section 3.2.1.
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A l .2.2 Control Group
The control group included 56 volunteers from the staff of Glasgow Dental Hospital 
with no evidence of GEOP. The same selection criteria were applied as described in 
section 3.2.2. Demographic data for the patient and control groups are presented in 
Table A l.l.
Al.2.3 DNA Purification
DNA separation was performed as described in section 3.2.3. DNA integrity was 
checked and DNA quantitated using agarose gel electrophoresis as previously 
described (sections 2.3.5 and 3.2.3).
A l .2.4 Screening of Subjects for the ILIA and ILIB  Polymorphisms 
Al.2.4.1 PCR
For the PCR reactions the following synthetic specific oligonucleotide primers were 
used (Komman et al., 1997):
ILIA -899 primer 1: 5’-AAG.CTT.GTT.CTA.CCA.CCT.GAA.CTA.GGC-3’
primer 2: 5’-TTA.CAT.ATG.AGC.CTT.CCA.TG-3’; both at a
concentration of 0.6pm.
ILIB  +3953 primer 1: 5,-CTC.AGG.TGT.CCT.CGA.AGA.AAT.CAA.A-3,
primer 2: 5’-GCT.TTT.TTG.CTG.TGA.GTC.CCG-3’; both at a
concentration of 0.2pm.
A master mix containing all the reagents minus the sample DNA was set up on ice. 
The upper master mix contained the primers. The total volume of each reaction was 
lOOpl. The contents of the lower master mixes are shown in Table A1.2. One 
microlitre of sample DNA was added to the upper layer of each reaction. The details 
of “hot start” PCR have been described previously (section 3.2.4.1). The 
thermocycling conditions were as follows:
ILIA: An initial denaturation step at 94°C for five minutes was followed by 45 cycles 
of denaturation at 94°C for one minute, annealing of primers at 50°C for one minute
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Table A l.l  Demographic data for analysis of IL1 polymorphisms
Total" Male3 Female3 Smokers3 Non-smokers3 Mean ageb
Patients
Controls
56 (100) 
56(100)
23 (41) 
23 (41)
33 (59) 
33 (59)
27 (48) 
16(29)
29 (52) 
40 (71)
31.36(16-40) 
34.39 (21-61)
a Numbers of individuals in each group; percentages in parentheses. 
b Mean age and range in parentheses, in years.
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Table A1.2 Lower master mixes
1. Lower master mix ILIA -889
Reaction Component Concentration 
in final volume
Vol per 100 pi 
(per reaction)
Mg Free Buffer (lOx) l x 10.0 pi
50mM MgCl2 ImM 2.0 pi
Dynazyme/Taq
polymerase
2 units 0.4 pi
dNTPs (20mM) 0.2mM 1.0 pi
m b g h 2o -- 36.6 pi
2. Lower master mix IL1B +3953
Reaction Component Concentration 
in final volume
Vol per 100 pi 
(per reaction)
PCR Buffer (lOx) 1 X 10.0 pi
50mM MgCl2 ImM 2.0 pi
Dynazyme/Taq
polymerase
2 units 0.4 pi
dNTPs (20mM) 0.2mM 1.0 pi
m b g h 2o — 36.6 pi
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and primer extension at 72°C for one minute. A final extension step at 72°C for 10 
minutes completed the cycling.
IL1B : Two cycles of denaturation at 95°C for two minutes, annealing of primers at 
67.5°C for one minute and extension at 74°C for one minute was followed by 35 cycles 
at 95°C for one minute, 67.5°C for one minute and 74°C for one minute. Finally three 
cycles of 95°C for one minute, 67.5°C for one minute and 74°C for five minutes 
completed the reaction.
The outcome of each PCR was confirmed by electrophoresis on a 2% agarose gel as 
described in section 3.2.4.1.
A1.2.4.2 Purification of PCR products
The DNA was precipitated as described previously in section 3.2.4.2.
A1.2.4.3 Restriction endonuclease digestion of PCR products
ILIA: Amplified DNA was digested with Ncol in a volume of 20 pi. Six microlitres 
of sample DNA were added to the digestion mixture which comprised 2 pi of 
recommended lOx restriction enzyme buffer (supplied by the enzyme manufacturer), 
0.4 pi Ncol (10 units/pl), 0.4 pi 2mM spermidine and MBG water to 20 pi. Digestion 
reactions were thoroughly vortex-mixed and incubated at 37°C for a minimum of three 
hours.
IL1B: Amplified DNA was digested with Taql in a volume of 20 pi. Six microlitres 
of sample DNA were added to the digestion mixture which comprised 2 pi of 
recommended lOx restriction enzyme buffer (supplied by the enzyme manufacturer), 
1.0 pi Taql (10 units/pl), 0.4 pi 2mM spermidine and MBG water to 20 pi. Digestion 
reactions were thoroughly vortex-mixed and incubated at 65°C for a minimum of three 
hours.
The digested ILIA and IL1B products were subjected to electrophoresis on 4.0 % 
agarose gels as described previously (section 2.3.5).
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A l.2.4.4 Contamination controls
The same protocol was applied to the PCR and post-PCR procedures as described in 
section 3.2.4.4.
Al.2.5 Statistical Analysis
Statistical analysis was performed using the CLUMP programme devised by Sham and 
Curtis (1995) (section 4.2.6). This programme was used so that the three genotype 
frequencies (1/1 homozygotes, heterozygotes and 2/2 homozygotes) as well as 
individual allele frequencies could be analysed at the same time.
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Table A1.3 Stock solutions and buffers
The stock solutions and buffers were as previously described in Chapters Two and 
Three with the addition of:
Mg Free Buffer
lOmM Tris HC1 
50mM KC1 
0.1% Triton®X-100 
50mM M gCl2
Diluted to desired concentration in reaction mixture (l.OmM).
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A1.3 Results
A 1.3.1 Purified Genomic DNA
DNA integrity was tested as previously described (section 3.3.1, Figure 3.2).
Al.3.2 PCR Products
To confirm amplification of the 99bp {ILIA -889) and 194bp {IL1B +3953) products, 
samples were run on 2.0 % agarose gels. A 100-bp marker was used to verify the size 
of the products.
A1.3.3 Digestion of PCR Products
In order to investigate the frequency of alleles of the ILIA -889 and IL1B +3953 
polymorphisms, in patients and controls, digested PCR products were run on 4.0 % 
agarose gels. Figures A1.2 and A1.3 show photographs of typical gels. Fragments of 
99 bp (allele 2) and approximately 83 bp (allele 1) are seen for patients and controls 
heterozygous for ILIA -889. For the IL1B +3953 polymorphism fragments of 182 bp 
(allele 2) and 97 and 85 bp (allele 1) are visible for heterozygotes. In this study, the 
expected 16 bp {ILIA -889) and 12 bp {IL1B +3953) fragments described by Komman 
et al. (1997) were not seen, probably because of the small size of the fragments.
The frequencies of the ILIA -889  and ILIB +3953 genotypes and alleles in GEOP 
patients and controls are presented in Tables A 1.4 and A 1.5. Data for smokers is 
shown separately from non-smokers. The IL1A2 carriage rate for the control 
population was 57.1%. This is higher than other published reports where carriage rates 
of 48.5% and 45.7% were found (McDowell et al., 1995; Jouvenne et al., 1999). The 
ILIB +3953 genotype and allele frequencies were similar to those previously published 
(Pociot et al., 1992; Bioque et al., 1995; Hacker et al., 1999). No statistically significant 
differences were found between patients and controls for any of the genotype or allele 
frequencies investigated (p = 1.0). When smoking status was included in the analysis as
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Figure A1.2 4.0% agarose gel showing digested ILIA products.
1 2 3 4 5 6  7 8 M
Lanes 1, 3-6 and 8 show fragments o f approximately 99- and 83 bp (heterozygous). Lane 2 
shows a fragment o f 83 bp resulting from complete digestion (homozygous for allele 1). 
Lane 7 shows undigested product o f 99 bp (homozygous for allele 2). M = 100 bp marker. 
The expected 16 bp fragment is not visible on the gel due to its small size.
Figure A1.3 4.0% agarose gel showing digested ILIB products.
1 2 3 4  5 6  7 8  9 M
Lanes 1-3 and 6 show fragments o f approximately 182-, 97- and 85 bp (heterozygous). 
Lane 4, 5 and 7-9 show fragments o f 97- and 85 bp resulting from complete digestion 
(homozygous for allele 1). None o f the samples shown are homozygous for allele 2, for 
which a fragment o f 182 bp would be visible. M = 100 bp marker. The expected 12 bp 
fragment is not visible on the gel due to its small size.
Table A1.4 Frequency of ILIA -  889 genotype and alleles in GEOP patients and
controls
Genotype Patients n (%) Controls n (%)
27 [S] 29 [NS] 56 [T] 16 [S] 40 [NS] 56 [T]
1/1 12 (44.4) 12(41.4) 24 (42.9) 7 (43.7) 17 (42.5) 24 (42.9)
2/1 15 (55.6) 11 (37.9) 26 (46.4) 8(50) 17(42.5) 25 (44.6)
2/2 0(0) 6 (20.7) 6(10.7) 1 (6.3) 6(15) 7(12.5)
Alleles 54 58 112 32 80 112
1 39 (72.2) 35 (60.3) 74 (66.1) 22 (68.8) 51 (63.75) 73 (65.2)
2 15 (27.8) 23 (39.7) 38 (33.9) 10(31.2) 29 (36.25) 39 (34.8)
Table A1.5 Frequency of I L I B  + 3953 genotype and alleles in GEOP patients 
and controls
Genotype Patients n (%) Controls n (%)
27 [S] 29 [NS] 56 [T] 16 [S] 40 [NS] 56 [T]
1/1 14(51.9) 14 (48.3) 28 (50) 10(62.5) 18(45) 28 (50)
2/1 11 (40.7) 10(34.5) 21 (37.5) 4(25) 17(42.5) 21 (37.5)
2/2 2 (7.4) 5 (17.2) 7(12.5) 2(12.5) 5 (12.5) 7 (12.5)
Alleles 54 58 112 32 80 112
1 39 (72.2) 38 (65.5) 77 (68.8) 24 (75) 53 (66.2) 77 (68.8)
2 15 (27.8) 20 (34.5) 35 (31.2) 8(25) 27 (33.8) 35 (31.2)
S = smokers, NS = non-smokers, T = total, n = number in each group.
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a covariate there was still no significant difference between the patient and control 
groups (p > 0.5).
The composite genotype (IL1A2/  IL1B2) described by Komman et al. (1997) was also 
investigated in this group of GEOP patients (Table A1.6). No significant differences 
were found between patients and controls whether smoking was included as a 
covariate or not (p > 0.51).
A1.4 Discussion
No association was found between GEOP and either ILIA -889  or ILIB +3953 in this 
study of north European Caucasians. The association previously found by Komman et 
al. (IL1A2/IL1B2) in AP patients only occurred in non-smokers (Komman et al., 
1997). Those non-smokers who were positive for the composite genotype had the 
same risk of disease as smokers who were either genotype-positive or genotype- 
negative. Smoking has been identified as the major environmental risk factor 
associated with increased incidence and severity of periodontitis (Grossi et al., 1994; 
1995; Page and Beck, 1997). In the study of Komman et al. (1997) there were only 18 
patients in the severe non-smoking group and although the odds ratio between severe 
versus mild AP was large (18.90), the confidence intervals were very wide (1.04- 
343.05). It is possible that this finding occurred by chance following multiple 
comparisons. In addition to the polymorphisms already mentioned, ILIB -511 (di 
Giovine et al., 1992), IL1RN VNTR (intron 2) (Tarlow et al., 1993) and TNFA (tumour 
necrosis factor alpha)-308 (Wilson et al., 1992) were also investigated. No 
associations were found between AP and any of these alleles.
Another recent report of a population of Caucasian AP patients, found an association 
between allele 2 of the ILIB +3953 gene and advanced periodontitis. This genotype 
occurred more frequently in patients with advanced disease, when compared to 
patients with either mild or moderate disease (Gore et al., 1998). However, there was 
no significant difference between the advanced group and the healthy control group 
with regard to this allele. No associations were found between the ILIA -889 gene and 
any of the disease categories or between patients and healthy controls. Furthermore,
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Table A1.6 Frequency of composite IL1A2 /IL1B2 genotype in patients and
controls
Genotype Patients n (%) Controls n (%)
27 [S] 29 [NS] 56 [T] 16 [S] 40 [NS] 56 [T]
+ 12 (44.4) 14(48.3) 26(46.4) 5(31.2) 21(52.5) 26 (46.4)
15(55.6) 15 (51.7) 30(53.6) 11 (68.8) 19(47.5) 30 (53.6)
2 6 1
an investigation of the composite genotype (Komman et al., 1997) demonstrated a 
very significant association (p = 0.002, 2-tail Fisher’s exact test) between this 
genotype and both patient and control groups. These findings are difficult to interpret 
but do appear to bring into question the results of the earlier study (Komman et al., 
1997). However, the findings of the more recent study should also be treated with 
caution, as the numbers of individuals in the different categories of disease severity 
were small (n = 10 for mild, 10 for moderate, 12 for severe). Because of the small size 
o f the groups, no analysis of the contribution of smoking as a confounding variable 
could be carried out (Gore et al., 1998).
A recent study in North America found very significant evidence of linkage 
disequilibrium between allele one of the ILIA gene and allele one of the ILIB  gene and 
GEOP (Diehl et al., 1999). A number of multiplex families were used to investigate 
these candidate genes in EOP. In this report, both the transmission disequilibrium test 
(TDT) and the affected sib pair design were used to examine the association between 
the two IL1 polymorphisms. The TDT test compares the number of transmissions of 
specific alleles from heterozygous parents to affected offspring. For GEOP subjects 
allele one of the ILIA -889  polymorphism was transmitted significantly more 
frequently than allele two (p = 0.0065). There were seventeen transmissions of allele 
one of the ILIB +3953 gene and only two transmissions of allele two (p = 0.0005). 
Similar but non-significant trends were found for LEOP. Associations were observed 
in both smokers and non-smokers. The homozygous (1,1) ILIB +3953 genotype was 
also transmitted significantly more often to GEOP affected individuals than to 
unaffected subjects (p = 0.014). These findings were consistent in both African 
Americans and Caucasians, although the numbers in some categories were small. 
Further analyses revealed that the transmission disequilibrium is more strongly 
associated with the ILIB +3953 polymorphism. These results provide evidence that 
the ILIB +3953 polymorphism (allele one) may be in linkage disequilbrium with one 
EOP gene. Results from the affected sib pair analysis were less compelling. The 
finding of an association between allele one of ILIA -889  and ILIB +3953 and GEOP 
(Diehl et al., 1999) is diametrically opposed to the increased frequency of the 
combined IL1A2/IL1B2 reported previously in severe AP patients (Komman et al.,
1997). This observation may be due to differences between diagnostic groups. 
Another possibility is that both reported associations are false positives due to chance
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deviations in the populations studied. The study reported here has failed to find an 
association with any allele or combination of alleles of these polymorphisms and 
GEOP. However, using the TDT to investigate associations between candidate genes 
and complex multifactorial diseases such as periodontitis is much more likely to 
uncover genetic markers. This method which uses family data eliminates the problem 
of matching cases and controls. In addition, the possibility of aggregation in families 
being due to a shared family environment, such as diet, oral hygiene or transmission of 
virulent strains of bacteria, is eliminated by the TDT.
As previously mentioned the IL1A2 allele carriage rate was higher in the control 
population presented here than in other published reports (McDowell et al., 1995; 
Jouvenne et al., 1999). This may be due to variation between different populations. It 
is also possible that the high level of oral hygiene of the control population used in this 
study may have masked any genetic predisposition to periodontitis. However, since 
the frequency of GEOP in the general population is in the region of 0.3% (Oliver et al.,
1998) it seems unlikely that the selection of the control population would have affected 
the results.
Two research groups have recently investigated the prognostic value of the composite 
IL1 genotype (Komman et al., 1997) in AP patients (McGuire and Nunn, 1999; Ehmke 
et al., 1999). The first study assessed the effectiveness of clinical parameters and IL1 
genotype in predicting prognosis and tooth survival in 42 Caucasian patients on 
maintenance therapy for 14 years (McGuire and Nunn, 1999). The results showed that 
the IL1 haplotype increased the risk of tooth loss by 2.7-fold and heavy smoking (> 40 
pack years) by 2.9-fold. The combined effect of genotype and heavy smoking 
increased the risk of tooth loss by 7.7-fold. These findings should be treated with 
caution since analysis was performed on a site rather than a patient basis. Of the 47 
teeth lost because of periodontal disease, 27 were in genotype-positive individuals. It 
is possible that most of these teeth were extracted from one or two patients.
A subsequent study assessed the prognostic value of the IL1 genotype on the 
progression of AP following non-surgical treatment (Ehmke et al., 1999). Of 33 
patients tested, 16 were genotype-positive. Following two years of maintenance care, 
no differences in the survival rate of teeth nor in sites exhibiting probing attachment 
loss of 2 mm or more were detected between subjects who carried the genotype and
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those who did not. Further research is required in order to discover whether this 
genotype has a role to play in determining the outcome of the disease process in 
periodontitis.
In conclusion, no association was found between GEOP and the IL1 polymorphisms 
investigated in the population presented here. The findings of this study and the other 
European study (Ehmke et al., 1999) bring into doubt the usefulness of these candidate 
genes as markers of susceptibility to periodontitis. Alternatively ILIA -889  and ILIB  
+3953 may play only a small part in determining the level of the immune response in 
EOP. Therefore, investigating candidate genes such as these in moderately sized 
groups of unrelated patients and controls may not uncover associations which do in 
fact exist.
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Appendix 2 DNA Analysis of IL1 Polymorphisms in a 
Large Caucasian Family with Generalised Early 
Onset Periodontitis
A2.1 Introduction
The results of disequilibrium analysis of the ILIA -889  (McDowell et al., 1995) and 
ILIB  +3953 (Pociot et al., 1992) polymorphisms in a Caucasian population of 
unrelated patients with GEOP and a control group was presented in Appendix One. 
No associations were found between any allele individually or any combination of 
alleles (Hodge et al., 1999). It has been suggested that associations between candidate 
genes and diseases may be masked in large unrelated populations because cases and 
controls are not genetically homogeneous.
A study of a large Scottish Caucasian family with a high proportion of individuals 
affected by GEOP was presented in Chapter Five. The kindred was found to be 
suitable for linkage analysis. It is suggested that investigating the ILIA -889  and ILIB  
+3953 polymorphisms in this large family with GEOP may uncover associations 
which were hidden in the earlier study of unrelated patients and controls (Hodge et al.,
1999). The aim of this study was to test this hypothesis.
A2.2 Materials and Methods
A2.2.1 The Large Kindred
The method of diagnosis of the proband and relatives of the proband has been 
described in sections 5.2.1, 5.2.2 and 2.3.1. Three categories were defined according 
to reliability of diagnosis of EOP. The extent and severity of disease for age were also 
taken into consideration. The categories were “definitely”, “probably” and “possibly” 
affected. Figure A2.1 briefly summarises the process of diagnosis. A pedigree of the 
large family is shown in Figure A2.2.
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Figure A2.1 Flow diagram for diagnosis of EOP relatives
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A2.2.2 DNA Purification
DNA separation was performed as described in section 3.2.3. DNA integrity was 
checked and DNA quantitated using agarose gel electrophoresis as previously 
described (sections 2.3.5 and 3.2.3).
A2.2.3 Screening of Relatives for the ILIA and ILIB  Polymorphisms
The screening of relatives for the ILIA -889 and ILIB +3953 polymorphisms was 
previously described in section Al.2.4.
A2.2.4 Statistical Analysis
The program Mlink, part of the Fastlink version of the LINKAGE package (Lathrop et 
al., 1984; Lathrop and Lalouel, 1984; Lathrop et al., 1986), was used to investigate the 
presence of linkage between the IL1 polymorphisms and a GEOP susceptibility gene 
in the large family. Linkage is the association within families of two or more non-allelic 
genes resulting from their proximity on the same chromosome. This program calculates 
the lod score for each polymorphism for a set of recombination fractions. 
Recombination is the formation of new combinations of linked genes by crossing over 
between loci. The recombination fraction (0) is the fraction of meiotic events that 
show a recombination between two loci. The lod score is a base 10 logarithm of the 
odds favouring linkage. A lod score of +3 (1000:1 odds) is taken as proof of linkage; a 
score of -2 (100:1 odds against) indicates no linkage.
In order to carry out linkage analysis of these candidate genes as possible markers for 
EOP the allele frequencies of the control population presented in Table A1.4 and A1.5 
were required. The model assumed 75% penetrance up to 25 years of age and 97% 
thereafter. Penetrance is the observable expression of the mutant gene. A phenocopy 
rate of 3% was used in the analysis. The population prevalence of GEOP was set at 
0.3% (Oliver et al., 1998). This gave an allele frequency of 0.15%.
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A2.3 Results
A2.3.1 Digested PCR Products
Digestion of the ILIA  and ILIB  PCR products has been previously described in section 
Al.3.3. The results of the genotyping of these polymorphisms for the large family are 
illustrated in Figure A2.2. Almost all of the relatives who had blood samples available 
for analysis carried the homozygous 1/1 genotype for both polymorphisms. Two family 
members (11:9 and 111:14) were heterozygous for ILIA -899 and two (11:9 and 111:20) 
were heterozygous for ILIB +3953. Because of the high degree of homozygosity for 
alleles of ILIA -899 and ILIB +3953 in this family it was not informative for linkage
A2.3.2 Statistical Analysis
The results of the linkage analysis are presented in Table A2.1. It can be seen that the 
data provide very little information about linkage to either marker. Since nearly all 
members typed are homozygous for allele one of ILIA  and ILIB  it is not possible to 
detect whether recombination has taken place. The affected members are unlikely to 
be homozygous for the disease, yet they have the double A l.l /B l . l  haplotype. 
Considering the high frequency of allele one of ILIA and ILIB  in the general 
population, and the closeness of the ILIA and ILIB  markers, it is not surprising that the 
A1B1/A1B1 genotype should appear in incoming parents as well. Where it is 
detectable, there is evidence of recombination either between the disease gene and 
ILIA  or between ILIA and ILIB.
A2.4 Discussion
No association was found between GEOP and either ILIA -889  or ILIB +3953 in this 
family study of north European Caucasians. The results of the linkage analysis 
presented in Table A2.1 indicate that this family is uninformative for linkage of these 
IL1 genes. A lod score of +3 is taken as proof of linkage and a score of -2 indicates no 
linkage. It can be seen from the data presented in Table A2.1 that the lod scores range 
from 0.1 to 0.01 for the IL1 polymorphisms when tested over a range of recombination 
fractions from 0.0 to 0.4.
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Table A2.1 Lod scores for two point analyses of the I L I A  -8 8 9  and I L I B  +3953 
polymorphisms and a mutant EOP gene in the large pedigree
Recombination
fraction
ILIA -889 ILIB +3953
0.0 0.08 0.10
0.01 0.08 0.09
0.05 0.07 0.08
0.1 0.06 0.07
0.2 0.04 0.04
0.3 0.02 0.02
0.4 0.01 0.01
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The finding of an association between allele one of ILIA -889  and ILIB +3953 and 
GEOP in a study of 35 multiplex families in North America has been discussed in 
section A 1.4 (Diehl et al., 1999). It is possible that the present study failed to find an 
association because of the heterogeneous nature of EOP. Different families may carry 
different susceptibility genes. In addition the lack of heterozygosity among generation 
II of the large family precluded the use of the TDT. There was a high prevalence of 
the homozygous (1/1) genotype for ILIA -889 and ILIB +3953 among both affected 
and unaffected family members (Figure A2.2).
In conclusion, the analysis of this large kindred failed to either confirm or reject an 
association between the ILIA -889  and ILIB +3953 polymorphisms and GEOP. 
These results together with the findings of studies discussed previously (section A 1.4) 
bring into doubt the usefulness of these IL1 polymorphisms as markers of 
susceptibility to periodontitis at present. If they do play a small role in determining the 
level of the immune response, they may in the future be found to form part of an 
extended haplotype, which underlies a predisposition to this disease.
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Appendix 3 Pedigrees of Additional Families with Early 
Onset Peridontitis
A3.1 Introduction
The following appendix contains pedigrees of nuclear and multiplex families which 
were identified in the search for the large family presented in Chapter Five. The same 
system of diagnosis has been used for these pedigrees as is presented in section 5.2.1, 
5.2.2 and 2.3.1.
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